JPH0582400B2 - - Google Patents
Info
- Publication number
- JPH0582400B2 JPH0582400B2 JP85135217A JP13521785A JPH0582400B2 JP H0582400 B2 JPH0582400 B2 JP H0582400B2 JP 85135217 A JP85135217 A JP 85135217A JP 13521785 A JP13521785 A JP 13521785A JP H0582400 B2 JPH0582400 B2 JP H0582400B2
- Authority
- JP
- Japan
- Prior art keywords
- chain
- glycoprotein
- ricin
- aqueous solution
- periodate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 102000003886 Glycoproteins Human genes 0.000 claims abstract description 60
- 108090000288 Glycoproteins Proteins 0.000 claims abstract description 60
- 108010039491 Ricin Proteins 0.000 claims abstract description 56
- 238000007254 oxidation reaction Methods 0.000 claims abstract description 45
- 230000003647 oxidation Effects 0.000 claims abstract description 37
- -1 periodate ions Chemical class 0.000 claims abstract description 17
- 230000000259 anti-tumor effect Effects 0.000 claims abstract description 13
- 210000003705 ribosome Anatomy 0.000 claims abstract description 12
- 239000000243 solution Substances 0.000 claims description 60
- 210000004027 cell Anatomy 0.000 claims description 49
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 claims description 36
- 108700004714 Gelonium multiflorum GEL Proteins 0.000 claims description 31
- 238000006243 chemical reaction Methods 0.000 claims description 25
- 239000007864 aqueous solution Substances 0.000 claims description 22
- 125000003396 thiol group Chemical group [H]S* 0.000 claims description 22
- 230000000694 effects Effects 0.000 claims description 18
- DGVVWUTYPXICAM-UHFFFAOYSA-N βâMercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 claims description 15
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 10
- 239000004472 Lysine Substances 0.000 claims description 10
- 238000004519 manufacturing process Methods 0.000 claims description 9
- 238000007069 methylation reaction Methods 0.000 claims description 4
- 235000000346 sugar Nutrition 0.000 claims description 4
- 244000003416 Asparagus officinalis Species 0.000 claims description 3
- 235000005340 Asparagus officinalis Nutrition 0.000 claims description 3
- 229910052783 alkali metal Inorganic materials 0.000 claims description 3
- 230000000415 inactivating effect Effects 0.000 claims description 2
- 239000003112 inhibitor Substances 0.000 claims description 2
- 230000011987 methylation Effects 0.000 claims description 2
- 239000012634 fragment Substances 0.000 claims 4
- 102100041033 Golgin subfamily B member 1 Human genes 0.000 claims 2
- 108010053687 macrogolgin Proteins 0.000 claims 2
- 230000002035 prolonged effect Effects 0.000 claims 2
- 125000006239 protecting group Chemical group 0.000 claims 2
- XJPVMJZUYFERAR-UHFFFAOYSA-N [O-]C(C1=CC=CC(S[S+](C(C=C2C(O)=O)=CC=C2[N+]([O-])=O)[N+]([O-])=O)=C1)=O Chemical compound [O-]C(C1=CC=CC(S[S+](C(C=C2C(O)=O)=CC=C2[N+]([O-])=O)[N+]([O-])=O)=C1)=O XJPVMJZUYFERAR-UHFFFAOYSA-N 0.000 claims 1
- 238000002955 isolation Methods 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 52
- 125000000837 carbohydrate group Chemical group 0.000 abstract description 17
- KHIWWQKSHDUIBK-UHFFFAOYSA-M periodate Chemical compound [O-]I(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-M 0.000 abstract description 3
- 230000008569 process Effects 0.000 abstract description 2
- 239000002596 immunotoxin Substances 0.000 description 50
- 230000002637 immunotoxin Effects 0.000 description 50
- 231100000608 immunotoxin Toxicity 0.000 description 50
- 229940051026 immunotoxin Drugs 0.000 description 50
- 244000302512 Momordica charantia Species 0.000 description 34
- 235000009811 Momordica charantia Nutrition 0.000 description 34
- HDFGOPSGAURCEO-UHFFFAOYSA-N N-ethylmaleimide Chemical compound CCN1C(=O)C=CC1=O HDFGOPSGAURCEO-UHFFFAOYSA-N 0.000 description 31
- 239000008363 phosphate buffer Substances 0.000 description 26
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 21
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 description 21
- 239000000872 buffer Substances 0.000 description 20
- KIUMMUBSPKGMOY-UHFFFAOYSA-N 3,3'-Dithiobis(6-nitrobenzoic acid) Chemical compound C1=C([N+]([O-])=O)C(C(=O)O)=CC(SSC=2C=C(C(=CC=2)[N+]([O-])=O)C(O)=O)=C1 KIUMMUBSPKGMOY-UHFFFAOYSA-N 0.000 description 18
- 238000000502 dialysis Methods 0.000 description 18
- 230000036470 plasma concentration Effects 0.000 description 18
- 238000012360 testing method Methods 0.000 description 16
- 241000283973 Oryctolagus cuniculus Species 0.000 description 13
- 230000008034 disappearance Effects 0.000 description 13
- 230000004048 modification Effects 0.000 description 13
- 238000012986 modification Methods 0.000 description 13
- 238000002360 preparation method Methods 0.000 description 13
- 238000005859 coupling reaction Methods 0.000 description 12
- 238000002347 injection Methods 0.000 description 11
- 239000007924 injection Substances 0.000 description 11
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- 230000008878 coupling Effects 0.000 description 10
- 238000010168 coupling process Methods 0.000 description 10
- 239000000203 mixture Substances 0.000 description 10
- 238000001243 protein synthesis Methods 0.000 description 10
- 102000004169 proteins and genes Human genes 0.000 description 10
- 108090000623 proteins and genes Proteins 0.000 description 10
- 230000014616 translation Effects 0.000 description 10
- DOSMHBDKKKMIEF-UHFFFAOYSA-N 2-[3-(diethylamino)-6-diethylazaniumylidenexanthen-9-yl]-5-[3-[3-[4-(1-methylindol-3-yl)-2,5-dioxopyrrol-3-yl]indol-1-yl]propylsulfamoyl]benzenesulfonate Chemical compound C1=CC(=[N+](CC)CC)C=C2OC3=CC(N(CC)CC)=CC=C3C(C=3C(=CC(=CC=3)S(=O)(=O)NCCCN3C4=CC=CC=C4C(C=4C(NC(=O)C=4C=4C5=CC=CC=C5N(C)C=4)=O)=C3)S([O-])(=O)=O)=C21 DOSMHBDKKKMIEF-UHFFFAOYSA-N 0.000 description 9
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- GHAZCVNUKKZTLG-UHFFFAOYSA-N N-ethyl-succinimide Natural products CCN1C(=O)CCC1=O GHAZCVNUKKZTLG-UHFFFAOYSA-N 0.000 description 9
- 102100036240 Regulating synaptic membrane exocytosis protein 1 Human genes 0.000 description 9
- 101710108510 Regulating synaptic membrane exocytosis protein 1 Proteins 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 9
- 239000008280 blood Substances 0.000 description 9
- 230000001472 cytotoxic effect Effects 0.000 description 9
- 241001465754 Metazoa Species 0.000 description 8
- 230000003013 cytotoxicity Effects 0.000 description 8
- 231100000135 cytotoxicity Toxicity 0.000 description 8
- 230000007423 decrease Effects 0.000 description 8
- 125000002228 disulfide group Chemical group 0.000 description 8
- 230000002401 inhibitory effect Effects 0.000 description 8
- 238000010253 intravenous injection Methods 0.000 description 8
- 239000000427 antigen Substances 0.000 description 7
- 108091007433 antigens Proteins 0.000 description 7
- 102000036639 antigens Human genes 0.000 description 7
- 230000000903 blocking effect Effects 0.000 description 7
- 238000005119 centrifugation Methods 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 6
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 6
- 230000037396 body weight Effects 0.000 description 6
- 238000010367 cloning Methods 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 230000002829 reductive effect Effects 0.000 description 6
- 239000007858 starting material Substances 0.000 description 6
- 229920001817 Agar Polymers 0.000 description 5
- 240000007711 Peperomia pellucida Species 0.000 description 5
- 210000001744 T-lymphocyte Anatomy 0.000 description 5
- 239000008272 agar Substances 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 5
- 230000004071 biological effect Effects 0.000 description 5
- 210000004204 blood vessel Anatomy 0.000 description 5
- 230000002255 enzymatic effect Effects 0.000 description 5
- 125000000524 functional group Chemical group 0.000 description 5
- 150000004676 glycans Polymers 0.000 description 5
- 125000000311 mannosyl group Chemical group C1([C@@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 230000002688 persistence Effects 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 150000003573 thiols Chemical group 0.000 description 5
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 4
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 4
- 238000001042 affinity chromatography Methods 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 231100000599 cytotoxic agent Toxicity 0.000 description 4
- 239000002619 cytotoxin Substances 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 238000001962 electrophoresis Methods 0.000 description 4
- 238000003018 immunoassay Methods 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 238000012423 maintenance Methods 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- 150000004804 polysaccharides Polymers 0.000 description 4
- 239000012460 protein solution Substances 0.000 description 4
- 239000012279 sodium borohydride Substances 0.000 description 4
- 229910000033 sodium borohydride Inorganic materials 0.000 description 4
- 230000001988 toxicity Effects 0.000 description 4
- 231100000419 toxicity Toxicity 0.000 description 4
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 3
- 101710112752 Cytotoxin Proteins 0.000 description 3
- 240000006497 Dianthus caryophyllus Species 0.000 description 3
- 235000009355 Dianthus caryophyllus Nutrition 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- 235000019270 ammonium chloride Nutrition 0.000 description 3
- 229940098773 bovine serum albumin Drugs 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- VDQQXEISLMTGAB-UHFFFAOYSA-N chloramine T Chemical compound [Na+].CC1=CC=C(S(=O)(=O)[N-]Cl)C=C1 VDQQXEISLMTGAB-UHFFFAOYSA-N 0.000 description 3
- 231100000433 cytotoxic Toxicity 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 229930191339 dianthin Natural products 0.000 description 3
- 230000008030 elimination Effects 0.000 description 3
- 238000003379 elimination reaction Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 229960002897 heparin Drugs 0.000 description 3
- 229920000669 heparin Polymers 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 230000007688 immunotoxicity Effects 0.000 description 3
- 231100000386 immunotoxicity Toxicity 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 3
- 239000010452 phosphate Substances 0.000 description 3
- 238000003127 radioimmunoassay Methods 0.000 description 3
- 239000012429 reaction media Substances 0.000 description 3
- 230000000717 retained effect Effects 0.000 description 3
- 230000007017 scission Effects 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 108010050014 systemin Proteins 0.000 description 3
- HOWHQWFXSLOJEF-MGZLOUMQSA-N systemin Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)OC(=O)[C@@H]1CCCN1C(=O)[C@H]1N(C(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H]2N(CCC2)C(=O)[C@H]2N(CCC2)C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)CCC1 HOWHQWFXSLOJEF-MGZLOUMQSA-N 0.000 description 3
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 2
- 239000012980 RPMI-1640 medium Substances 0.000 description 2
- 102100036261 Regulating synaptic membrane exocytosis protein 3 Human genes 0.000 description 2
- 101710108506 Regulating synaptic membrane exocytosis protein 3 Proteins 0.000 description 2
- 229920005654 Sephadex Polymers 0.000 description 2
- 239000012507 Sephadex⢠Substances 0.000 description 2
- 229920002684 Sepharose Polymers 0.000 description 2
- 241000221019 Suregada multiflora Species 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000002246 antineoplastic agent Substances 0.000 description 2
- 244000309466 calf Species 0.000 description 2
- 238000011088 calibration curve Methods 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003638 chemical reducing agent Substances 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 230000005757 colony formation Effects 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000021615 conjugation Effects 0.000 description 2
- 229940099500 cystamine Drugs 0.000 description 2
- 239000007857 degradation product Substances 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 210000003527 eukaryotic cell Anatomy 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- 210000003494 hepatocyte Anatomy 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 238000001155 isoelectric focusing Methods 0.000 description 2
- 230000005923 long-lasting effect Effects 0.000 description 2
- 230000000873 masking effect Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000000691 measurement method Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000002085 persistent effect Effects 0.000 description 2
- 239000008055 phosphate buffer solution Substances 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 230000002285 radioactive effect Effects 0.000 description 2
- 238000000163 radioactive labelling Methods 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 239000007790 solid phase Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 210000001768 subcellular fraction Anatomy 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- HBOMLICNUCNMMY-KJFJCRTCSA-N 1-[(4s,5s)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione Chemical compound O=C1NC(=O)C(C)=CN1C1O[C@H](CO)[C@@H](N=[N+]=[N-])C1 HBOMLICNUCNMMY-KJFJCRTCSA-N 0.000 description 1
- NULDEVQACXJZLL-UHFFFAOYSA-N 2-(2-aminoethyldisulfanyl)ethylazanium;chloride Chemical compound Cl.NCCSSCCN NULDEVQACXJZLL-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- DJBRKGZFUXKLKO-UHFFFAOYSA-N 3-(pyridin-2-yldisulfanyl)propanoic acid Chemical compound OC(=O)CCSSC1=CC=CC=N1 DJBRKGZFUXKLKO-UHFFFAOYSA-N 0.000 description 1
- GFUOAUHUTVPUIJ-UHFFFAOYSA-N 3-[(3-carboxyphenyl)disulfanyl]benzoic acid Chemical compound OC(=O)C1=CC=CC(SSC=2C=C(C=CC=2)C(O)=O)=C1 GFUOAUHUTVPUIJ-UHFFFAOYSA-N 0.000 description 1
- QFVHZQCOUORWEI-UHFFFAOYSA-N 4-[(4-anilino-5-sulfonaphthalen-1-yl)diazenyl]-5-hydroxynaphthalene-2,7-disulfonic acid Chemical compound C=12C(O)=CC(S(O)(=O)=O)=CC2=CC(S(O)(=O)=O)=CC=1N=NC(C1=CC=CC(=C11)S(O)(=O)=O)=CC=C1NC1=CC=CC=C1 QFVHZQCOUORWEI-UHFFFAOYSA-N 0.000 description 1
- YPXQSGWOGQPLQO-UHFFFAOYSA-N 5-nitro-1,3-dihydrobenzimidazole-2-thione Chemical compound [O-][N+](=O)C1=CC=C2N=C(S)NC2=C1 YPXQSGWOGQPLQO-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 240000000254 Agrostemma githago Species 0.000 description 1
- 235000009899 Agrostemma githago Nutrition 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 244000035744 Hura crepitans Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical group C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 229930191564 Monensin Natural products 0.000 description 1
- GAOZTHIDHYLHMS-UHFFFAOYSA-N Monensin A Natural products O1C(CC)(C2C(CC(O2)C2C(CC(C)C(O)(CO)O2)C)C)CCC1C(O1)(C)CCC21CC(O)C(C)C(C(C)C(OC)C(C)C(O)=O)O2 GAOZTHIDHYLHMS-UHFFFAOYSA-N 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000872931 Myoporum sandwicense Species 0.000 description 1
- BNSTVBLCTRZUDD-KEWYIRBNSA-N N-[(3R,4S,5S,6R)-2,3,4,5-tetrahydroxy-6-(hydroxymethyl)oxan-2-yl]acetamide Chemical group CC(=O)NC1(O)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O BNSTVBLCTRZUDD-KEWYIRBNSA-N 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical group CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- 125000000729 N-terminal amino-acid group Chemical group 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 1
- 102100036266 Regulating synaptic membrane exocytosis protein 2 Human genes 0.000 description 1
- 108050002620 Regulating synaptic membrane exocytosis protein 2 Proteins 0.000 description 1
- PNDPGZBMCMUPRI-XXSWNUTMSA-N [125I][125I] Chemical compound [125I][125I] PNDPGZBMCMUPRI-XXSWNUTMSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 239000002981 blocking agent Substances 0.000 description 1
- 238000010504 bond cleavage reaction Methods 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 150000001718 carbodiimides Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- OOTFVKOQINZBBF-UHFFFAOYSA-N cystamine Chemical compound CCSSCCN OOTFVKOQINZBBF-UHFFFAOYSA-N 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- YBGBJYVHJTVUSL-UHFFFAOYSA-L disodium;2-oxopentanedioate Chemical compound [Na+].[Na+].[O-]C(=O)CCC(=O)C([O-])=O YBGBJYVHJTVUSL-UHFFFAOYSA-L 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 229940043264 dodecyl sulfate Drugs 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- DANUORFCFTYTSZ-UHFFFAOYSA-N epinigericin Natural products O1C2(C(CC(C)(O2)C2OC(C)(CC2)C2C(CC(O2)C2C(CC(C)C(O)(CO)O2)C)C)C)C(C)C(OC)CC1CC1CCC(C)C(C(C)C(O)=O)O1 DANUORFCFTYTSZ-UHFFFAOYSA-N 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000010200 folin Substances 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 210000003168 insulating cell Anatomy 0.000 description 1
- 230000026045 iodination Effects 0.000 description 1
- 238000006192 iodination reaction Methods 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229940044173 iodine-125 Drugs 0.000 description 1
- 239000002555 ionophore Substances 0.000 description 1
- 230000000236 ionophoric effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 210000004324 lymphatic system Anatomy 0.000 description 1
- 229960003151 mercaptamine Drugs 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000003228 microsomal effect Effects 0.000 description 1
- 229960005358 monensin Drugs 0.000 description 1
- GAOZTHIDHYLHMS-KEOBGNEYSA-N monensin A Chemical compound C([C@@](O1)(C)[C@H]2CC[C@@](O2)(CC)[C@H]2[C@H](C[C@@H](O2)[C@@H]2[C@H](C[C@@H](C)[C@](O)(CO)O2)C)C)C[C@@]21C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H](OC)[C@H](C)C(O)=O)O2 GAOZTHIDHYLHMS-KEOBGNEYSA-N 0.000 description 1
- DANUORFCFTYTSZ-BIBFWWMMSA-N nigericin Chemical compound C([C@@H]1C[C@H]([C@H]([C@]2([C@@H](C[C@](C)(O2)C2O[C@@](C)(CC2)C2[C@H](CC(O2)[C@@H]2[C@H](C[C@@H](C)[C@](O)(CO)O2)C)C)C)O1)C)OC)[C@H]1CC[C@H](C)C([C@@H](C)C(O)=O)O1 DANUORFCFTYTSZ-BIBFWWMMSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 210000004197 pelvis Anatomy 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 230000006920 protein precipitation Effects 0.000 description 1
- WHMDPDGBKYUEMW-UHFFFAOYSA-N pyridine-2-thiol Chemical compound SC1=CC=CC=N1 WHMDPDGBKYUEMW-UHFFFAOYSA-N 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 239000000700 radioactive tracer Substances 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 108010066476 ribonuclease B Proteins 0.000 description 1
- 210000004708 ribosome subunit Anatomy 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- 229940001584 sodium metabisulfite Drugs 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- BUBOVHRAKJTFKI-UHFFFAOYSA-M sodium;4-hydroxy-2,4-dioxobutanoate Chemical compound [Na+].OC(=O)C(=O)CC([O-])=O BUBOVHRAKJTFKI-UHFFFAOYSA-M 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000723 toxicological property Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 125000000969 xylosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)CO1)* 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
- A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
- A61K47/6817—Toxins
- A61K47/6819—Plant toxins
- A61K47/6825—Ribosomal inhibitory proteins, i.e. RIP-I or RIP-II, e.g. Pap, gelonin or dianthin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
- A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
- A61K47/6817—Toxins
- A61K47/6819—Plant toxins
- A61K47/6825—Ribosomal inhibitory proteins, i.e. RIP-I or RIP-II, e.g. Pap, gelonin or dianthin
- A61K47/6827—Ricin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6889—Conjugates wherein the antibody being the modifying agent and wherein the linker, binder or spacer confers particular properties to the conjugates, e.g. peptidic enzyme-labile linkers or acid-labile linkers, providing for an acid-labile immuno conjugate wherein the drug may be released from its antibody conjugated part in an acidic, e.g. tumoural or environment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Toxicology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Botany (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Analytical Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Description
ãæè¡åéã
ãã®çºæã¯æ°èŠãªæè
«çæ§ç³ã¿ã³ãã¯è³ªïŒã°ãª
ã³ã¿ã³ãã¯è³ªïŒã«ä¿ãããç¹ã«ãã®çæ°Žåç©åäœ
ãéãšãŠçŽ é žå¡©ã€ãªã³ã§é žåã修食ãããç³ã¿ã³
ãã¯è³ªã«é¢ããã æ¬çºæã®æ°èŠãªç³ã¿ã³ãã¯è³ªã¯ãªããœãŒã ãäž
掻æ§åãããã€ãã®å¹èœãæç¶ããããšãç¹åŸŽãš
ããã ãåŸæ¥æè¡ã®èª¬æã ãã®ãªããœãŒã ãäžæŽ»æ§åããç³ã¿ã³ãã¯è³ªãš
ã¯ãªããœãŒã ãäžæŽ»æ§åããçæ žçŽ°èäžã§ã®ã¿ã³
ãã¯è³ªåæã劚害ãã巚倧ååã®ãµãã«ã©ã€ãå
äœãæããå šãŠã®ç©è³ªåã¯ãã®åç»ç©è³ªãæå³
ããããã倩ç¶ã®ãã®ãåã¯çåæããããã®
ã§ã现èã®éºäŒåããã®ç®çã®ããã«ä¿®é£Ÿããã
ãã®ã§ãã€ãŠããããããã«ãã®ã¢ããé žã®å®èœ
åºã修食ããæäœãšå®¹æã«çµåããããã«ããã
ã®ã§ãã€ãŠãããã ãã®ãªããœãŒã ãäžæŽ»æ§åããç³ã¿ã³ãã¯è³ªã
以äžâGPIRâãšèšå·åããŠç€ºãã ãã®æ现æžã«ãããŠãéãšãŠçŽ é žå¡©ã€ãªã³ãšã¯
IO4 -ã€ãªã³ãæå³ããããã«ã¡ã¿éãšãŠçŽ é žå¡©
ãåŒç§°ããããšãããã ãã®GPIRã¯æäœãšã®çµåã«ããå ç«æ¯çŽ ã補
é ããéã®äžéäœãšããŠç¹ã«æçšã§ããã ç±³åœç¹èš±No.4340535ããã©ã³ã¹ç¹èš±No.2504010ã
ãã³No.2516794ã«ã¯ã³ã³ãžãŠã²ãŒããšåŒã°ããæ
ã¬ã³å€ã®è£œé ã«ã€ããŠé瀺ããããããã¯ïŒéçµ
åã«ãããªã·ã³ã®ïŒ¡éããç Žå£ãããã¹ã现èã®
æåã«å¯Ÿããæäœåã¯ãã®åç»ãšçµåããããšã«
ããåŸããããšããŠããããã®çš®ã®çæç©ãæ¬æ
现æžã«ãããŠã¯äžè¬çã«å ç«æ¯çŽ ãšåŒã¶ã äžèšã®ãªã·ã³ïŒ¡éãæããå ç«æ¯çŽ ã«é¡äŒŒãã
ã³ã³ãžãŠã²ãŒãã§ãæã¬ã³å€ãšããŠé©åœãªç©è³ªã
ç¥ãããŠãããããã¯ïŒéçµåã«ããæäœåã¯æ
äœåç»ç©ãä»ã®ãªããœãŒã äžæŽ»æ§åç³ã¿ã³ãã¯
質ãããšãã°ã²ãããŠã ãã«ããããŒã©ã
ïŒGelonium multiflorumïŒãïŒEur.J.Biochem.ïŒ
1981ïŒ116ïŒ447â454ïŒCancer Res.ïŒ1984ïŒ44ïŒ
129â133ïŒãåã¯ã¢ã¢ã«ãã«ã«ã©ã³ãã¢
ïŒMomordica charantiaïŒïŒMOMïŒããæœåºã
ããææ¢äœïŒç±³åœç¹èš±No.4368149ïŒãšçµåããã
ãšã«ããåŸãããã ãããã®GPIRã¯ãªã·ã³ã®ïŒ¡éãšäŒŒãç¹æ§ãæ
ããååéã20000ãªãã30000çšåºŠã§ãã
ïŒCance SurveyïŒ1982ïŒïŒïŒ489â520ïŒã ãããã®å ç«æ¯çŽ ã®çŽ°èæ¯çŽ 掻æ§ãçš®ã ã®ã¢ãž
ãŠãã³ãç©è³ªãããšãã°ã¢ã³ã¢ããŠã å¡©ãã¢ã
ã³ããããã¯ã«ã«ããã·ã«ã€ãªãããªã¢ïŒããšã
ã°ã¢ãã³ã·ã³ããã³ãã²ãªã·ã³ïŒã§å¢åŒ·ãããã
ãšãã§ããããšãç¥ãããŠããã ããããå ç«æ¯çŽ ã®æ²»çå¹æã¯æŽ»æ§åãããŠã
ããåŠããåããããã®æäœéšåãä»ããŠç Žå£ã
ããã¹ãç®æšçŽ°èäžã«å±åšåãåŸãå Žåã«ã®ã¿å
åã«å¹æãçºæ®ãããã®ã§ããããã®å ç«æ¯çŽ ã
ãã®ç®æšçŽ°èäžã«å±åšåãåŸããåŠãã¯å ç«æ¯çŽ
ãè¡æµããã³çŽ°èå€æµäœå ã«ã掻æ§åç¶æ ã§ç®æš
现èã«å°éãåŸãæéããã³å¯Ÿå¿ããæåã«å¹é©
ããååãªæ¿åºŠã以ã€ãŠçãåŸããåŠãã«äŸåã
ãŠããã éèå 泚å°åŸã®å ç«æ¯çŽ ã®è¡æŒ¿ã«ããé€å»æ©æ§
ãçš®ã ã®åç©ã«ã€ããŠå€ãç 究ãããŠããããã®
çµæãçç©åŠçã«æŽ»æ§ãªå ç«æ¯çŽ ã泚å°åŸã«æ¥æ¿
ã«æžå°ããããšãæãããšãªããããšãã°ã©ãã
ãã®å Žåãäºç¡«åããªããžãå«ãåè¢ãçšãããª
ã·ã³ã®ïŒ¡éããããªã³ãçã®æåT65ã«å¯Ÿãã
ã¢ãã¯ãã³æäœïŒæäœT101ïŒãšçµåããŠåæã
ããå ç«æ¯çŽ ãçšããã¢ãã«ã«ãããŠã泚å°çŽåŸ
ã®å ç«æ¯çŽ ã®97ïŒ ã30å以å ã«æ¶å€±ãã17æé以
å ã«99.9ïŒ ãæ¶å€±ããã ãã®ãããªå ç«æ¯æ§ã®æ¥æ¿ãªæ¶å€±ã®çµæãç Žå£
ãããã¹ã现èäžã®ç®æšæåã®é«æ¯çã«å¯Ÿã飜å
ãããããªå ç«æ¯æ§ã®èœåãååã«æç¶ãããã
ãšãã§ããªããªãããã®å ç«æ¯çŽ ã®è¡æŒ¿äžã§ã®æ¶
倱ãçžå¿ããéæ¥åæäœãšæ¯èŒãããšãå察ã«ã
è¡æŒ¿äžã®æäœã¯æ¯èŒçé·æéé«ãå²åã§ä¿æãã
ãããšãç¥ãããŠãããæé«ã«ç²Ÿè£œãããå ç«æ¯
çŽ è£œå€ã§ãéæ¥åæäœãåžžã«ããçšåºŠæ®çããŠã
ãããã®å ç«æ¯çŽ ãšéæ¥åæäœã®æ¶å€±é床ã®å·®ã«
ãããåœåã«ãããŠã極ããŠå°ããæ¯çã§ãã€ã
æäœãæ°æéã®åŸã«å€æ°ãå ããããã«ãªãã次
第ã«ç«¶äºã«ããå ç«æ¯çŽ ã®ç®æšã«å¯Ÿããåºå®ã®ã
ãã®åŒ·åãªæ®æäœãšãªãã å ç«æ¯çŽ ã®è¡æŒ¿å®¿åæ§ã掻æ§ç¶æ ã§å¢å€§ããç®
æšæåã«å¯Ÿããå ææéããã³çšåºŠãå¢å€§ããã
ããšã¯æ¥µããŠææ矩ãªããšã§ããã ããã«ãæŸå°èœã§ã©ãã«ãããªã·ã³ã®ïŒ¡éãæ
ããå ç«æ¯çŽ ãåç©äžã«ç¹å®ã®ç®æšãäžããããš
ãªã泚å°ããçäœå±åšåå®éšã«ããã°æ³šå°æ°ååŸ
ã«ãã®æ¥åäœã¯èããã«å€ãå±åšããããšãåã€
ããããã¯ãªã·ã³ã®ïŒ¡éãéçµåç¶æ ã§æ³šå°ãã
å ŽåãåãåŸåãèŠãããããã®ããšã¯å ç«æ¯çŽ
ã现èæ¯æ§ãµããŠããããä»ããŠèããäžã«åºå®
ããããšã瀺ããŠããããªã·ã³ã®ïŒ¡éã¯ãã³ããŒ
ã¹æ®æž£ããã³ïŒ®âã¢ã»ãã«ã°ã«ã³ãŒã¹ã¢ãã³æ®æž£
ãå«ãããªãªãµã€ãåºãæããç³ã¿ã³ãã¯è³ªã§ã
ãããã®ãã³ããŒã¹æ®æž£ã®ãããã®ã¯æ«ç«¯äœçœ®ã«
ååšããŠããããšãç¥ãããŠããïŒAgri.Biol.
Chem.1978ïŒ42ïŒ501ïŒããããã®ãã³ããŒã¹æ®æž£
ãæããç³ã¿ã³ãã¯è³ªãèªèãåŸããªã»ãã¿ãŒã
èããäžã«ååšããããããã®ãªã»ãã¿ãŒïŒã¯ã
ããŒçŽ°èã«äž»ãšããŠååšããïŒã«ããèªèããã
ç³ã¿ã³ãã¯è³ªã¯è¡æµãã代è¬çŽ°èã«åºå®ãããã
ãšã«ããæ¥éã«é€å»ããããããã¯ç¹ã«ãβâã°
ã«ããŠããããŒãŒããã³ãªããã¯ã¬ã¢ãŒãŒïŒ¢ã®å Ž
åã«è¯ãèšé²ãããŠããïŒArch.Biochem.
Biophys.ïŒ1978ïŒ188ïŒ418ïŒAdvances in
EnzymologyïŒããŠãŒãšãŒã¯ã1974ïŒPediat.
Res.ïŒ1977ïŒ11ïŒ816ïŒããããã®æç®ã«ããã°ãª
ã·ã³ã®ïŒ¡éãæããå ç«æ¯çŽ ã®æ¥æ¿ãªè§£æ¶ã¯èã
ã现èãç¹ã«ã¯ãããŒçŽ°èã§ã®ãªã·ã³ïŒ¡éã®ãã³
ããŒã¹æ®æž£ã®èªèã«ãã説æããããšãã§ããã ä»ã®GPIRã«ã€ããŠã®è¡æŒ¿äžã§ã®è§£æ¶æ©æ§ãã
ãšãã°ã²ããã³åã¯MOMã«ã€ããŠãéè泚å°åŸ
ã«ã€ããŠç 究ããçµæã¯ããªã·ã³ã®ïŒ¡éã®å Žåãš
åæ§ã«GPIRã®è¡æŒ¿ã«ãããã¬ãã«ã¯æ¥éã«æžå°
ããããšã瀺ããŠãããããªãã¡ãã©ãããã®å Ž
åã粟補ã²ããã³ã®æ³šå°åŸè¡æµäžã®93ïŒ ãïŒæé
以å ã«æ¶å€±ãã24æé以å ã«99.99ïŒ ãæ¶å€±ããã ç³ã¿ã³ãã¯è³ªã«å«ãŸãããããªãªãµã€ãæ§é ã
éãšãŒãé žå¡©ã€ãªã³ã§é žåããããšã«ãããé£æ¥
ããççŽ ååã第ïŒã第ïŒããããã·ã«åºãæã
ãççŽ éã®åæãçãããGPIRäžã®ç°ç¶ãªãŒãº
ïŒosesïŒã®å Žåã®åŠããé£æ¥ããããããã·ã«åº
ã第ïŒçŽã®å Žåãé žåã«ããççŽ äžã«ïŒã€ã®ã¢ã«
ãããåºãçãããããããã®éã«åæãçã
ãã ãæ¬çºæã®å ·äœç説æã ãšããã§ãæè «çæ§ç³ã¿ã³ãã¯è³ªã®çæ°Žåç©å
äœãéãšãŠçŽ é žå¡©ã€ãªã³ã§é žå修食ãããå Žåã
ãã®ç³ã¿ã³ãã¯è³ªã®çç©åŠç掻æ§ãå®è³ªçã«å€å
ããã«æç¶ããããšãèŠãåºãããã ããã«ãªããœãŒã ãäžæŽ»æ§åããç³ã¿ã³ãã¯è³ª
ã®çæ°Žåç©åäœãéãšãŠçŽ é žå¡©ã€ãªã³ã§é žå修食
ããããšããçç©åŠç掻æ§ãæç¶ããçäœè¡æµã
ãåŸã ã«è§£æ¶ããããšããïŒéã®ç¹åŸŽãæããæ°
èŠãªç³ã¿ã³ãã¯è³ªãåŸãããããšãæå€ã«ãèŠã
åºãããã åãçååŠçç 究ã®çµæãéãšãŠçŽ é žå¡©ã§
GPIRãé žåããå Žåãåå¿ãGPIRã®ãªãµã€ã
éšåã«éžæçã«èµ·ããããããéšãæ§æããã¢ã
ãé žã®é åã«å šã圱é¿ããªãããšã蚌æãããã ãã®ãªããœãŒã ãäžæŽ»æ§åããæç¶æ§ãæãã
æ°èŠãªç³ã¿ã³ãã¯è³ªã以äžãGPIRâLaãšåŒç§°ã
ãã ãã®GPIRâLaãæäœãšçµåãããšãããã®ã³
ã³ãžãŠã²ãŒãïŒæ¥åäœïŒã¯å ç«æ¯æ§ã«ã€ããŠã®ç
ç©åŠçç¹æ§ãç¶æããè¡æŒ¿ã«ãããæ¶å€±ãé ãã
ãšãèŠãåºãããã ãããã€ãŠãæ¬çºæã¯éãšãŠçŽ é žå¡©ã€ãªã³ã§é ž
å修食ãããçæ°Žåç©åäœãæããæ°èŠãªæè «ç
æ§ç³ã¿ã³ãã¯è³ªãæäŸãããã®ã§ããããã®æ°èŠ
ãªç³ã¿ã³ãã¯è³ªã¯é修食ç³ã¿ã³ãã¯è³ªãšåæ§ã®æŽ»
æ§ã瀺ãããã€åæžæãããé·ããããã«æ¬çºæ
ã®æ°èŠãªç³ã¿ã³ãã¯è³ªã¯ãã®ããªãŒã«åºããéãš
ãŠçŽ é žã¢ã«ã«ãªéå±å¡©ã®æ°Žæº¶æ¶²ã§0.2ã24æéã
ïŒã15âã®æž©åºŠãææã§åŠçããŠä¿è·ããå¿ èŠã«
ããããªãŒã«åºã®é®æã解é€ããå ¬ç¥ã®æ¹æ³ã§æ
çµè£œåãåé¢ããŠåŸãããšãã§ããã å šãŠã®æè «çæ§ç³ã¿ã³ãã¯è³ªãå ¬ç¥ã®æ¹æ³ã§ã
ã®çæ°Žåç©åäœãéãšãŠçŽ é žå¡©ã€ãªã³ã§åå¿ã
ãã修食ãããããšãã§ããã æ¬çºæã«ãããå šãŠã®GPIRã¯æ¥µããŠããããª
现èæ¯æ§ã瀺ãããªããªãã°ããããã¯çŽ°èã«åº
å®ãããªãããç¹å®ã®çŽ°èãèªèããæäœãšçµå
ããã®ã¡ã¯ããã®æäœãç®æšïŒã¿ãŒã²ããïŒãèª
èãããšããããã®çŽ°èã«å¯Ÿã倧ãã现èæ¯æ§ã
瀺ãããšã«ãªãã ãã®GPIRåºçºç©è³ªã®äŸãšããŠã¯ãªã·ã³ïŒ¡éã
ã²ããã³ãMOMããã®æœåºç©ãããã ãã®ä»ã®GPIRã§éãšãŠçŽ é žå¡©ã€ãªã³ã«é žåã
ããåºçºç©è³ªã®äŸãšããŠã¯ä»¥äžã®ãã®ãæããã
ãã ãžã¢ã³ãã³30âŠâŠãžã¢ã³ãµã¹ ã«ã«ãšãã€ã©ã¹ ïŒDianthinïŒïŒDianthus CaryophyllusïŒ ãžã¢ã³ãã³32âŠâŠåäž ã¢ã°ãã¹ãã³ïŒ¡âŠâŠã¢ã°ãã¹ãã ã®ãµãŽ ïŒAgrostinAïŒïŒAgrostemma githagoïŒ ã¢ã°ãã¹ãã³ïŒ¢âŠâŠåäž ã¢ã°ãã¹ãã³ïŒ£âŠâŠåäž HCIâŠâŠããŠã© ã¯ã¬ãã¿ã³ã¹ ïŒHura crepitansïŒ ã¢ã¹ãã©ã¬ã¹ãªãã€ã·âŠâŠã¢ã¹ãã©ã¬ã¹ãªãã€
ã·ããªã¹ ããªã¹ææ¢äœïŒAsparagus officinalisïŒ ãã®ç®çã«æ²¿ã€ãŠä¿®é£ŸãããéºäŒåã®çŽ°èã«ã
ãçåæçã«è£œé ãããåæ§ã®ç©è³ªãæå¹ã§ã
ãã ãªããœãŒã ãäžæŽ»æ§åããèœåã瀺ãéãäžèš
GPIRã®åç»ãåºçºç©è³ªãšããŠçšããããšãã§ã
ããå°ãªããšãããªãŒã«åºã®äžã€ãä¿è·ããã倩
ç¶ãªã·ã³ã®ïŒ¡éã¯å¥œãŸããåºçºç©è³ªã®äžã€ã§ã
ãã ãªã·ã³ã®ïŒ¡éã¯å€ç³åäœãç°ãªãA1ïŒA2ãšã
ãŠè¡šããããïŒæåãããªã€ãŠãããéãšãŠçŽ é ž
å¡©ã«ããé žåã¯ãããA1ïŒA2éã«å¯Ÿãåæ§ã«ã
ããªããããããïŒæåã«åçã®è¬çå¹æã®åäž
ãäžããã çŽç²ãªãªã·ã³ïŒ¡éã®è£œæ³ã«ã€ããŠã¯ç±³åœç¹èš±No.
4340535ã«èšèŒãããŠãããã²ããã³ããã³
MOMã«ã€ããŠãå ¬ç¥ã§ããã GPIRåºçºç©è³ªã®ããªãŒã«åºã®ä¿è·ã¯ãã®ããª
ãŒã«åºãæäœãšçµåãããã®ã«çšããããå Žåã«
æãŸããã ä»ã®å®èœåºããã®çµåã«çšããããå Žåãããš
ãã°ããã·ã³ã®ããšããŒã«ããããã·ã«åºãåã¯
GPIRã®ã¢ããåºåã¯ã«ã«ããã·ã«åºãçšããã
ãå Žåããã®ä¿è·ããããªã€ãŠãããããã¯ãã
ãªããªããŠãããã ããããã³ã°ïŒé®æïŒã¯SHåºãããªãŒã«ïŒäº
ç¡«åç©çœ®æåã¯éå ã«ãããã®ã¡ã«é€å»ãåŸãå
åç©ãšã®åå¿ã«ãããããªãããšãã§ããããã®
ãããªååç©ã®äŸãšããŠã¯ïŒïŒ2â²âãžãããâ
ïŒïŒ5â²âãžããªãžå®æ¯éŠé žïŒDTNBïŒãïŒâïŒããª
ãžã³âïŒâã€ã«âãžã¹ã«ãã¢ãã«ïŒããããªã³
é žãåã¯ãžããªãžã«âïŒïŒ2â²âãžã¹ã«ãã€ããã
ããã¯ãžããªãžã«âïŒïŒ4â²âãžã¹ã«ãã€ãã§ã
ãããã®ãããªåŠçããããªããªãå Žåã¯é žåå
å¿ã®éã«éé¢ããªãŒã«ãæ¶å€±ãããã®å Žåããã
ã¯å šäœçã«åçã§ããªããéå°ã®ããããã³ã°å€
ã¯éæãã®ä»ã®åŠçã«ããé€å»ãããã éãšãŠçŽ é žå¡©ã«ããé žååå¿ã¯PHïŒãïŒã奜ãŸ
ããã¯ïŒã6.5ã§ãããªãããããã®éãšãŠçŽ é ž
å¡©ã¯éå°ã«çšãããããéãšãŠçŽ é žå¡©ã®æ¿åºŠãé ž
åãããé£äœã®ãžãªãŒã«ã®æ¿åºŠãã倧ããããã
ããªãã¡ã现èæ¯çŽ ãµããŠãããïŒã10mgïŒmlã®
æ¿åºŠã«å¯ŸãéãšãŠçŽ é žãããªãŠã 10ã50mMã®æ¿
床ãé©åœã§ããããã®åŠçã¯æž©åºŠïŒã15âã奜ãŸ
ããã¯ïŒãïŒâãææã«ãŠ0.2ã24æéã§ãããª
ãããã åå¿ã¯æ®çããéãšãŠçŽ é žå¡©ãæ¶è²»ããåå¿
å€ãããšãã°éå°ã®ãšãã¬ã³ã°ãªã³ãŒã«ã®æ·»å ã«
ããåæ¢ããããšãã§ããã€ãã§ãå¯çæç©ãé
æçã«ããé€å»ããããã®åå¿ã®çµæåŸããã補
åã¯å ¬ç¥ã®æ¹æ³ã«ããåé¢ããããšãã§ããã åºçºç©è³ªã®ããªãŒã«åºããããã¯ãããå Žåã
ãã®ããããã³ã°è§£é€ã¯ãããã¯ãããããªãŒã«
åºãããšãã°ïŒâã¡ã«ã«ãããšã¿ããŒã«ã解æŸã
ãåŸãéå å€ã§åå¿ãããŠãããªãããšãã§ãã
ããã«ãããªããœãŒã ãäžæŽ»æ§åããæç¶æ§ãæ
ããæ°èŠãªç³ã¿ã³ãã¯è³ªãåŸãããå ç«æ¯çŽ ãäž
ããæäœãšã®çµåã®ããã«çšããããã ãªã·ã³ïŒ¡ã®å ŽåãåŸãããæ°èŠãªååïŒä»¥äžïŒ¡
âLaãšèšãïŒã¯äžèšã®åŠãç¹åŸŽãæããã ååéã¯å€©ç¶ïŒ¡éãšå®è³ªçã«ç°ããã®ã§ãªãã
ããªã¢ã¯ãªã«ã¢ããåŸé é»æ°æ³³åã§èŠãéããã
ã®ä¿®é£ŸåŠçã¯ãã®ã¿ã³ãã¯è³ªã®ããªããŒã極ããŠ
å°éçæãããå£åçæç©ã¯çããªãã éé¢ããªãŒã«åºã®å²åãïŒã¢ã«åœã0.7以äžã§
ããã ãªã·ã³ã®ïŒ¡éãææ¢ããã©ãããæäœã«å¯Ÿãã
å ç«åå¿æ§ã倩ç¶ïŒ¡éã®å ç«åå¿æ§ãšå€ããªãã é现èã¢ãã«ã«ãããããã±ã質åæã«å¯Ÿãã
ææ¢æ§ã倩ç¶ïŒ¡éã®çéã«ãã€ãŠããããããã
ã®ã®50ïŒ ä»¥äžã§ããã ã©ãããã«0.4mgïŒKgïŒäœéïŒã®æäžéã§éè
æäžããã®ã¡23æé以å ã®ïŒ¡éïŒïŒ¡âLaïŒã®è¡
挿ã«ãããæ®ççã¯10ïŒ ä»¥äžïŒå€©ç¶ã®ïŒ¡éã«ã€ã
ãŠã¯0.015ïŒ ïŒã§ãã500å以äžã®å¢å€§ã瀺ãã ã²ããã³ã®å ŽåãéãšãŠçŽ é žå¡©ã§é žåããŠåŸã
ååã¯ä»¥äžã®åŠãç¹åŸŽãæãã ååéã¯å€©ç¶ã®ã²ããã³ã®ãã®ãšå®è³ªçã«å€ã
ãªãã 倩ç¶ã®ã²ããã³ãšå€ããªãæã²ããã³ã©ããã
æäœã«å¯Ÿããå ç«åå¿æ§ã瀺ãã ã©ãããã«0.3mgïŒKgïŒäœéïŒã®æäžãéèå
æäžããã®ã¡24æé以å ã«ããã®ä¿®é£Ÿã²ããã³ã¯
ïŒïŒ 以äžè¡æŒ¿ã«æ®çãïŒå€©ç¶ã²ããã³ã®å Žå0.01
ïŒ ïŒããããã€ãŠ200å以äžã®æ®ççã®åäžã瀺ã
ãã ãã®ãªããœãŒã ãäžæŽ»æ§åããç³ã¿ã³ãã¯è³ªã
ãã®ã³ã³ãžãŠã²ãŒãåã¯ç³ã¿ã³ãã¯è³ªã®è£œé ã¯ã
ãšãã°ç±³åœç¹èš±No.4340535ã«èšèŒãããæ¹æ³ã§ã
ããªãããšãã§ããããããéžã°ãã现èæ¯çŽ ãµ
ããŠãããã倩ç¶ã«å°ãªããšãäžã€ã®ããªãŒã«ã
æãçµåã«é©åããŠãããã®ã§ããã°ããã®åºã¯
掻æ§åäºç¡«ååºãæããæäœåã¯æäœåç»ãšã®å
å¿ã«çšãããããããããéžã°ãã现èãµããŠã
ããã倩ç¶ã«ããªãŒã«åºãæãããã®ã§ãªãã
ã°ãéé¢ããªãŒã«ãæããå®èœåºãå°ãªããšãäž
ã€ãå ¬ç¥ã®æ¹æ³ã§ãã®ãµããŠãããã«å°å ¥ããã
ããšãã§ããããã«ããäžè¿°ã®çµåãç¶ç¶ãã
ãããã®å®èœåºã®å°å ¥ã¯éãšãŠçŽ é žå¡©ã€ãªã³ã«ã
ãé žåå·¥çšã®åã«ãããªãããã®å Žåãé žåå·¥çš
ã®éã«ãã®ããªãŒã«ã©ãžã«ã«ãããããã³ã°ããŠ
ãããé žåå·¥çšåŸã«ãã®ããããã³ã°ã解æŸãã
ããã«ããŠãããããåé žåå·¥çšã®ã®ã¡ã«ãã®å°
å ¥ããããªã€ãŠãããã ãã®ããã«ããŠåŸããã修食å ç«æ¯çŽ ã¯è¬çå¹
æã«ã€ããŠæ°èŠãªç¹åŸŽãããªãã¡æ¬æ¥ã®çŽ°èæ¯æ§
ã«å ããŠãè¡æŒ¿äžã«ãããæ¶å€±é 延æ§ïŒæç¶æ§ïŒ
ãè¯å¥œãªãã®ãšãªãã å®æœäŸ ïŒ SHåºãâãšãã«ãã¬ã€ããã§ããããã³ã°
ãããã¡ãã«åéã®é žåã æ£ããå®èœåããããªã·ã³ïŒ¡éã®è£œé ïŒ ïŒ¡éã®ãããµã¡ãã«å Means and Feeneyã®æ¹æ³ïŒBiochemistry
ïŒïŒ2192ïŒ1968ïŒïŒã«ããã¡ãã«ååå¿ãïŒâã§
æªæããªãã0.2MããŠé žå¡©ç·©è¡æ¶²ïŒPHïŒ10ïŒ
äžã§ãããªã€ãã20mgã®ããªããšãŒãåããã
ïŒtritiatedïŒããŠçŽ åæ°ŽçŽ ïŒ9.5mCiïŒmmolã
å«ãïŒãé35mlïŒïŒmgïŒmlïŒã«å ããããã«
ïŒïŒ ãã«ã ã¢ã«ããã350ÎŒlãå ããïŒ30åé
ã«äºã70ÎŒlã¥ã€ïŒåïŒã éå°ã®æ·»å ç©è³ªã125mMãªã³é žå¡©ç·©è¡å€
ïŒPHïŒïŒãçšããŠé£ç¶çã«éæé€å»ããïŒ40
ã300mlïŒæéã®å²åã§ïŒãéæåŸãã¿ã³ãã¯è³ª
溶液ãé å¿åé¢ãããããµã¡ãã«åéïŒ2.6
mgïŒmlå«æïŒã36.5mlåŸãã ïŒ ïŒ®âãšãã«ãã¬ã€ãããçšããããããã³ã° ãããµã¡ãã«åéã®å€©ç¶SHåºã
Enzymology11541ïŒ1967ïŒã«èšèŒã®æ¹æ³ã§ãã
ããã³ã°ãããããªãã¡ãåã®å·¥çšã§åŸããªã·
ã³ïŒ¡éã20ã¢ã«çéã®ïŒ®âãšãã«ãã¬ã€ãã
ïŒïŒ¡éïŒã¢ã«åœãïŒã®ååšäžã§30âã§ïŒæéå¹
é€ãããã€ãã§PHïŒã®125mMãªã³é žå¡©ç·©è¡æ¶²
ãçšããŠé£ç¶çã«éæããŠéå°ã®æ·»å ç©è³ªãé€
å»ããããã®æäœã500mlïŒæéã®å²åã§20æ
éç¹°ãè¿ããããã®æ¿çž®ã®ã®ã¡ïŒmgïŒmlã®å²å
ã§å«ããªã·ã³ïŒ¡éã®æº¶æ¶²13mlãåŸãããã«ã¯
ELLMANè©Šè¬ã§å€å¥ãåŸããããªããªãŒã«åº
ã¯ãã¯ãååšããªãã€ãããã®ããã«ããŠåŸã
çæç©ã以äžããããµã¡ãã«åéïŒNEMïŒ
ãšç§°åŒããã ïŒ éãšãŠçŽ é žå¡©ã«ããé žå äžè¿°ã®å·¥çšã§åŸãNEM溶液ïŒmlãïŒâãPH
ïŒ4.5ã§ææã§40åéNaIO4ïŒ12.8mgïŒãšåå¿ã
ããã€ãã§ããã®åå¿ããšãã¬ã³ã°ãªã³ãŒã«
600ÎŒãæ·»å ããããšã«ããåæ¢ããããã€
ãã§ããã®åå¿åªäœã0.1Mã®çé žå¡©ç·©è¡æ¶²
ïŒPHïŒ10ïŒãçšãé£ç¶çã«éæãããïŒ500mlïŒ
æéã®å²åã§20æéïŒã é现èã¢ãã«ã§æž¬å®ããæç¶æ§ïŒ¡éã®é µçŽ 掻
æ§ ãªã·ã³ïŒ¡éã®åºæ¬ççç©åŠçç¹æ§ã¯ãªããœãŒã
ãµããŠããã60Sã®å£åã«ãã现èäžã§ã®ã¿ã³ã
ã¯è³ªåæãé»å®³ããããšã§ããã è©Šéšç®¡ã«ããæ¹æ³ã«ãããŠãã©ããã®èããã®
äžäœçŽ°èåç»ã§é©åœã«è£å®ãããã®ãçšãããã
ãã¯äººå·¥ã¡ãã»ã³ãžã€ãŒRNAãããªãã¡ããªãŠ
ãªãã€ã«é žã®ååšäžã§14Câããšãã«ã¢ããªã³ã
çµèŸŒãããšãã§ãããã®ã§ããã ãã®äžäœçŽ°èåç»ã®è£œé ããã³14Câããšãã«
ã¢ã©ãã³ã®çµèŸŒã¿ã®æž¬å®ã¯Biochemica
Biophysica Acta 1973ïŒ312ïŒ608â615ã«èšèŒã
ããŠããæ¹æ³ã§ããã¯ããœãŒã åç»ããã³ã©ãã
è现èã®ãµã€ããŸã«åç»ãçšããŠãããªã€ãããŸ
ãããã®ïŒ¡éãå«ããµã³ãã«ãé©åœã«åžéãã溶
液ã®åœ¢ã§ã0.2ïŒ ã®ïŒâã¡ãã«ã«ãããšã¿ããŒã«
ããã³15ÎŒgïŒmlã®ãŠã·è¡æž ã¢ã«ããã³ãå«ã
50mMããªã¹HClç·©è¡æ¶²ïŒPHïŒ7.6ïŒäžã«å°å ¥ã
ãã ã«ãŠã³ãããŒã¿ãçšããææ¢å€ãªãã®å¯Ÿç §åªäœ
ãšã®æ¯èŒã§ããªã·ã³ïŒ¡éãå«ãååå¿åªäœã«ã€ã
ãŠã¿ã³ãã¯è³ªäžã«çµèŸŒãŸãã14Câããšãã«ã¢ã©
ãã³ææ¢çïŒïŒ ïŒãèšç®ããã ãã®ææ¢æŽ»æ§ã枬å®ããçµæãé žåéã«ã€ã
ãŠã¯IC50ã2.7ã»10-10ã¢ã«ïŒïœãèªãããããä»
æ¹ãå¯Ÿç §ïŒ¡éã®IC50ã¯1.03ã»10-10ã¢ã«ïŒïœã§ã
ãããããã€ãŠããã®ä¿®é£Ÿã¯ïŒ¡éã®æŽ»æ§æ倱ã«åœ±
é¿ãäžããŠããªãã å®æœäŸ ïŒ ãã®å®æœäŸã¯éãšãŠçŽ é žãããªãŠã ã§ä¿®é£Ÿãã
ãªã·ã³ïŒ¡éãéè泚å°ããå Žåã®æ¶å€±ã®é 延æ§ã
蚌æããããã®ãã®ã§ããã éãšãŠçŽ é žãããªãŠã ã«ãããªã·ã³ïŒ¡éã®ä¿®
食 (1) DTNBãçšãã倩ç¶SHã®ããããã³ã° ãªã·ã³ïŒ¡éãç±³åœç¹èš±No.4340535ã«èšèŒãããŠ
ããæ¹æ³ã§è£œé ã粟補ãããïŒïŒ2â²âãžãããâ
ïŒïŒ5â²âãžããªïŒå®æ¯éŠé žïŒDTNBïŒã®æº¶æ¶²20åœ
éãããªãã¡ãPHïŒã®125mMãªã³é žå¡©ç·©è¡æ¶²ã«
溶ãããDTNBã®0.1M溶液ã385ÎŒïŒãã®æº¶æ¶²
ã¯æ°Žé žåãããªãŠã ã§PHïŒïŒã«èª¿ç¯ããïŒãã
PBSç·©è¡æ¶²ã«æº¶ããã5.6mgïŒmlã®å²åã§å«ããª
ã·ã³ïŒ¡é10ml溶液ã«å ããïŒããé žå¡©ã«ã€ããŠã¯
20mMïŒNaClã«ã€ããŠã¯150mMã®PHïŒïŒã®ç·©è¡
液ïŒãå¹é€ã¯20âã§20åéç¶ããããã®æº¶æ¶²ãïŒ
âã§PBSç·©è¡æ¶²ãçšããŠéæããããªãŒã«åºã
ããããã³ã°ããéã53mgãïŒmgïŒmlã®å²åã§
å«ã溶液ãšããŠåŸãã (2) ããããã³ã°ãããéã®éãšãŠçŽ é žå¡©ã«
ããé žå éãšãŠçŽ é žãããªãŠã ã®0.5M氎溶液120ÎŒãã
1Mé ¢é žã§PHïŒïŒã«èª¿æŽããããããã³ã°æžã¿ïŒ¡
éãïŒmgïŒmlå«ã溶液ïŒmläžã«å ãããå¹é€ã¯æ
æã§ïŒâã§16æéãããªã€ããé žååå¿åæ¢ã¯ãš
ãã¬ã³ã°ãªã³ãŒã«ã®1M氎溶液620ÎŒãå ããã
ãšã«ãããããªã€ããå¹é€åŸã20âã§15åéãå
å¿åªäœãïŒâã§PBSç·©è¡æ¶²ã§éæããããã®é
ãšãŠçŽ é žå¡©ã«ããé žåã«ããã¿ã³ãã¯è³ªã®ããã
ãªæåºãåŸããããã30åéã10000Ãã§é å¿
åé¢ãé€å»ããé žåããã³ããããã³ã°ããã
éã3.4mgïŒmlã®æ¿åºŠã§24mgåŸãã (3) ããªãŒã«åºã®ããããã³ã°è§£æŸ ïŒâã¡ã«ã«ãããšã¿ããŒã«ãéå å€ãšããŠæçµ
æ¿åºŠïŒïŒ ã§é žåãããããã³ã°åéïŒPBSç·©
è¡æ¶²äžã«3.4mgïŒmlå«ãïŒïŒmlã«å ãããå¹é€ã
20âã§ïŒæéãããªããã€ãã§ãã®æº¶æ¶²ãïŒâã§
PBSç·©è¡æ¶²ãçšããŠéæããããã®çµæé žåã
ããéã2.8mgïŒmlã®æ¿åºŠã§19mgåŸãã DTNBæ³ïŒEnzymologyïŒ1972ïŒ25ïŒ457
Academic PressïŒãçšãããã®ä¿®é£Ÿãããé
ãïŒã¢ã«åœã0.70ã®éé¢ããªãŒã«åºãæããããš
ãå€æããããã®ä¿®é£ŸïŒ¡éã®ååéã¯ããã·ã«ãµ
ã«ããšãŒãã®ååšäžã§ã®ããªã¢ã¯ãªã«ã¢ããåŸé
é»æ°æ³³åã«ãã30000±3000ã§ããããšãå€æã
ãã å€ç³åäœãé žåãããéããã¿ã³ãã¯è³ªåæ
ã®ææ¢ã«ãããé µçŽ æŽ»æ§ããã³è¬çåŠçç¹æ§ã«ã€
ããŠç 究ããã æç¶æ§ïŒ¡éã®é µçŽ 掻æ§ã®é现èã¢ãã«ã«ãã
æž¬å® ææ¢æŽ»æ§ãå®æœäŸïŒã®æ¹æ³ã§æž¬å®ããããã®çµ
æãé žåéã®IC50ã¯ïŒÃ10-10ã¢ã«ïŒã§ããã
å¯Ÿç §ïŒ¡éã®IC50ã¯1.2Ã10-10ã¢ã«ïŒã§ãã€ãã
ãããã€ãŠä¿®é£Ÿã«ããéã®æŽ»æ§æ倱ã¯èªããã
ãªãã€ãã æç¶æ§ïŒ¡éïŒïŒ¡âLaïŒã®è¬çå¹æ ãã®ïŒ¡éãã©ãããã«è³ãä»ããŠéèæäžã
ãããã®ïŒ¡éæäžéã¯0.415mgïŒKgã§ãã€ããè¡
液ãµã³ãã«ããããªã³äžã«ééããããŠæ¡åã
ãããã®è¡æŒ¿ãäžèšã«RIMâïŒã®èšå·ã§ç€ºãã
ã©ãžãªã€ã ãã¢ãã»ã€ãã¹ãã§åæããã ãã®æ¹æ³ã¯ïŒ¡éã修食ããããšãªãã«å€å®ãåŸ
ãå©ç¹ãæããããã®å€å®ããã€ã¯ã滎å®ãã¬ãŒ
ããçšããŠãããªã€ãããã®ãã¬ãŒãã®èäœã«ã¯
éåžåå€ã¹ãã€ã¯ãèšããããŠããŠããããããŒ
ã¹äžã®ç©Žã«æµžå ¥ããããã«ãªã€ãŠããããããã®
ã¹ãã€ã¯ã¯åºäœçžãããªããã®ã§ããããªã·ã³ã®
éã瀺ãã芪åæ§ã¯ãããã°ã©ãã€ã§ç²Ÿè£œãã
ãéçŸæäœïŒä»¥äžã«Ac1ã®èšå·ã§ç€ºãïŒããã®åº
äœçžäžã«åžåãããããã®ç®çã®ãããPBSç·©
è¡æ¶²äžã«10ÎŒgïŒmlå«ãAc1ã®æº¶æ¶²ãäžèšç©Žã«å
ããŠæ³šå ¥ãããäžèšã¹ãã€ã¯ãïŒâã§24æéã
Ac1溶液ãšæåã«æ¥è§Šãããã€ãã§20âã§ïŒæ
éãèå ãŠã·è¡æž ãšæ¥è§Šãããå šãŠã®åºå®éšäœã
飜åãããããã®é£œåããå ç«åžåå€ã20âãïŒ
æéãçš®ã ã®æ¿åºŠã®è¡æŒ¿ãµã³ãã«ãåã¯æ¢ç¥ã®æ¿
床ã®ïŒ¡é溶液ãšæ¥è§Šãããç®çæ²ç·ãäœæããã
PBSç·©è¡æ¶²ã§æŽæµåŸããã®å ç«åžåå€ããªã·ã³
éã瀺ãéçŸæäœïŒèŠªåã¯ãããã°ã©ãã€ã§ç²Ÿ
補ããæŸå°èœã©ãã«ãæœãããã®ã以äžAc2ãšèš
ãïŒãš20âã§ïŒæéæ¥è§Šãããããã®Ac2ã®æŸå°
èœã©ãã«ã¯ã¯ãã©ãã³ïŒŽã®ååšäžã§ãšãŠçŽ 125ã
çšããGreenwoodããã³Hunterã®æ¹æ³
ïŒBiochem.J.ïŒ1963ïŒ89ïŒ114ïŒã§ãããªã€ãã
ãã®ã©ãã«ããAc2æäœã¯ïŒã10ãã€ã¯ãããŠãŒ
ãªâïŒÎŒgã瀺ããããã®ã©ãã«åAc2106cpmã
200ÎŒãšããŠã0.1ïŒ ãŠã·è¡æž ã¢ã«ããã³ãå«ã
PBSç·©è¡æ¶²äžã«å°å ¥ãããPBSç·©è¡æ¶²äžã§æŽæµ
ã®ã®ã¡ãäžã¹ãã€ã¯ãåãã¯ãããçµåããAc2
ã®éãæŸå°èœæž¬å®ã«ããèšéããããµã³ãã«äžã®
éã®æ¿åºŠã¯ãç°ãªãæ¢ç¥ã®æ¿åºŠã§ïŒ¡éãå°å ¥ã
ãããšã«ãã€ãŠäœãããç®çæ²ç·ã«å¯ŸããŠåç §ã
ãããšã«ãã枬å®ãããæç¶æ§ïŒ¡éãåç©ã«æ³šå°
ããéãåãéãçšãçžåœããç®çæ²ç·ãäœæ
ããã ãã®æ¹æ³ã§æž¬å®ãããè¡æŒ¿äžã®ïŒ¡éã®æ¿åºŠã¯å
çŸæ§ããããä¿¡é Œã§ãããã®ã§ããããã®æ¢ç¥ã
ããå€ã¯1ngïŒmlã§ãããåå®éšéã®åçŸæ§ã®æ€
èšã®çµæãå€åé¢æ°ãïŒã200ngïŒmlã®æ¿åºŠã«ã€
ããŠ10ïŒ ä»¥äžã§ãã€ãã ãããã®å®éšã®çµæã¯æ²ç·ã§ç€ºãããæéã¯æšª
軞ã«ãé¶æã®è¡æŒ¿æ¿åºŠçè«å€ã«å¯Ÿããèšé²ããã
çæç©ã®è¡æŒ¿æ¿åºŠã®ïŒ ãlogã¹ã±ãŒã«ã§çžŠè»žã«ç€º
ããããã®å€ãããªãã¡ãâçžå¯Ÿè¡æŒ¿æ¿åºŠâ
ïŒRPCïŒã¯äžèšã®åŒã§èšç®ãããã RPCïŒæéâïœâã§æž¬å®ããæ¿åºŠïŒæ³šå°éïŒè¡æŒ¿éÃ1
00 è¡æŒ¿éã¯åç©ã®äœéã®ïŒKgåœã36mlã§èããã
ãŠããã 第ïŒå³ã¯å€©ç¶ãªã·ã³ïŒ¡éãéè泚å°ããå Žåã®
è¡æŒ¿ã«ãããæ¶å€±æ²ç·ãæéã®é¢æ°ãšããŠç€ºãã
ãã®ã§ããããã®æ²ç·(1)ã¯ïŒã€ã®çžã瀺ããŠã
ãã第ïŒã«ãã®å€©ç¶ãªã·ã³ïŒ¡éã泚å°åŸïŒæéã§
è¡æŒ¿äžã«æ®ãçã¯ããã0.1ïŒ ïŒæäžéã«å¯ŸããŠïŒ
ã§ãããè¡æ¶²ããæ¥æ¿ã«æ¶å€±ããããšã瀺ããŠã
ãã第ïŒã®çžã«ãããŠã¯ãã®æ¶å€±ããããããã
ã§ããã ããããå€ç³åäœãé žåãããéã«ãããŠ
ã¯ããã®æ¶å€±æ§ã¯èãããæ¹ãããããããªã
ã¡ãé補åã®å€§éšåãæ¶å€±ããããšãšãªã第ïŒ
ã®æ¶å€±çžã¯èãããæå¶ããããã®çµæãéã®
è¡æŒ¿ã«ãããæ®çã¬ãã«ãèãããå¢å€§ããã泚
å°20æéåŸã§ã¯é žåéã®æ¿åºŠã¯ä¿®é£ŸãããŠããª
ãéïŒæ²ç·ïŒïŒã®å Žåã®600åã«ããªãã å®æœäŸ ïŒ ãã®å®æœäŸã¯NEMã§ä¿è·ãããéã®è¬ç©å
æ åŠçæ§è³ªã«å¯ŸããéãšãŠçŽ é žå¡©ã«ããé žåã®å¹
æãæ€èšãããã®ã§ããã ïŒ ãªã·ã³ã®ïŒ¡éã®ä¿®é£Ÿ ïœ ïŒ®âãšãã«ãã¬ã€ããã«ããéé¢SHã®ä¿è· ãªã·ã³ã®ïŒ¡éãïŒmgïŒmlã®å²åã§å«æãããªã·
ã³ïŒ¡é氎溶液40mlïŒïŒ¡é4.1ãã€ã¯ãã¢ã«ïŒãïŒ
âã¡ã«ã«ãããšã¿ããŒã«ã®æ°Žæº¶æ¶²ã§åŠçããŠïŒ¡é
ã®æçµæ¿åºŠãïŒïŒ ãšãªãããã«ããã ãã®æº¶æ¶²ãïŒæéæŸçœ®ããåŸãPHïŒã®125mM
ãªã³é žç·©è¡æ¶²ã§é£ç¶çã«éæããããªã³é žç·©è¡æ¶²
ã¯æ¯æ300mlã®å²åã§40æéæ°ãããã®ãšäº€æã
ãããšã«ãã³ïŒEllmanïŒã®æ¹æ³ãçšããŠããªã·
ã³ã®ïŒ¡éïŒã¢ã«åœã0.9åœéã®SHã枬å®ãããã ãã®SHåºããã¡ãœããºã»ã€ã³ã»ãšã³ã¶ã€ã¢ã
ãžãŒïŒMethods in EnzymologyïŒã11541ïŒ1967ïŒ
ã«èšèŒãããŠããæ¹æ³ã«ãã€ãŠïŒ®âãšãã«ãã¬ã€
ããã§ä¿è·ãããããªãã¡ãäžèšå·¥çšã§åŸããªã·
ã³ïŒ¡éãããã®ïŒ¡éïŒã¢ã«åœã20åœéã®ïŒ®âãšã
ã«ãã¬ã€ããã®ååšäžã«30âã§ïŒæéã€ã³ããŠã
ãŒããéå°ã®è©Šè¬ãPHïŒã®125mMãªã³é žç·©è¡æ¶²
ã§é£ç¶çã«éæããããšã«ãã€ãŠé€å»ããããã®
éããªã³é žç·©è¡æ¶²ã¯ãæ¯æ500mlã®å²åã§20æé
ã«ããã€ãŠæ°ãããã®ãšäº€æãããããã«ããã
ãšã«ãã³ã®è©Šè¬ã§æž¬å®ãåŸãããªãŒã«åºãå«ãŸãª
ãã§ïŒ¡éãæ¿åºŠïŒmgïŒmlã§å«ã溶液ãåŸãããã
ããŠåŸãçæç©ã以äžïŒ¡éïŒNEMïŒãšããããš
ãšããã ïœ éãšãŠçŽ é žå¡©ã«ããéïŒNEMïŒã®é žå éãšãŠçŽ é žå¡©ã«ããéïŒNEMïŒã®é žåã¯å®
æœäŸïŒã®ææ³ã«ãã€ãŠãããªã€ãã ïŒ é žåãããéïŒNEMïŒã®ç¹æ§ ïœ é žåãããéïŒNEMïŒã®é µçŽ æŽ»æ§ ã¿ã³ãã¯åæã«å¯Ÿããé»å®³æŽ»æ§ãå®æœäŸïŒã®æ
æ³ãçšããŠæž¬å®ããããã®çµæãé žåãããé
ïŒNEMïŒã®é µçŽ 掻æ§ã¯ãIC50ã§4.3Ã10-10ã¢ã«ïŒ
ãªããã«ã§ãã€ãã ïœ é žåãããéïŒNEMïŒã®è¬ç©åæ åŠçæ§
質 é žåããããŸãã¯é žåãããŠããªãé
ïŒNEMïŒããŠãµã®ã®è³è¡ç®¡ã«äžå泚å°ããã泚
å°ããéã®éã¯0.100mgïŒKgã«çžåœãããã®ã§ã
ã€ãã23æéåŸã«æ¡åããè¡æŒ¿ããå®æœäŸïŒã«èš
èŒããå ç«æž¬å®æ³ãçšããŠåæãããçµæã以äž
ã®è¡šã«èšèŒããã
ã³ã¿ã³ãã¯è³ªïŒã«ä¿ãããç¹ã«ãã®çæ°Žåç©åäœ
ãéãšãŠçŽ é žå¡©ã€ãªã³ã§é žåã修食ãããç³ã¿ã³
ãã¯è³ªã«é¢ããã æ¬çºæã®æ°èŠãªç³ã¿ã³ãã¯è³ªã¯ãªããœãŒã ãäž
掻æ§åãããã€ãã®å¹èœãæç¶ããããšãç¹åŸŽãš
ããã ãåŸæ¥æè¡ã®èª¬æã ãã®ãªããœãŒã ãäžæŽ»æ§åããç³ã¿ã³ãã¯è³ªãš
ã¯ãªããœãŒã ãäžæŽ»æ§åããçæ žçŽ°èäžã§ã®ã¿ã³
ãã¯è³ªåæã劚害ãã巚倧ååã®ãµãã«ã©ã€ãå
äœãæããå šãŠã®ç©è³ªåã¯ãã®åç»ç©è³ªãæå³
ããããã倩ç¶ã®ãã®ãåã¯çåæããããã®
ã§ã现èã®éºäŒåããã®ç®çã®ããã«ä¿®é£Ÿããã
ãã®ã§ãã€ãŠããããããã«ãã®ã¢ããé žã®å®èœ
åºã修食ããæäœãšå®¹æã«çµåããããã«ããã
ã®ã§ãã€ãŠãããã ãã®ãªããœãŒã ãäžæŽ»æ§åããç³ã¿ã³ãã¯è³ªã
以äžâGPIRâãšèšå·åããŠç€ºãã ãã®æ现æžã«ãããŠãéãšãŠçŽ é žå¡©ã€ãªã³ãšã¯
IO4 -ã€ãªã³ãæå³ããããã«ã¡ã¿éãšãŠçŽ é žå¡©
ãåŒç§°ããããšãããã ãã®GPIRã¯æäœãšã®çµåã«ããå ç«æ¯çŽ ã補
é ããéã®äžéäœãšããŠç¹ã«æçšã§ããã ç±³åœç¹èš±No.4340535ããã©ã³ã¹ç¹èš±No.2504010ã
ãã³No.2516794ã«ã¯ã³ã³ãžãŠã²ãŒããšåŒã°ããæ
ã¬ã³å€ã®è£œé ã«ã€ããŠé瀺ããããããã¯ïŒéçµ
åã«ãããªã·ã³ã®ïŒ¡éããç Žå£ãããã¹ã现èã®
æåã«å¯Ÿããæäœåã¯ãã®åç»ãšçµåããããšã«
ããåŸããããšããŠããããã®çš®ã®çæç©ãæ¬æ
现æžã«ãããŠã¯äžè¬çã«å ç«æ¯çŽ ãšåŒã¶ã äžèšã®ãªã·ã³ïŒ¡éãæããå ç«æ¯çŽ ã«é¡äŒŒãã
ã³ã³ãžãŠã²ãŒãã§ãæã¬ã³å€ãšããŠé©åœãªç©è³ªã
ç¥ãããŠãããããã¯ïŒéçµåã«ããæäœåã¯æ
äœåç»ç©ãä»ã®ãªããœãŒã äžæŽ»æ§åç³ã¿ã³ãã¯
質ãããšãã°ã²ãããŠã ãã«ããããŒã©ã
ïŒGelonium multiflorumïŒãïŒEur.J.Biochem.ïŒ
1981ïŒ116ïŒ447â454ïŒCancer Res.ïŒ1984ïŒ44ïŒ
129â133ïŒãåã¯ã¢ã¢ã«ãã«ã«ã©ã³ãã¢
ïŒMomordica charantiaïŒïŒMOMïŒããæœåºã
ããææ¢äœïŒç±³åœç¹èš±No.4368149ïŒãšçµåããã
ãšã«ããåŸãããã ãããã®GPIRã¯ãªã·ã³ã®ïŒ¡éãšäŒŒãç¹æ§ãæ
ããååéã20000ãªãã30000çšåºŠã§ãã
ïŒCance SurveyïŒ1982ïŒïŒïŒ489â520ïŒã ãããã®å ç«æ¯çŽ ã®çŽ°èæ¯çŽ 掻æ§ãçš®ã ã®ã¢ãž
ãŠãã³ãç©è³ªãããšãã°ã¢ã³ã¢ããŠã å¡©ãã¢ã
ã³ããããã¯ã«ã«ããã·ã«ã€ãªãããªã¢ïŒããšã
ã°ã¢ãã³ã·ã³ããã³ãã²ãªã·ã³ïŒã§å¢åŒ·ãããã
ãšãã§ããããšãç¥ãããŠããã ããããå ç«æ¯çŽ ã®æ²»çå¹æã¯æŽ»æ§åãããŠã
ããåŠããåããããã®æäœéšåãä»ããŠç Žå£ã
ããã¹ãç®æšçŽ°èäžã«å±åšåãåŸãå Žåã«ã®ã¿å
åã«å¹æãçºæ®ãããã®ã§ããããã®å ç«æ¯çŽ ã
ãã®ç®æšçŽ°èäžã«å±åšåãåŸããåŠãã¯å ç«æ¯çŽ
ãè¡æµããã³çŽ°èå€æµäœå ã«ã掻æ§åç¶æ ã§ç®æš
现èã«å°éãåŸãæéããã³å¯Ÿå¿ããæåã«å¹é©
ããååãªæ¿åºŠã以ã€ãŠçãåŸããåŠãã«äŸåã
ãŠããã éèå 泚å°åŸã®å ç«æ¯çŽ ã®è¡æŒ¿ã«ããé€å»æ©æ§
ãçš®ã ã®åç©ã«ã€ããŠå€ãç 究ãããŠããããã®
çµæãçç©åŠçã«æŽ»æ§ãªå ç«æ¯çŽ ã泚å°åŸã«æ¥æ¿
ã«æžå°ããããšãæãããšãªããããšãã°ã©ãã
ãã®å Žåãäºç¡«åããªããžãå«ãåè¢ãçšãããª
ã·ã³ã®ïŒ¡éããããªã³ãçã®æåT65ã«å¯Ÿãã
ã¢ãã¯ãã³æäœïŒæäœT101ïŒãšçµåããŠåæã
ããå ç«æ¯çŽ ãçšããã¢ãã«ã«ãããŠã泚å°çŽåŸ
ã®å ç«æ¯çŽ ã®97ïŒ ã30å以å ã«æ¶å€±ãã17æé以
å ã«99.9ïŒ ãæ¶å€±ããã ãã®ãããªå ç«æ¯æ§ã®æ¥æ¿ãªæ¶å€±ã®çµæãç Žå£
ãããã¹ã现èäžã®ç®æšæåã®é«æ¯çã«å¯Ÿã飜å
ãããããªå ç«æ¯æ§ã®èœåãååã«æç¶ãããã
ãšãã§ããªããªãããã®å ç«æ¯çŽ ã®è¡æŒ¿äžã§ã®æ¶
倱ãçžå¿ããéæ¥åæäœãšæ¯èŒãããšãå察ã«ã
è¡æŒ¿äžã®æäœã¯æ¯èŒçé·æéé«ãå²åã§ä¿æãã
ãããšãç¥ãããŠãããæé«ã«ç²Ÿè£œãããå ç«æ¯
çŽ è£œå€ã§ãéæ¥åæäœãåžžã«ããçšåºŠæ®çããŠã
ãããã®å ç«æ¯çŽ ãšéæ¥åæäœã®æ¶å€±é床ã®å·®ã«
ãããåœåã«ãããŠã極ããŠå°ããæ¯çã§ãã€ã
æäœãæ°æéã®åŸã«å€æ°ãå ããããã«ãªãã次
第ã«ç«¶äºã«ããå ç«æ¯çŽ ã®ç®æšã«å¯Ÿããåºå®ã®ã
ãã®åŒ·åãªæ®æäœãšãªãã å ç«æ¯çŽ ã®è¡æŒ¿å®¿åæ§ã掻æ§ç¶æ ã§å¢å€§ããç®
æšæåã«å¯Ÿããå ææéããã³çšåºŠãå¢å€§ããã
ããšã¯æ¥µããŠææ矩ãªããšã§ããã ããã«ãæŸå°èœã§ã©ãã«ãããªã·ã³ã®ïŒ¡éãæ
ããå ç«æ¯çŽ ãåç©äžã«ç¹å®ã®ç®æšãäžããããš
ãªã泚å°ããçäœå±åšåå®éšã«ããã°æ³šå°æ°ååŸ
ã«ãã®æ¥åäœã¯èããã«å€ãå±åšããããšãåã€
ããããã¯ãªã·ã³ã®ïŒ¡éãéçµåç¶æ ã§æ³šå°ãã
å ŽåãåãåŸåãèŠãããããã®ããšã¯å ç«æ¯çŽ
ã现èæ¯æ§ãµããŠããããä»ããŠèããäžã«åºå®
ããããšã瀺ããŠããããªã·ã³ã®ïŒ¡éã¯ãã³ããŒ
ã¹æ®æž£ããã³ïŒ®âã¢ã»ãã«ã°ã«ã³ãŒã¹ã¢ãã³æ®æž£
ãå«ãããªãªãµã€ãåºãæããç³ã¿ã³ãã¯è³ªã§ã
ãããã®ãã³ããŒã¹æ®æž£ã®ãããã®ã¯æ«ç«¯äœçœ®ã«
ååšããŠããããšãç¥ãããŠããïŒAgri.Biol.
Chem.1978ïŒ42ïŒ501ïŒããããã®ãã³ããŒã¹æ®æž£
ãæããç³ã¿ã³ãã¯è³ªãèªèãåŸããªã»ãã¿ãŒã
èããäžã«ååšããããããã®ãªã»ãã¿ãŒïŒã¯ã
ããŒçŽ°èã«äž»ãšããŠååšããïŒã«ããèªèããã
ç³ã¿ã³ãã¯è³ªã¯è¡æµãã代è¬çŽ°èã«åºå®ãããã
ãšã«ããæ¥éã«é€å»ããããããã¯ç¹ã«ãβâã°
ã«ããŠããããŒãŒããã³ãªããã¯ã¬ã¢ãŒãŒïŒ¢ã®å Ž
åã«è¯ãèšé²ãããŠããïŒArch.Biochem.
Biophys.ïŒ1978ïŒ188ïŒ418ïŒAdvances in
EnzymologyïŒããŠãŒãšãŒã¯ã1974ïŒPediat.
Res.ïŒ1977ïŒ11ïŒ816ïŒããããã®æç®ã«ããã°ãª
ã·ã³ã®ïŒ¡éãæããå ç«æ¯çŽ ã®æ¥æ¿ãªè§£æ¶ã¯èã
ã现èãç¹ã«ã¯ãããŒçŽ°èã§ã®ãªã·ã³ïŒ¡éã®ãã³
ããŒã¹æ®æž£ã®èªèã«ãã説æããããšãã§ããã ä»ã®GPIRã«ã€ããŠã®è¡æŒ¿äžã§ã®è§£æ¶æ©æ§ãã
ãšãã°ã²ããã³åã¯MOMã«ã€ããŠãéè泚å°åŸ
ã«ã€ããŠç 究ããçµæã¯ããªã·ã³ã®ïŒ¡éã®å Žåãš
åæ§ã«GPIRã®è¡æŒ¿ã«ãããã¬ãã«ã¯æ¥éã«æžå°
ããããšã瀺ããŠãããããªãã¡ãã©ãããã®å Ž
åã粟補ã²ããã³ã®æ³šå°åŸè¡æµäžã®93ïŒ ãïŒæé
以å ã«æ¶å€±ãã24æé以å ã«99.99ïŒ ãæ¶å€±ããã ç³ã¿ã³ãã¯è³ªã«å«ãŸãããããªãªãµã€ãæ§é ã
éãšãŒãé žå¡©ã€ãªã³ã§é žåããããšã«ãããé£æ¥
ããççŽ ååã第ïŒã第ïŒããããã·ã«åºãæã
ãççŽ éã®åæãçãããGPIRäžã®ç°ç¶ãªãŒãº
ïŒosesïŒã®å Žåã®åŠããé£æ¥ããããããã·ã«åº
ã第ïŒçŽã®å Žåãé žåã«ããççŽ äžã«ïŒã€ã®ã¢ã«
ãããåºãçãããããããã®éã«åæãçã
ãã ãæ¬çºæã®å ·äœç説æã ãšããã§ãæè «çæ§ç³ã¿ã³ãã¯è³ªã®çæ°Žåç©å
äœãéãšãŠçŽ é žå¡©ã€ãªã³ã§é žå修食ãããå Žåã
ãã®ç³ã¿ã³ãã¯è³ªã®çç©åŠç掻æ§ãå®è³ªçã«å€å
ããã«æç¶ããããšãèŠãåºãããã ããã«ãªããœãŒã ãäžæŽ»æ§åããç³ã¿ã³ãã¯è³ª
ã®çæ°Žåç©åäœãéãšãŠçŽ é žå¡©ã€ãªã³ã§é žå修食
ããããšããçç©åŠç掻æ§ãæç¶ããçäœè¡æµã
ãåŸã ã«è§£æ¶ããããšããïŒéã®ç¹åŸŽãæããæ°
èŠãªç³ã¿ã³ãã¯è³ªãåŸãããããšãæå€ã«ãèŠã
åºãããã åãçååŠçç 究ã®çµæãéãšãŠçŽ é žå¡©ã§
GPIRãé žåããå Žåãåå¿ãGPIRã®ãªãµã€ã
éšåã«éžæçã«èµ·ããããããéšãæ§æããã¢ã
ãé žã®é åã«å šã圱é¿ããªãããšã蚌æãããã ãã®ãªããœãŒã ãäžæŽ»æ§åããæç¶æ§ãæãã
æ°èŠãªç³ã¿ã³ãã¯è³ªã以äžãGPIRâLaãšåŒç§°ã
ãã ãã®GPIRâLaãæäœãšçµåãããšãããã®ã³
ã³ãžãŠã²ãŒãïŒæ¥åäœïŒã¯å ç«æ¯æ§ã«ã€ããŠã®ç
ç©åŠçç¹æ§ãç¶æããè¡æŒ¿ã«ãããæ¶å€±ãé ãã
ãšãèŠãåºãããã ãããã€ãŠãæ¬çºæã¯éãšãŠçŽ é žå¡©ã€ãªã³ã§é ž
å修食ãããçæ°Žåç©åäœãæããæ°èŠãªæè «ç
æ§ç³ã¿ã³ãã¯è³ªãæäŸãããã®ã§ããããã®æ°èŠ
ãªç³ã¿ã³ãã¯è³ªã¯é修食ç³ã¿ã³ãã¯è³ªãšåæ§ã®æŽ»
æ§ã瀺ãããã€åæžæãããé·ããããã«æ¬çºæ
ã®æ°èŠãªç³ã¿ã³ãã¯è³ªã¯ãã®ããªãŒã«åºããéãš
ãŠçŽ é žã¢ã«ã«ãªéå±å¡©ã®æ°Žæº¶æ¶²ã§0.2ã24æéã
ïŒã15âã®æž©åºŠãææã§åŠçããŠä¿è·ããå¿ èŠã«
ããããªãŒã«åºã®é®æã解é€ããå ¬ç¥ã®æ¹æ³ã§æ
çµè£œåãåé¢ããŠåŸãããšãã§ããã å šãŠã®æè «çæ§ç³ã¿ã³ãã¯è³ªãå ¬ç¥ã®æ¹æ³ã§ã
ã®çæ°Žåç©åäœãéãšãŠçŽ é žå¡©ã€ãªã³ã§åå¿ã
ãã修食ãããããšãã§ããã æ¬çºæã«ãããå šãŠã®GPIRã¯æ¥µããŠããããª
现èæ¯æ§ã瀺ãããªããªãã°ããããã¯çŽ°èã«åº
å®ãããªãããç¹å®ã®çŽ°èãèªèããæäœãšçµå
ããã®ã¡ã¯ããã®æäœãç®æšïŒã¿ãŒã²ããïŒãèª
èãããšããããã®çŽ°èã«å¯Ÿã倧ãã现èæ¯æ§ã
瀺ãããšã«ãªãã ãã®GPIRåºçºç©è³ªã®äŸãšããŠã¯ãªã·ã³ïŒ¡éã
ã²ããã³ãMOMããã®æœåºç©ãããã ãã®ä»ã®GPIRã§éãšãŠçŽ é žå¡©ã€ãªã³ã«é žåã
ããåºçºç©è³ªã®äŸãšããŠã¯ä»¥äžã®ãã®ãæããã
ãã ãžã¢ã³ãã³30âŠâŠãžã¢ã³ãµã¹ ã«ã«ãšãã€ã©ã¹ ïŒDianthinïŒïŒDianthus CaryophyllusïŒ ãžã¢ã³ãã³32âŠâŠåäž ã¢ã°ãã¹ãã³ïŒ¡âŠâŠã¢ã°ãã¹ãã ã®ãµãŽ ïŒAgrostinAïŒïŒAgrostemma githagoïŒ ã¢ã°ãã¹ãã³ïŒ¢âŠâŠåäž ã¢ã°ãã¹ãã³ïŒ£âŠâŠåäž HCIâŠâŠããŠã© ã¯ã¬ãã¿ã³ã¹ ïŒHura crepitansïŒ ã¢ã¹ãã©ã¬ã¹ãªãã€ã·âŠâŠã¢ã¹ãã©ã¬ã¹ãªãã€
ã·ããªã¹ ããªã¹ææ¢äœïŒAsparagus officinalisïŒ ãã®ç®çã«æ²¿ã€ãŠä¿®é£ŸãããéºäŒåã®çŽ°èã«ã
ãçåæçã«è£œé ãããåæ§ã®ç©è³ªãæå¹ã§ã
ãã ãªããœãŒã ãäžæŽ»æ§åããèœåã瀺ãéãäžèš
GPIRã®åç»ãåºçºç©è³ªãšããŠçšããããšãã§ã
ããå°ãªããšãããªãŒã«åºã®äžã€ãä¿è·ããã倩
ç¶ãªã·ã³ã®ïŒ¡éã¯å¥œãŸããåºçºç©è³ªã®äžã€ã§ã
ãã ãªã·ã³ã®ïŒ¡éã¯å€ç³åäœãç°ãªãA1ïŒA2ãšã
ãŠè¡šããããïŒæåãããªã€ãŠãããéãšãŠçŽ é ž
å¡©ã«ããé žåã¯ãããA1ïŒA2éã«å¯Ÿãåæ§ã«ã
ããªããããããïŒæåã«åçã®è¬çå¹æã®åäž
ãäžããã çŽç²ãªãªã·ã³ïŒ¡éã®è£œæ³ã«ã€ããŠã¯ç±³åœç¹èš±No.
4340535ã«èšèŒãããŠãããã²ããã³ããã³
MOMã«ã€ããŠãå ¬ç¥ã§ããã GPIRåºçºç©è³ªã®ããªãŒã«åºã®ä¿è·ã¯ãã®ããª
ãŒã«åºãæäœãšçµåãããã®ã«çšããããå Žåã«
æãŸããã ä»ã®å®èœåºããã®çµåã«çšããããå Žåãããš
ãã°ããã·ã³ã®ããšããŒã«ããããã·ã«åºãåã¯
GPIRã®ã¢ããåºåã¯ã«ã«ããã·ã«åºãçšããã
ãå Žåããã®ä¿è·ããããªã€ãŠãããããã¯ãã
ãªããªããŠãããã ããããã³ã°ïŒé®æïŒã¯SHåºãããªãŒã«ïŒäº
ç¡«åç©çœ®æåã¯éå ã«ãããã®ã¡ã«é€å»ãåŸãå
åç©ãšã®åå¿ã«ãããããªãããšãã§ããããã®
ãããªååç©ã®äŸãšããŠã¯ïŒïŒ2â²âãžãããâ
ïŒïŒ5â²âãžããªãžå®æ¯éŠé žïŒDTNBïŒãïŒâïŒããª
ãžã³âïŒâã€ã«âãžã¹ã«ãã¢ãã«ïŒããããªã³
é žãåã¯ãžããªãžã«âïŒïŒ2â²âãžã¹ã«ãã€ããã
ããã¯ãžããªãžã«âïŒïŒ4â²âãžã¹ã«ãã€ãã§ã
ãããã®ãããªåŠçããããªããªãå Žåã¯é žåå
å¿ã®éã«éé¢ããªãŒã«ãæ¶å€±ãããã®å Žåããã
ã¯å šäœçã«åçã§ããªããéå°ã®ããããã³ã°å€
ã¯éæãã®ä»ã®åŠçã«ããé€å»ãããã éãšãŠçŽ é žå¡©ã«ããé žååå¿ã¯PHïŒãïŒã奜ãŸ
ããã¯ïŒã6.5ã§ãããªãããããã®éãšãŠçŽ é ž
å¡©ã¯éå°ã«çšãããããéãšãŠçŽ é žå¡©ã®æ¿åºŠãé ž
åãããé£äœã®ãžãªãŒã«ã®æ¿åºŠãã倧ããããã
ããªãã¡ã现èæ¯çŽ ãµããŠãããïŒã10mgïŒmlã®
æ¿åºŠã«å¯ŸãéãšãŠçŽ é žãããªãŠã 10ã50mMã®æ¿
床ãé©åœã§ããããã®åŠçã¯æž©åºŠïŒã15âã奜ãŸ
ããã¯ïŒãïŒâãææã«ãŠ0.2ã24æéã§ãããª
ãããã åå¿ã¯æ®çããéãšãŠçŽ é žå¡©ãæ¶è²»ããåå¿
å€ãããšãã°éå°ã®ãšãã¬ã³ã°ãªã³ãŒã«ã®æ·»å ã«
ããåæ¢ããããšãã§ããã€ãã§ãå¯çæç©ãé
æçã«ããé€å»ããããã®åå¿ã®çµæåŸããã補
åã¯å ¬ç¥ã®æ¹æ³ã«ããåé¢ããããšãã§ããã åºçºç©è³ªã®ããªãŒã«åºããããã¯ãããå Žåã
ãã®ããããã³ã°è§£é€ã¯ãããã¯ãããããªãŒã«
åºãããšãã°ïŒâã¡ã«ã«ãããšã¿ããŒã«ã解æŸã
ãåŸãéå å€ã§åå¿ãããŠãããªãããšãã§ãã
ããã«ãããªããœãŒã ãäžæŽ»æ§åããæç¶æ§ãæ
ããæ°èŠãªç³ã¿ã³ãã¯è³ªãåŸãããå ç«æ¯çŽ ãäž
ããæäœãšã®çµåã®ããã«çšããããã ãªã·ã³ïŒ¡ã®å ŽåãåŸãããæ°èŠãªååïŒä»¥äžïŒ¡
âLaãšèšãïŒã¯äžèšã®åŠãç¹åŸŽãæããã ååéã¯å€©ç¶ïŒ¡éãšå®è³ªçã«ç°ããã®ã§ãªãã
ããªã¢ã¯ãªã«ã¢ããåŸé é»æ°æ³³åã§èŠãéããã
ã®ä¿®é£ŸåŠçã¯ãã®ã¿ã³ãã¯è³ªã®ããªããŒã極ããŠ
å°éçæãããå£åçæç©ã¯çããªãã éé¢ããªãŒã«åºã®å²åãïŒã¢ã«åœã0.7以äžã§
ããã ãªã·ã³ã®ïŒ¡éãææ¢ããã©ãããæäœã«å¯Ÿãã
å ç«åå¿æ§ã倩ç¶ïŒ¡éã®å ç«åå¿æ§ãšå€ããªãã é现èã¢ãã«ã«ãããããã±ã質åæã«å¯Ÿãã
ææ¢æ§ã倩ç¶ïŒ¡éã®çéã«ãã€ãŠããããããã
ã®ã®50ïŒ ä»¥äžã§ããã ã©ãããã«0.4mgïŒKgïŒäœéïŒã®æäžéã§éè
æäžããã®ã¡23æé以å ã®ïŒ¡éïŒïŒ¡âLaïŒã®è¡
挿ã«ãããæ®ççã¯10ïŒ ä»¥äžïŒå€©ç¶ã®ïŒ¡éã«ã€ã
ãŠã¯0.015ïŒ ïŒã§ãã500å以äžã®å¢å€§ã瀺ãã ã²ããã³ã®å ŽåãéãšãŠçŽ é žå¡©ã§é žåããŠåŸã
ååã¯ä»¥äžã®åŠãç¹åŸŽãæãã ååéã¯å€©ç¶ã®ã²ããã³ã®ãã®ãšå®è³ªçã«å€ã
ãªãã 倩ç¶ã®ã²ããã³ãšå€ããªãæã²ããã³ã©ããã
æäœã«å¯Ÿããå ç«åå¿æ§ã瀺ãã ã©ãããã«0.3mgïŒKgïŒäœéïŒã®æäžãéèå
æäžããã®ã¡24æé以å ã«ããã®ä¿®é£Ÿã²ããã³ã¯
ïŒïŒ 以äžè¡æŒ¿ã«æ®çãïŒå€©ç¶ã²ããã³ã®å Žå0.01
ïŒ ïŒããããã€ãŠ200å以äžã®æ®ççã®åäžã瀺ã
ãã ãã®ãªããœãŒã ãäžæŽ»æ§åããç³ã¿ã³ãã¯è³ªã
ãã®ã³ã³ãžãŠã²ãŒãåã¯ç³ã¿ã³ãã¯è³ªã®è£œé ã¯ã
ãšãã°ç±³åœç¹èš±No.4340535ã«èšèŒãããæ¹æ³ã§ã
ããªãããšãã§ããããããéžã°ãã现èæ¯çŽ ãµ
ããŠãããã倩ç¶ã«å°ãªããšãäžã€ã®ããªãŒã«ã
æãçµåã«é©åããŠãããã®ã§ããã°ããã®åºã¯
掻æ§åäºç¡«ååºãæããæäœåã¯æäœåç»ãšã®å
å¿ã«çšãããããããããéžã°ãã现èãµããŠã
ããã倩ç¶ã«ããªãŒã«åºãæãããã®ã§ãªãã
ã°ãéé¢ããªãŒã«ãæããå®èœåºãå°ãªããšãäž
ã€ãå ¬ç¥ã®æ¹æ³ã§ãã®ãµããŠãããã«å°å ¥ããã
ããšãã§ããããã«ããäžè¿°ã®çµåãç¶ç¶ãã
ãããã®å®èœåºã®å°å ¥ã¯éãšãŠçŽ é žå¡©ã€ãªã³ã«ã
ãé žåå·¥çšã®åã«ãããªãããã®å Žåãé žåå·¥çš
ã®éã«ãã®ããªãŒã«ã©ãžã«ã«ãããããã³ã°ããŠ
ãããé žåå·¥çšåŸã«ãã®ããããã³ã°ã解æŸãã
ããã«ããŠãããããåé žåå·¥çšã®ã®ã¡ã«ãã®å°
å ¥ããããªã€ãŠãããã ãã®ããã«ããŠåŸããã修食å ç«æ¯çŽ ã¯è¬çå¹
æã«ã€ããŠæ°èŠãªç¹åŸŽãããªãã¡æ¬æ¥ã®çŽ°èæ¯æ§
ã«å ããŠãè¡æŒ¿äžã«ãããæ¶å€±é 延æ§ïŒæç¶æ§ïŒ
ãè¯å¥œãªãã®ãšãªãã å®æœäŸ ïŒ SHåºãâãšãã«ãã¬ã€ããã§ããããã³ã°
ãããã¡ãã«åéã®é žåã æ£ããå®èœåããããªã·ã³ïŒ¡éã®è£œé ïŒ ïŒ¡éã®ãããµã¡ãã«å Means and Feeneyã®æ¹æ³ïŒBiochemistry
ïŒïŒ2192ïŒ1968ïŒïŒã«ããã¡ãã«ååå¿ãïŒâã§
æªæããªãã0.2MããŠé žå¡©ç·©è¡æ¶²ïŒPHïŒ10ïŒ
äžã§ãããªã€ãã20mgã®ããªããšãŒãåããã
ïŒtritiatedïŒããŠçŽ åæ°ŽçŽ ïŒ9.5mCiïŒmmolã
å«ãïŒãé35mlïŒïŒmgïŒmlïŒã«å ããããã«
ïŒïŒ ãã«ã ã¢ã«ããã350ÎŒlãå ããïŒ30åé
ã«äºã70ÎŒlã¥ã€ïŒåïŒã éå°ã®æ·»å ç©è³ªã125mMãªã³é žå¡©ç·©è¡å€
ïŒPHïŒïŒãçšããŠé£ç¶çã«éæé€å»ããïŒ40
ã300mlïŒæéã®å²åã§ïŒãéæåŸãã¿ã³ãã¯è³ª
溶液ãé å¿åé¢ãããããµã¡ãã«åéïŒ2.6
mgïŒmlå«æïŒã36.5mlåŸãã ïŒ ïŒ®âãšãã«ãã¬ã€ãããçšããããããã³ã° ãããµã¡ãã«åéã®å€©ç¶SHåºã
Enzymology11541ïŒ1967ïŒã«èšèŒã®æ¹æ³ã§ãã
ããã³ã°ãããããªãã¡ãåã®å·¥çšã§åŸããªã·
ã³ïŒ¡éã20ã¢ã«çéã®ïŒ®âãšãã«ãã¬ã€ãã
ïŒïŒ¡éïŒã¢ã«åœãïŒã®ååšäžã§30âã§ïŒæéå¹
é€ãããã€ãã§PHïŒã®125mMãªã³é žå¡©ç·©è¡æ¶²
ãçšããŠé£ç¶çã«éæããŠéå°ã®æ·»å ç©è³ªãé€
å»ããããã®æäœã500mlïŒæéã®å²åã§20æ
éç¹°ãè¿ããããã®æ¿çž®ã®ã®ã¡ïŒmgïŒmlã®å²å
ã§å«ããªã·ã³ïŒ¡éã®æº¶æ¶²13mlãåŸãããã«ã¯
ELLMANè©Šè¬ã§å€å¥ãåŸããããªããªãŒã«åº
ã¯ãã¯ãååšããªãã€ãããã®ããã«ããŠåŸã
çæç©ã以äžããããµã¡ãã«åéïŒNEMïŒ
ãšç§°åŒããã ïŒ éãšãŠçŽ é žå¡©ã«ããé žå äžè¿°ã®å·¥çšã§åŸãNEM溶液ïŒmlãïŒâãPH
ïŒ4.5ã§ææã§40åéNaIO4ïŒ12.8mgïŒãšåå¿ã
ããã€ãã§ããã®åå¿ããšãã¬ã³ã°ãªã³ãŒã«
600ÎŒãæ·»å ããããšã«ããåæ¢ããããã€
ãã§ããã®åå¿åªäœã0.1Mã®çé žå¡©ç·©è¡æ¶²
ïŒPHïŒ10ïŒãçšãé£ç¶çã«éæãããïŒ500mlïŒ
æéã®å²åã§20æéïŒã é现èã¢ãã«ã§æž¬å®ããæç¶æ§ïŒ¡éã®é µçŽ 掻
æ§ ãªã·ã³ïŒ¡éã®åºæ¬ççç©åŠçç¹æ§ã¯ãªããœãŒã
ãµããŠããã60Sã®å£åã«ãã现èäžã§ã®ã¿ã³ã
ã¯è³ªåæãé»å®³ããããšã§ããã è©Šéšç®¡ã«ããæ¹æ³ã«ãããŠãã©ããã®èããã®
äžäœçŽ°èåç»ã§é©åœã«è£å®ãããã®ãçšãããã
ãã¯äººå·¥ã¡ãã»ã³ãžã€ãŒRNAãããªãã¡ããªãŠ
ãªãã€ã«é žã®ååšäžã§14Câããšãã«ã¢ããªã³ã
çµèŸŒãããšãã§ãããã®ã§ããã ãã®äžäœçŽ°èåç»ã®è£œé ããã³14Câããšãã«
ã¢ã©ãã³ã®çµèŸŒã¿ã®æž¬å®ã¯Biochemica
Biophysica Acta 1973ïŒ312ïŒ608â615ã«èšèŒã
ããŠããæ¹æ³ã§ããã¯ããœãŒã åç»ããã³ã©ãã
è现èã®ãµã€ããŸã«åç»ãçšããŠãããªã€ãããŸ
ãããã®ïŒ¡éãå«ããµã³ãã«ãé©åœã«åžéãã溶
液ã®åœ¢ã§ã0.2ïŒ ã®ïŒâã¡ãã«ã«ãããšã¿ããŒã«
ããã³15ÎŒgïŒmlã®ãŠã·è¡æž ã¢ã«ããã³ãå«ã
50mMããªã¹HClç·©è¡æ¶²ïŒPHïŒ7.6ïŒäžã«å°å ¥ã
ãã ã«ãŠã³ãããŒã¿ãçšããææ¢å€ãªãã®å¯Ÿç §åªäœ
ãšã®æ¯èŒã§ããªã·ã³ïŒ¡éãå«ãååå¿åªäœã«ã€ã
ãŠã¿ã³ãã¯è³ªäžã«çµèŸŒãŸãã14Câããšãã«ã¢ã©
ãã³ææ¢çïŒïŒ ïŒãèšç®ããã ãã®ææ¢æŽ»æ§ã枬å®ããçµæãé žåéã«ã€ã
ãŠã¯IC50ã2.7ã»10-10ã¢ã«ïŒïœãèªãããããä»
æ¹ãå¯Ÿç §ïŒ¡éã®IC50ã¯1.03ã»10-10ã¢ã«ïŒïœã§ã
ãããããã€ãŠããã®ä¿®é£Ÿã¯ïŒ¡éã®æŽ»æ§æ倱ã«åœ±
é¿ãäžããŠããªãã å®æœäŸ ïŒ ãã®å®æœäŸã¯éãšãŠçŽ é žãããªãŠã ã§ä¿®é£Ÿãã
ãªã·ã³ïŒ¡éãéè泚å°ããå Žåã®æ¶å€±ã®é 延æ§ã
蚌æããããã®ãã®ã§ããã éãšãŠçŽ é žãããªãŠã ã«ãããªã·ã³ïŒ¡éã®ä¿®
食 (1) DTNBãçšãã倩ç¶SHã®ããããã³ã° ãªã·ã³ïŒ¡éãç±³åœç¹èš±No.4340535ã«èšèŒãããŠ
ããæ¹æ³ã§è£œé ã粟補ãããïŒïŒ2â²âãžãããâ
ïŒïŒ5â²âãžããªïŒå®æ¯éŠé žïŒDTNBïŒã®æº¶æ¶²20åœ
éãããªãã¡ãPHïŒã®125mMãªã³é žå¡©ç·©è¡æ¶²ã«
溶ãããDTNBã®0.1M溶液ã385ÎŒïŒãã®æº¶æ¶²
ã¯æ°Žé žåãããªãŠã ã§PHïŒïŒã«èª¿ç¯ããïŒãã
PBSç·©è¡æ¶²ã«æº¶ããã5.6mgïŒmlã®å²åã§å«ããª
ã·ã³ïŒ¡é10ml溶液ã«å ããïŒããé žå¡©ã«ã€ããŠã¯
20mMïŒNaClã«ã€ããŠã¯150mMã®PHïŒïŒã®ç·©è¡
液ïŒãå¹é€ã¯20âã§20åéç¶ããããã®æº¶æ¶²ãïŒ
âã§PBSç·©è¡æ¶²ãçšããŠéæããããªãŒã«åºã
ããããã³ã°ããéã53mgãïŒmgïŒmlã®å²åã§
å«ã溶液ãšããŠåŸãã (2) ããããã³ã°ãããéã®éãšãŠçŽ é žå¡©ã«
ããé žå éãšãŠçŽ é žãããªãŠã ã®0.5M氎溶液120ÎŒãã
1Mé ¢é žã§PHïŒïŒã«èª¿æŽããããããã³ã°æžã¿ïŒ¡
éãïŒmgïŒmlå«ã溶液ïŒmläžã«å ãããå¹é€ã¯æ
æã§ïŒâã§16æéãããªã€ããé žååå¿åæ¢ã¯ãš
ãã¬ã³ã°ãªã³ãŒã«ã®1M氎溶液620ÎŒãå ããã
ãšã«ãããããªã€ããå¹é€åŸã20âã§15åéãå
å¿åªäœãïŒâã§PBSç·©è¡æ¶²ã§éæããããã®é
ãšãŠçŽ é žå¡©ã«ããé žåã«ããã¿ã³ãã¯è³ªã®ããã
ãªæåºãåŸããããã30åéã10000Ãã§é å¿
åé¢ãé€å»ããé žåããã³ããããã³ã°ããã
éã3.4mgïŒmlã®æ¿åºŠã§24mgåŸãã (3) ããªãŒã«åºã®ããããã³ã°è§£æŸ ïŒâã¡ã«ã«ãããšã¿ããŒã«ãéå å€ãšããŠæçµ
æ¿åºŠïŒïŒ ã§é žåãããããã³ã°åéïŒPBSç·©
è¡æ¶²äžã«3.4mgïŒmlå«ãïŒïŒmlã«å ãããå¹é€ã
20âã§ïŒæéãããªããã€ãã§ãã®æº¶æ¶²ãïŒâã§
PBSç·©è¡æ¶²ãçšããŠéæããããã®çµæé žåã
ããéã2.8mgïŒmlã®æ¿åºŠã§19mgåŸãã DTNBæ³ïŒEnzymologyïŒ1972ïŒ25ïŒ457
Academic PressïŒãçšãããã®ä¿®é£Ÿãããé
ãïŒã¢ã«åœã0.70ã®éé¢ããªãŒã«åºãæããããš
ãå€æããããã®ä¿®é£ŸïŒ¡éã®ååéã¯ããã·ã«ãµ
ã«ããšãŒãã®ååšäžã§ã®ããªã¢ã¯ãªã«ã¢ããåŸé
é»æ°æ³³åã«ãã30000±3000ã§ããããšãå€æã
ãã å€ç³åäœãé žåãããéããã¿ã³ãã¯è³ªåæ
ã®ææ¢ã«ãããé µçŽ æŽ»æ§ããã³è¬çåŠçç¹æ§ã«ã€
ããŠç 究ããã æç¶æ§ïŒ¡éã®é µçŽ 掻æ§ã®é现èã¢ãã«ã«ãã
æž¬å® ææ¢æŽ»æ§ãå®æœäŸïŒã®æ¹æ³ã§æž¬å®ããããã®çµ
æãé žåéã®IC50ã¯ïŒÃ10-10ã¢ã«ïŒã§ããã
å¯Ÿç §ïŒ¡éã®IC50ã¯1.2Ã10-10ã¢ã«ïŒã§ãã€ãã
ãããã€ãŠä¿®é£Ÿã«ããéã®æŽ»æ§æ倱ã¯èªããã
ãªãã€ãã æç¶æ§ïŒ¡éïŒïŒ¡âLaïŒã®è¬çå¹æ ãã®ïŒ¡éãã©ãããã«è³ãä»ããŠéèæäžã
ãããã®ïŒ¡éæäžéã¯0.415mgïŒKgã§ãã€ããè¡
液ãµã³ãã«ããããªã³äžã«ééããããŠæ¡åã
ãããã®è¡æŒ¿ãäžèšã«RIMâïŒã®èšå·ã§ç€ºãã
ã©ãžãªã€ã ãã¢ãã»ã€ãã¹ãã§åæããã ãã®æ¹æ³ã¯ïŒ¡éã修食ããããšãªãã«å€å®ãåŸ
ãå©ç¹ãæããããã®å€å®ããã€ã¯ã滎å®ãã¬ãŒ
ããçšããŠãããªã€ãããã®ãã¬ãŒãã®èäœã«ã¯
éåžåå€ã¹ãã€ã¯ãèšããããŠããŠããããããŒ
ã¹äžã®ç©Žã«æµžå ¥ããããã«ãªã€ãŠããããããã®
ã¹ãã€ã¯ã¯åºäœçžãããªããã®ã§ããããªã·ã³ã®
éã瀺ãã芪åæ§ã¯ãããã°ã©ãã€ã§ç²Ÿè£œãã
ãéçŸæäœïŒä»¥äžã«Ac1ã®èšå·ã§ç€ºãïŒããã®åº
äœçžäžã«åžåãããããã®ç®çã®ãããPBSç·©
è¡æ¶²äžã«10ÎŒgïŒmlå«ãAc1ã®æº¶æ¶²ãäžèšç©Žã«å
ããŠæ³šå ¥ãããäžèšã¹ãã€ã¯ãïŒâã§24æéã
Ac1溶液ãšæåã«æ¥è§Šãããã€ãã§20âã§ïŒæ
éãèå ãŠã·è¡æž ãšæ¥è§Šãããå šãŠã®åºå®éšäœã
飜åãããããã®é£œåããå ç«åžåå€ã20âãïŒ
æéãçš®ã ã®æ¿åºŠã®è¡æŒ¿ãµã³ãã«ãåã¯æ¢ç¥ã®æ¿
床ã®ïŒ¡é溶液ãšæ¥è§Šãããç®çæ²ç·ãäœæããã
PBSç·©è¡æ¶²ã§æŽæµåŸããã®å ç«åžåå€ããªã·ã³
éã瀺ãéçŸæäœïŒèŠªåã¯ãããã°ã©ãã€ã§ç²Ÿ
補ããæŸå°èœã©ãã«ãæœãããã®ã以äžAc2ãšèš
ãïŒãš20âã§ïŒæéæ¥è§Šãããããã®Ac2ã®æŸå°
èœã©ãã«ã¯ã¯ãã©ãã³ïŒŽã®ååšäžã§ãšãŠçŽ 125ã
çšããGreenwoodããã³Hunterã®æ¹æ³
ïŒBiochem.J.ïŒ1963ïŒ89ïŒ114ïŒã§ãããªã€ãã
ãã®ã©ãã«ããAc2æäœã¯ïŒã10ãã€ã¯ãããŠãŒ
ãªâïŒÎŒgã瀺ããããã®ã©ãã«åAc2106cpmã
200ÎŒãšããŠã0.1ïŒ ãŠã·è¡æž ã¢ã«ããã³ãå«ã
PBSç·©è¡æ¶²äžã«å°å ¥ãããPBSç·©è¡æ¶²äžã§æŽæµ
ã®ã®ã¡ãäžã¹ãã€ã¯ãåãã¯ãããçµåããAc2
ã®éãæŸå°èœæž¬å®ã«ããèšéããããµã³ãã«äžã®
éã®æ¿åºŠã¯ãç°ãªãæ¢ç¥ã®æ¿åºŠã§ïŒ¡éãå°å ¥ã
ãããšã«ãã€ãŠäœãããç®çæ²ç·ã«å¯ŸããŠåç §ã
ãããšã«ãã枬å®ãããæç¶æ§ïŒ¡éãåç©ã«æ³šå°
ããéãåãéãçšãçžåœããç®çæ²ç·ãäœæ
ããã ãã®æ¹æ³ã§æž¬å®ãããè¡æŒ¿äžã®ïŒ¡éã®æ¿åºŠã¯å
çŸæ§ããããä¿¡é Œã§ãããã®ã§ããããã®æ¢ç¥ã
ããå€ã¯1ngïŒmlã§ãããåå®éšéã®åçŸæ§ã®æ€
èšã®çµæãå€åé¢æ°ãïŒã200ngïŒmlã®æ¿åºŠã«ã€
ããŠ10ïŒ ä»¥äžã§ãã€ãã ãããã®å®éšã®çµæã¯æ²ç·ã§ç€ºãããæéã¯æšª
軞ã«ãé¶æã®è¡æŒ¿æ¿åºŠçè«å€ã«å¯Ÿããèšé²ããã
çæç©ã®è¡æŒ¿æ¿åºŠã®ïŒ ãlogã¹ã±ãŒã«ã§çžŠè»žã«ç€º
ããããã®å€ãããªãã¡ãâçžå¯Ÿè¡æŒ¿æ¿åºŠâ
ïŒRPCïŒã¯äžèšã®åŒã§èšç®ãããã RPCïŒæéâïœâã§æž¬å®ããæ¿åºŠïŒæ³šå°éïŒè¡æŒ¿éÃ1
00 è¡æŒ¿éã¯åç©ã®äœéã®ïŒKgåœã36mlã§èããã
ãŠããã 第ïŒå³ã¯å€©ç¶ãªã·ã³ïŒ¡éãéè泚å°ããå Žåã®
è¡æŒ¿ã«ãããæ¶å€±æ²ç·ãæéã®é¢æ°ãšããŠç€ºãã
ãã®ã§ããããã®æ²ç·(1)ã¯ïŒã€ã®çžã瀺ããŠã
ãã第ïŒã«ãã®å€©ç¶ãªã·ã³ïŒ¡éã泚å°åŸïŒæéã§
è¡æŒ¿äžã«æ®ãçã¯ããã0.1ïŒ ïŒæäžéã«å¯ŸããŠïŒ
ã§ãããè¡æ¶²ããæ¥æ¿ã«æ¶å€±ããããšã瀺ããŠã
ãã第ïŒã®çžã«ãããŠã¯ãã®æ¶å€±ããããããã
ã§ããã ããããå€ç³åäœãé žåãããéã«ãããŠ
ã¯ããã®æ¶å€±æ§ã¯èãããæ¹ãããããããªã
ã¡ãé補åã®å€§éšåãæ¶å€±ããããšãšãªã第ïŒ
ã®æ¶å€±çžã¯èãããæå¶ããããã®çµæãéã®
è¡æŒ¿ã«ãããæ®çã¬ãã«ãèãããå¢å€§ããã泚
å°20æéåŸã§ã¯é žåéã®æ¿åºŠã¯ä¿®é£ŸãããŠããª
ãéïŒæ²ç·ïŒïŒã®å Žåã®600åã«ããªãã å®æœäŸ ïŒ ãã®å®æœäŸã¯NEMã§ä¿è·ãããéã®è¬ç©å
æ åŠçæ§è³ªã«å¯ŸããéãšãŠçŽ é žå¡©ã«ããé žåã®å¹
æãæ€èšãããã®ã§ããã ïŒ ãªã·ã³ã®ïŒ¡éã®ä¿®é£Ÿ ïœ ïŒ®âãšãã«ãã¬ã€ããã«ããéé¢SHã®ä¿è· ãªã·ã³ã®ïŒ¡éãïŒmgïŒmlã®å²åã§å«æãããªã·
ã³ïŒ¡é氎溶液40mlïŒïŒ¡é4.1ãã€ã¯ãã¢ã«ïŒãïŒ
âã¡ã«ã«ãããšã¿ããŒã«ã®æ°Žæº¶æ¶²ã§åŠçããŠïŒ¡é
ã®æçµæ¿åºŠãïŒïŒ ãšãªãããã«ããã ãã®æº¶æ¶²ãïŒæéæŸçœ®ããåŸãPHïŒã®125mM
ãªã³é žç·©è¡æ¶²ã§é£ç¶çã«éæããããªã³é žç·©è¡æ¶²
ã¯æ¯æ300mlã®å²åã§40æéæ°ãããã®ãšäº€æã
ãããšã«ãã³ïŒEllmanïŒã®æ¹æ³ãçšããŠããªã·
ã³ã®ïŒ¡éïŒã¢ã«åœã0.9åœéã®SHã枬å®ãããã ãã®SHåºããã¡ãœããºã»ã€ã³ã»ãšã³ã¶ã€ã¢ã
ãžãŒïŒMethods in EnzymologyïŒã11541ïŒ1967ïŒ
ã«èšèŒãããŠããæ¹æ³ã«ãã€ãŠïŒ®âãšãã«ãã¬ã€
ããã§ä¿è·ãããããªãã¡ãäžèšå·¥çšã§åŸããªã·
ã³ïŒ¡éãããã®ïŒ¡éïŒã¢ã«åœã20åœéã®ïŒ®âãšã
ã«ãã¬ã€ããã®ååšäžã«30âã§ïŒæéã€ã³ããŠã
ãŒããéå°ã®è©Šè¬ãPHïŒã®125mMãªã³é žç·©è¡æ¶²
ã§é£ç¶çã«éæããããšã«ãã€ãŠé€å»ããããã®
éããªã³é žç·©è¡æ¶²ã¯ãæ¯æ500mlã®å²åã§20æé
ã«ããã€ãŠæ°ãããã®ãšäº€æãããããã«ããã
ãšã«ãã³ã®è©Šè¬ã§æž¬å®ãåŸãããªãŒã«åºãå«ãŸãª
ãã§ïŒ¡éãæ¿åºŠïŒmgïŒmlã§å«ã溶液ãåŸãããã
ããŠåŸãçæç©ã以äžïŒ¡éïŒNEMïŒãšããããš
ãšããã ïœ éãšãŠçŽ é žå¡©ã«ããéïŒNEMïŒã®é žå éãšãŠçŽ é žå¡©ã«ããéïŒNEMïŒã®é žåã¯å®
æœäŸïŒã®ææ³ã«ãã€ãŠãããªã€ãã ïŒ é žåãããéïŒNEMïŒã®ç¹æ§ ïœ é žåãããéïŒNEMïŒã®é µçŽ æŽ»æ§ ã¿ã³ãã¯åæã«å¯Ÿããé»å®³æŽ»æ§ãå®æœäŸïŒã®æ
æ³ãçšããŠæž¬å®ããããã®çµæãé žåãããé
ïŒNEMïŒã®é µçŽ 掻æ§ã¯ãIC50ã§4.3Ã10-10ã¢ã«ïŒ
ãªããã«ã§ãã€ãã ïœ é žåãããéïŒNEMïŒã®è¬ç©åæ åŠçæ§
質 é žåããããŸãã¯é žåãããŠããªãé
ïŒNEMïŒããŠãµã®ã®è³è¡ç®¡ã«äžå泚å°ããã泚
å°ããéã®éã¯0.100mgïŒKgã«çžåœãããã®ã§ã
ã€ãã23æéåŸã«æ¡åããè¡æŒ¿ããå®æœäŸïŒã«èš
èŒããå ç«æž¬å®æ³ãçšããŠåæãããçµæã以äž
ã®è¡šã«èšèŒããã
ãè¡šã
泚å°ããŠãã23æéçµéåŸãé
žåé
ïŒNEMïŒã®æ¿åºŠã¯ãé žåããŠããªãé
ïŒNEMïŒã®ããã®800åã§ãã€ãã å®æœäŸ ïŒ ãã®å®æœäŸã¯ãé žååŠçæéãé žåéã®è¬ç©
åæ åŠçæ§è³ªã«åãŒãéèŠæ§ãæ€èšãããã®ã§ã
ãã éãšãŠçŽ é žãããªãŠã ã«ããåŠçæéãå€ãã
以å€ã¯å®æœäŸïŒã®ææ³ãçšããŠïŒçš®ã®é žåéã®
補å€ã調補ãããåŠçæéã¯æ¬¡ã®éãã§ãã€ãã
ããªãã¡ãïŒïŒãšãã¬ã³ã°ãªã³ãŒã«ãçšããŠåå¿
ãçŽã¡ã«åæ¢ïŒã20åã40åã2.5æéãïŒæéã
ããã³18æéã§ãã€ãã ãããïŒçš®ã®è£œå€ããŠãµã®ã«æ³šå°ãã23æéçµ
éåŸã®ïŒ¡éã®è¡æŒ¿äžçžå¯Ÿæ¿åºŠãå®æœäŸïŒã®ææ³ã«
ãã枬å®ããã çµæã第ïŒå³ã«ç€ºãããã®çµæãããïŒïŒïŒ¡é
ã®è¡æŒ¿äžæ¿åºŠã®å¢å ã¯ã確ãã«ãéãšãŠçŽ é žå¡©ã«
ããé žåã«åºã¥ãããšïŒåå¿ãçŽã¡ã«åæ¢ãããš
ãã¯ãéã®è¡æŒ¿äžæ¿åºŠã¯çã®ïŒ¡éã«ã€ããŠã®ã
ã®ãšåäžã§ããããã§ããïŒãããã³ïŒïŒæé©ã®
å¹æãåŸãããã«ã¯ãåå¿åŠçæéãæ¯èŒçé·ã
ããããšãå¿ èŠã§ããããšããããã å®æœäŸ ïŒ ãã®å®æœäŸã¯ãé žååŠçæéãNEMã§ä¿è·ã
ããã¡ãã«åéã®è¬ç©åæ åŠçæ§è³ªã«åãŒãé
èŠæ§ãæ€èšãããã®ã§ããã ïŒ æå¿åãªã·ã³ïŒ¡éã®èª¿è£œ ïœ ïŒ®âãšãã«ãã¬ã€ããã«ããéã®éé¢SH
ã®ä¿è· å®æœäŸïŒã®ææ³ãçšããŠãéã®éé¢SHã
âãšãã«ãã¬ã€ããã§ä¿è·ããã ïœ ïŒ¡éã®ã¡ãã«å ãã®ã¡ãã«ååå¿ã¯ãããŒã³ãºïŒMeansïŒã
ãã³ãã€ãŒããŒïŒFeeneyïŒã®æ¹æ³ïŒãã€ãªã±ã
ã¹ããªãŒïŒBiochemistryïŒïŒïŒ2192ïŒ1968ïŒã
çšããPHïŒã®0.2MããŠçŽ é žç·©è¡æ¶²äžïŒâã§æªæ
ããªãããããªã€ããããªããŠã åæ°ŽçŽ åããŠçŽ
38mgïŒ47mCiïŒããªã¢ã«å«æïŒãéïŒNEMïŒ
65.5mlïŒïŒmgïŒmlïŒã«å ããããã«ïŒïŒ ãã«ã ã¢
ã«ãããããïŒmlã200ãã€ã¯ããªããã«ã¥ã€ïŒ
åã«åããŠ30åã§æ·»å ããã éå°ã®è©Šè¬ããPHïŒã®125mMãªã³é žç·©è¡æ¶²
ïŒ40mlïŒã§æç¶çã«éæããããšã«ãã€ãŠé€å»ã
ããéæåŸãã¿ã³ãã¯æº¶æ¶²ãé å¿ãããããã
ãŠãæ¿åºŠmgïŒmlã®ã¡ãã«åé63mlãåŸãã ïœ éãšãŠçŽ é žå¡©ã«ããé žå éãšãŠçŽ é žãããªãŠã ã«ããåŠçæéãå€ãã
以å€ã¯å®æœäŸïŒã®ææ³ãçšããŠïŒçš®ã®é žåéã®
補å€ã調補ãããåŠçæéã¯æ¬¡ã®éãã§ãã€ãã
ããªãã¡ãïŒïŒãšãã¬ã³ã°ãªã³ãŒã«ãçšããŠåå¿
ãçŽã¡ã«åæ¢ïŒã20åã40åã2.5æéãïŒæéã
ããã³18æéã§ãã€ãã ãããïŒçš®ã®è£œå€ããŠãµã®ã«æ³šå°ãã23æéçµ
éåŸã®ïŒ¡éã®è¡æŒ¿äžçžå¯Ÿæ¿åºŠãå®æœäŸïŒã®ææ³ã«
ãã枬å®ããã çµæã第ïŒå³ã®æ²ç·ïŒã«ç€ºãããã®çµæããã
ïŒïŒã¡ãã«åéïŒNEMïŒã®è¡æŒ¿äžæ¿åºŠã®å¢å
ã¯ã確ãã«ãéãšãŠçŽ é žå¡©ã«ããé žåã«åºã¥ãã
ãšïŒåå¿ãçŽã¡ã«åæ¢ãããšãã¯ãã¡ãã«åé
ïŒNEMïŒã®è¡æŒ¿äžæ¿åºŠã¯ãã®ïŒ¡éã«ã€ããŠã®ã
ã®ãšåäžã§ããããã§ããïŒãããã³ïŒïŒæé©ã®
å¹æãåŸãããã«ã¯ãåå¿åŠçæéãæ¯èŒçé·ã
ããããšãå¿ èŠã§ããããšããããã å®æœäŸ ïŒ æ¬å®æœäŸã¯ãéãæ§æããïŒã€ã®ååé
ïŒA1éãšA2éïŒãå¥ã ã«é žåããå Žåããã®é ž
ååå¿ã¯ããªã·ã³ã®ïŒ¡éã«ã€ããŠå®æœäŸïŒã§è¿°ã¹
ããã®ãšé¡äŒŒã®å¹æãåãŒãããšã瀺ããŠããã ïŒ A1éãšA2éã®åæ 10.9mgïŒmlã®ïŒ¡éãå«æããPH7.0ã®125mMãª
ã³é žç·©è¡æ¶²28mlïŒïŒ¡éã¯309mgïŒããäžèšç·©è¡æ¶²
äžã§å¹³è¡¡ã«ããã³ã³ã«ãããªã³ïŒä»¥äžãConAãš
ç¥ãïŒ112mlãšã»ãã¢ããŒãºã®å ¥ã€ãã«ã©ã ã«æ³š
ãã ãA1éã¯åç·©è¡æ¶²ã§æº¶åºãããæã®æåã®
ããŒã¯ã§åŸãããA2éã¯PH6.0ã®0.1MããŠé žç·©è¡
液ã§æº¶åºãããããã®ç·©è¡æ¶²ã¯å¡©åãããªãŠã æ°Ž
溶液ã«å¯ŸããŠ0.5Mãαâã¡ãã«ãã³ãã·ãã«å¯Ÿ
ããŠ0.1Mã®æ¿åºŠã«ããã ãã®çµæA1éã¯184mgãA2éã¯103mgåŸãã
ããA1éãšA2éãçªçŽ ã®å å§äžã§éå€éã«ã
ãæ¿çž®ãããA2éã¯PH7.0ã®125mMãªã³é žç·©è¡æ¶²
ã§éæãããã éãSDSâã¢ã¯ãªã«ã¢ããã²ã«é»æ°æ³³åã«ã
ããçµæãååé30000ãš33000ã«å¯Ÿå¿ããŠïŒã€ã®
ãã³ããçŸãããæ¿ãæè²ãããA1éãååé
30000ã®ãã³ãã§ãèãæè²ãããA2éãååé
33000ã®ãã³ãã ã€ãã ïŒ ãªã·ã³A1éããã³A2éã®éãšãŠçŽ é žãããª
ãŠã ã«ãã修食 ãã®ä¿®é£Ÿã¯å®æœäŸïŒã§è¿°ã¹ããããªå¹æãåãŒ
ããããªãµãã«ã©ã€ããé žåãããéã®ã¿ã³ã
ã¯è³ªåæé»å®³ã«ãããé µçŽ æŽ»æ§ãšè¬ç©åæ åŠçç¹
æ§ã調ã¹ãã ïŒ ç¡çŽ°èç³»A1éåã³A2éã«ãããé µçŽ æŽ»æ§ã®
ç¶æ é»å®³äœçšãå®æœäŸïŒã§è¿°ã¹ãããã«ããŠæž¬å®ã
ããIC50ã¯é žåãããA1éããã³A2éã«å¯ŸããŠ
ãããã2.1Ã10-10molïŒã2.1Ã10-10molïŒ
ã§ãã€ããæ¬å®æœäŸã«ãããŠæ¯èŒäŸãšããŠçšãã
çã®A1éããã³A2éã®IC50ã¯ãããã1.9Ã10-10
molïŒã1.0Ã10-10molïŒã§ãã€ããåŸã€ãŠ
éããåæãããååéã®ä¿®é£Ÿã¯ãã®é µçŽ 掻æ§
ãæžããªãã ïŒ A1éïŒA1âLaïŒããã³A2éïŒA2âLaïŒã«
ãããè¬ç©åæ åŠçç¹æ§ã®ç¶æ A1è¥ããã¯A1âLaéãŸãã¯A2è¥ããã¯A2â
Laéããããã®è³ã®è¡ç®¡ãããäœéïŒKgåœãã
é415ÎŒgã®å²åã§ãïŒå泚å°ããã20æéåŸã«
æ¡åããè¡æŒ¿ãµã³ãã«ãå ç«è©ŠéšRIMâïŒïŒå®æœ
äŸïŒåç §ïŒã«ãã€ãŠåæãããçµæãäžè¡šã«ç€º
ããéåã³ïŒ¡âLaéã®å€ãå¯Ÿç §çã«ç€ºãã
ïŒNEMïŒã®æ¿åºŠã¯ãé žåããŠããªãé
ïŒNEMïŒã®ããã®800åã§ãã€ãã å®æœäŸ ïŒ ãã®å®æœäŸã¯ãé žååŠçæéãé žåéã®è¬ç©
åæ åŠçæ§è³ªã«åãŒãéèŠæ§ãæ€èšãããã®ã§ã
ãã éãšãŠçŽ é žãããªãŠã ã«ããåŠçæéãå€ãã
以å€ã¯å®æœäŸïŒã®ææ³ãçšããŠïŒçš®ã®é žåéã®
補å€ã調補ãããåŠçæéã¯æ¬¡ã®éãã§ãã€ãã
ããªãã¡ãïŒïŒãšãã¬ã³ã°ãªã³ãŒã«ãçšããŠåå¿
ãçŽã¡ã«åæ¢ïŒã20åã40åã2.5æéãïŒæéã
ããã³18æéã§ãã€ãã ãããïŒçš®ã®è£œå€ããŠãµã®ã«æ³šå°ãã23æéçµ
éåŸã®ïŒ¡éã®è¡æŒ¿äžçžå¯Ÿæ¿åºŠãå®æœäŸïŒã®ææ³ã«
ãã枬å®ããã çµæã第ïŒå³ã«ç€ºãããã®çµæãããïŒïŒïŒ¡é
ã®è¡æŒ¿äžæ¿åºŠã®å¢å ã¯ã確ãã«ãéãšãŠçŽ é žå¡©ã«
ããé žåã«åºã¥ãããšïŒåå¿ãçŽã¡ã«åæ¢ãããš
ãã¯ãéã®è¡æŒ¿äžæ¿åºŠã¯çã®ïŒ¡éã«ã€ããŠã®ã
ã®ãšåäžã§ããããã§ããïŒãããã³ïŒïŒæé©ã®
å¹æãåŸãããã«ã¯ãåå¿åŠçæéãæ¯èŒçé·ã
ããããšãå¿ èŠã§ããããšããããã å®æœäŸ ïŒ ãã®å®æœäŸã¯ãé žååŠçæéãNEMã§ä¿è·ã
ããã¡ãã«åéã®è¬ç©åæ åŠçæ§è³ªã«åãŒãé
èŠæ§ãæ€èšãããã®ã§ããã ïŒ æå¿åãªã·ã³ïŒ¡éã®èª¿è£œ ïœ ïŒ®âãšãã«ãã¬ã€ããã«ããéã®éé¢SH
ã®ä¿è· å®æœäŸïŒã®ææ³ãçšããŠãéã®éé¢SHã
âãšãã«ãã¬ã€ããã§ä¿è·ããã ïœ ïŒ¡éã®ã¡ãã«å ãã®ã¡ãã«ååå¿ã¯ãããŒã³ãºïŒMeansïŒã
ãã³ãã€ãŒããŒïŒFeeneyïŒã®æ¹æ³ïŒãã€ãªã±ã
ã¹ããªãŒïŒBiochemistryïŒïŒïŒ2192ïŒ1968ïŒã
çšããPHïŒã®0.2MããŠçŽ é žç·©è¡æ¶²äžïŒâã§æªæ
ããªãããããªã€ããããªããŠã åæ°ŽçŽ åããŠçŽ
38mgïŒ47mCiïŒããªã¢ã«å«æïŒãéïŒNEMïŒ
65.5mlïŒïŒmgïŒmlïŒã«å ããããã«ïŒïŒ ãã«ã ã¢
ã«ãããããïŒmlã200ãã€ã¯ããªããã«ã¥ã€ïŒ
åã«åããŠ30åã§æ·»å ããã éå°ã®è©Šè¬ããPHïŒã®125mMãªã³é žç·©è¡æ¶²
ïŒ40mlïŒã§æç¶çã«éæããããšã«ãã€ãŠé€å»ã
ããéæåŸãã¿ã³ãã¯æº¶æ¶²ãé å¿ãããããã
ãŠãæ¿åºŠmgïŒmlã®ã¡ãã«åé63mlãåŸãã ïœ éãšãŠçŽ é žå¡©ã«ããé žå éãšãŠçŽ é žãããªãŠã ã«ããåŠçæéãå€ãã
以å€ã¯å®æœäŸïŒã®ææ³ãçšããŠïŒçš®ã®é žåéã®
補å€ã調補ãããåŠçæéã¯æ¬¡ã®éãã§ãã€ãã
ããªãã¡ãïŒïŒãšãã¬ã³ã°ãªã³ãŒã«ãçšããŠåå¿
ãçŽã¡ã«åæ¢ïŒã20åã40åã2.5æéãïŒæéã
ããã³18æéã§ãã€ãã ãããïŒçš®ã®è£œå€ããŠãµã®ã«æ³šå°ãã23æéçµ
éåŸã®ïŒ¡éã®è¡æŒ¿äžçžå¯Ÿæ¿åºŠãå®æœäŸïŒã®ææ³ã«
ãã枬å®ããã çµæã第ïŒå³ã®æ²ç·ïŒã«ç€ºãããã®çµæããã
ïŒïŒã¡ãã«åéïŒNEMïŒã®è¡æŒ¿äžæ¿åºŠã®å¢å
ã¯ã確ãã«ãéãšãŠçŽ é žå¡©ã«ããé žåã«åºã¥ãã
ãšïŒåå¿ãçŽã¡ã«åæ¢ãããšãã¯ãã¡ãã«åé
ïŒNEMïŒã®è¡æŒ¿äžæ¿åºŠã¯ãã®ïŒ¡éã«ã€ããŠã®ã
ã®ãšåäžã§ããããã§ããïŒãããã³ïŒïŒæé©ã®
å¹æãåŸãããã«ã¯ãåå¿åŠçæéãæ¯èŒçé·ã
ããããšãå¿ èŠã§ããããšããããã å®æœäŸ ïŒ æ¬å®æœäŸã¯ãéãæ§æããïŒã€ã®ååé
ïŒA1éãšA2éïŒãå¥ã ã«é žåããå Žåããã®é ž
ååå¿ã¯ããªã·ã³ã®ïŒ¡éã«ã€ããŠå®æœäŸïŒã§è¿°ã¹
ããã®ãšé¡äŒŒã®å¹æãåãŒãããšã瀺ããŠããã ïŒ A1éãšA2éã®åæ 10.9mgïŒmlã®ïŒ¡éãå«æããPH7.0ã®125mMãª
ã³é žç·©è¡æ¶²28mlïŒïŒ¡éã¯309mgïŒããäžèšç·©è¡æ¶²
äžã§å¹³è¡¡ã«ããã³ã³ã«ãããªã³ïŒä»¥äžãConAãš
ç¥ãïŒ112mlãšã»ãã¢ããŒãºã®å ¥ã€ãã«ã©ã ã«æ³š
ãã ãA1éã¯åç·©è¡æ¶²ã§æº¶åºãããæã®æåã®
ããŒã¯ã§åŸãããA2éã¯PH6.0ã®0.1MããŠé žç·©è¡
液ã§æº¶åºãããããã®ç·©è¡æ¶²ã¯å¡©åãããªãŠã æ°Ž
溶液ã«å¯ŸããŠ0.5Mãαâã¡ãã«ãã³ãã·ãã«å¯Ÿ
ããŠ0.1Mã®æ¿åºŠã«ããã ãã®çµæA1éã¯184mgãA2éã¯103mgåŸãã
ããA1éãšA2éãçªçŽ ã®å å§äžã§éå€éã«ã
ãæ¿çž®ãããA2éã¯PH7.0ã®125mMãªã³é žç·©è¡æ¶²
ã§éæãããã éãSDSâã¢ã¯ãªã«ã¢ããã²ã«é»æ°æ³³åã«ã
ããçµæãååé30000ãš33000ã«å¯Ÿå¿ããŠïŒã€ã®
ãã³ããçŸãããæ¿ãæè²ãããA1éãååé
30000ã®ãã³ãã§ãèãæè²ãããA2éãååé
33000ã®ãã³ãã ã€ãã ïŒ ãªã·ã³A1éããã³A2éã®éãšãŠçŽ é žãããª
ãŠã ã«ãã修食 ãã®ä¿®é£Ÿã¯å®æœäŸïŒã§è¿°ã¹ããããªå¹æãåãŒ
ããããªãµãã«ã©ã€ããé žåãããéã®ã¿ã³ã
ã¯è³ªåæé»å®³ã«ãããé µçŽ æŽ»æ§ãšè¬ç©åæ åŠçç¹
æ§ã調ã¹ãã ïŒ ç¡çŽ°èç³»A1éåã³A2éã«ãããé µçŽ æŽ»æ§ã®
ç¶æ é»å®³äœçšãå®æœäŸïŒã§è¿°ã¹ãããã«ããŠæž¬å®ã
ããIC50ã¯é žåãããA1éããã³A2éã«å¯ŸããŠ
ãããã2.1Ã10-10molïŒã2.1Ã10-10molïŒ
ã§ãã€ããæ¬å®æœäŸã«ãããŠæ¯èŒäŸãšããŠçšãã
çã®A1éããã³A2éã®IC50ã¯ãããã1.9Ã10-10
molïŒã1.0Ã10-10molïŒã§ãã€ããåŸã€ãŠ
éããåæãããååéã®ä¿®é£Ÿã¯ãã®é µçŽ 掻æ§
ãæžããªãã ïŒ A1éïŒA1âLaïŒããã³A2éïŒA2âLaïŒã«
ãããè¬ç©åæ åŠçç¹æ§ã®ç¶æ A1è¥ããã¯A1âLaéãŸãã¯A2è¥ããã¯A2â
Laéããããã®è³ã®è¡ç®¡ãããäœéïŒKgåœãã
é415ÎŒgã®å²åã§ãïŒå泚å°ããã20æéåŸã«
æ¡åããè¡æŒ¿ãµã³ãã«ãå ç«è©ŠéšRIMâïŒïŒå®æœ
äŸïŒåç §ïŒã«ãã€ãŠåæãããçµæãäžè¡šã«ç€º
ããéåã³ïŒ¡âLaéã®å€ãå¯Ÿç §çã«ç€ºãã
ãè¡šã
æäž20æéåŸã«ã¯A1âLaéããã³A2âLaé
ã®æ¿åºŠã¯A1éããã³A2éã®ãããã500åã350
åã«ãªã€ãŠããã å®æœäŸ ïŒ æ¬å®æœäŸã«ãããŠã¯ïŒ¡éãšããããåæããã
A1éããã³A2éã®çããã³é žåãããç¶æ ã«ã
ããçååŠçãã¿ã¡ãŒã¿ã瀺ãã æ¬å®æœäŸã§çšããéã¯å®æœäŸïŒåã³ïŒã§èª¬æ
ããããã«ããŠæºåããã ïŒ çæ°Žåç©éšå ãããã¿ã³ãã¯è³ªã®çæ°Žåç©éšåã¯ãã¯ã©ã³ã
ïŒClampïŒã®æ¹æ³ïŒç³ã¿ã³ãã¯è³ªïŒãã®æ§æãæ§
é åã³æ©èœïŒãŽããã·ã€ã«ã¯ç·šïŒã5Aå·»ã第300
â321é ïŒãçšããã¬ã¹ã¯ãããã°ã©ãã€ãŒã«ã
ã€ãŠå®éãããåŸãããçµæãæŽçãããã®ãïŒ
ã€ã®è¡šã«ç€ºãã
ã®æ¿åºŠã¯A1éããã³A2éã®ãããã500åã350
åã«ãªã€ãŠããã å®æœäŸ ïŒ æ¬å®æœäŸã«ãããŠã¯ïŒ¡éãšããããåæããã
A1éããã³A2éã®çããã³é žåãããç¶æ ã«ã
ããçååŠçãã¿ã¡ãŒã¿ã瀺ãã æ¬å®æœäŸã§çšããéã¯å®æœäŸïŒåã³ïŒã§èª¬æ
ããããã«ããŠæºåããã ïŒ çæ°Žåç©éšå ãããã¿ã³ãã¯è³ªã®çæ°Žåç©éšåã¯ãã¯ã©ã³ã
ïŒClampïŒã®æ¹æ³ïŒç³ã¿ã³ãã¯è³ªïŒãã®æ§æãæ§
é åã³æ©èœïŒãŽããã·ã€ã«ã¯ç·šïŒã5Aå·»ã第300
â321é ïŒãçšããã¬ã¹ã¯ãããã°ã©ãã€ãŒã«ã
ã€ãŠå®éãããåŸãããçµæãæŽçãããã®ãïŒ
ã€ã®è¡šã«ç€ºãã
ãè¡šã
ãè¡šã
ãè¡šã
ãããã®çµæã¯éãšãŠçŽ é
žé
žåã¯ïŒ¡éã®ç³é¡ã®
äžéšãç Žå£ããããšã瀺ããŠãããéïŒåååœ
ãã®ïŒ¡éãA1éåã³A2éã®ãã³ããŒã¹æ®å·®ã¯å¹³
åããŠãããã3.17ïŒ2.11ïŒ2.94æ®å·®æžå°ããã
ã³ãŒã¹æ®åºã¯ã»ãŒå®å šã«æ¶å€±ãããã·ããŒã¹æ®åº
ã¯å¹³åããŠãããã1.24ïŒ1.00ïŒ1.05æ®åºæžå°ã
ããâã¢ã»ãã«ã°ã«ã³ãµãã³æ®åºã¯ãããã«æž
å°ããã ãã§ããã ïŒ ïŒ®æ«ç«¯é å éãšããããåæãããA1éããã³A2éã®
çããã³é žåç¶æ ã«ãããæ«ç«¯ã¢ããé žæ®åºã
ã¢ããé žé ååæè£ çœ®ã«ãã€ãŠæ±ºå®ããã åŸãããçµæãæŽçããŠäžè¡šã«ç€ºãã
äžéšãç Žå£ããããšã瀺ããŠãããéïŒåååœ
ãã®ïŒ¡éãA1éåã³A2éã®ãã³ããŒã¹æ®å·®ã¯å¹³
åããŠãããã3.17ïŒ2.11ïŒ2.94æ®å·®æžå°ããã
ã³ãŒã¹æ®åºã¯ã»ãŒå®å šã«æ¶å€±ãããã·ããŒã¹æ®åº
ã¯å¹³åããŠãããã1.24ïŒ1.00ïŒ1.05æ®åºæžå°ã
ããâã¢ã»ãã«ã°ã«ã³ãµãã³æ®åºã¯ãããã«æž
å°ããã ãã§ããã ïŒ ïŒ®æ«ç«¯é å éãšããããåæãããA1éããã³A2éã®
çããã³é žåç¶æ ã«ãããæ«ç«¯ã¢ããé žæ®åºã
ã¢ããé žé ååæè£ çœ®ã«ãã€ãŠæ±ºå®ããã åŸãããçµæãæŽçããŠäžè¡šã«ç€ºãã
ãè¡šã
ãè¡šã
çç¶æ
åã³é
žåç¶æ
ã®ïŒ¡éãA1éããã³A2é
ã«ãããæªç«¯ã¢ããé žïŒåã®é åã¯äºãã«å šã
åãããšãããã€ããããã¯é žååŠçã¯ã¢ããé ž
é åã«åœ±é¿ãäžããªãããšã瀺ããŠããããŸã
éã®ïŒ®æ«ç«¯ã¢ããé žïŒåã®é åã¯æ¬çºæã«å ç«ã€
ãŠãããïŒèŸ²èžçç©ååŠã第43å·»ã2221é ã1979
幎ïŒã«ãã€ãŠãªã·ã³ã®ïŒ¡éã«ã€ããŠæ±ºå®ãããã
ã®ãšå šãåãããšããããã ïŒ ConAïŒã»ãã¢ããŒã¹ã«å¯Ÿãã芪åæ§ DTNB ïŒïŒ5â²âãžããªãã¹ïŒïŒâãããå®æ¯
éŠé žïŒã§ãã¹ã¯ãããéå³ã¡ïŒ¡ïŒDTNBïŒïŒïŒ¡
ïŒDTNBïŒâLaïŒA1ïŒDTNBïŒïŒA1ïŒDTNBïŒâ
LaïŒA2ïŒDTNBïŒåã³A2ïŒDTNBïŒâLaéã®
ConAïŒã»ãã¢ããŒã¹ã«å¯Ÿãã芪åæ§ã調ã¹ãã
éãïŒmgå«ã溶液ïŒmlãConAãïŒmlå ¥ã€ãã«
ã©ã ã«æ³šãã ã280nmã«ãããåžå 床ã枬ã€ãåŸ
ã¯ãããã°ã©ãã€ãŒã«ããããPH7.0ã®125mMãª
ã³é žç·©è¡æ¶²ã§æŽæµããConAã«ãã€ãŠä¿æãããª
ãã€ãæåã®ããŒã¯ãåºç·æ°Žæºã«æ»ã€ãåŸãã«ã©
ã ã0.1MããŠé žç·©è¡æ¶²ã§æŽæµããããã®ç·©è¡æ¶²
ã¯å¡©åãããªãŠã 氎溶液ã«å¯ŸããŠ0.5MïŒÎ±âã¡
ãã«ãã³ãã·ãã«å¯ŸããŠ0.1Mã®æ¿åºŠã«ããã
280nmã«ãããåžå 床ãçŸåçã§è¡šç€ºããçµæã
äžè¡šã«ãŸãšããã
ã«ãããæªç«¯ã¢ããé žïŒåã®é åã¯äºãã«å šã
åãããšãããã€ããããã¯é žååŠçã¯ã¢ããé ž
é åã«åœ±é¿ãäžããªãããšã瀺ããŠããããŸã
éã®ïŒ®æ«ç«¯ã¢ããé žïŒåã®é åã¯æ¬çºæã«å ç«ã€
ãŠãããïŒèŸ²èžçç©ååŠã第43å·»ã2221é ã1979
幎ïŒã«ãã€ãŠãªã·ã³ã®ïŒ¡éã«ã€ããŠæ±ºå®ãããã
ã®ãšå šãåãããšããããã ïŒ ConAïŒã»ãã¢ããŒã¹ã«å¯Ÿãã芪åæ§ DTNB ïŒïŒ5â²âãžããªãã¹ïŒïŒâãããå®æ¯
éŠé žïŒã§ãã¹ã¯ãããéå³ã¡ïŒ¡ïŒDTNBïŒïŒïŒ¡
ïŒDTNBïŒâLaïŒA1ïŒDTNBïŒïŒA1ïŒDTNBïŒâ
LaïŒA2ïŒDTNBïŒåã³A2ïŒDTNBïŒâLaéã®
ConAïŒã»ãã¢ããŒã¹ã«å¯Ÿãã芪åæ§ã調ã¹ãã
éãïŒmgå«ã溶液ïŒmlãConAãïŒmlå ¥ã€ãã«
ã©ã ã«æ³šãã ã280nmã«ãããåžå 床ã枬ã€ãåŸ
ã¯ãããã°ã©ãã€ãŒã«ããããPH7.0ã®125mMãª
ã³é žç·©è¡æ¶²ã§æŽæµããConAã«ãã€ãŠä¿æãããª
ãã€ãæåã®ããŒã¯ãåºç·æ°Žæºã«æ»ã€ãåŸãã«ã©
ã ã0.1MããŠé žç·©è¡æ¶²ã§æŽæµããããã®ç·©è¡æ¶²
ã¯å¡©åãããªãŠã 氎溶液ã«å¯ŸããŠ0.5MïŒÎ±âã¡
ãã«ãã³ãã·ãã«å¯ŸããŠ0.1Mã®æ¿åºŠã«ããã
280nmã«ãããåžå 床ãçŸåçã§è¡šç€ºããçµæã
äžè¡šã«ãŸãšããã
ãè¡šã
ConAã¯ãã³ããŒã¹æ«ç«¯ããã€ãç³ã¿ã³ãã¯è³ª
ã«èŠªåæ§ããã€ãŠããããšãç¥ãããŠããããã®
ãããªæ®åºããã€ãéã¯ConAãšçµåãããã
ãã¯ããå€ããã³ããŒã¹ã§çœ®æãããA2éã«ã
ããŠç¹ã«é¡èã«ãããããŸãé žåãããšãã®èŠªå
æ§ãæ¶å€±ããããšãèŠãåºãããããããã¯ãã®
çš®ã®ç³è³ªæ®åºã«å ±éã«èªããããã ïŒ ã¢ã«åžå ä¿æ°ïŒïŒ¥ïŒïŒ ïŒcmïŒã®æ±ºå® 280nmã«ãããåžåä¿æ°ïŒïŒ¥ïŒïŒ ïŒcmïŒãšã¯ïŒmlåœ
ããã¿ã³ãã¯è³ªãïŒmgå«ã溶液ã®280nmã«ããã
åžåä¿æ°ã§ããããçšããŠæšæºçŽåºŠã®ãŠã·è¡æž ã¢
ã«ããã³ã䜿ã€ãFOLINè©Šéšã«ãã€ãŠã¿ã³ãã¯
質æ¿åºŠã決å®ããã çµæãäžè¡šã«èŠçŽããã
ã«èŠªåæ§ããã€ãŠããããšãç¥ãããŠããããã®
ãããªæ®åºããã€ãéã¯ConAãšçµåãããã
ãã¯ããå€ããã³ããŒã¹ã§çœ®æãããA2éã«ã
ããŠç¹ã«é¡èã«ãããããŸãé žåãããšãã®èŠªå
æ§ãæ¶å€±ããããšãèŠãåºãããããããã¯ãã®
çš®ã®ç³è³ªæ®åºã«å ±éã«èªããããã ïŒ ã¢ã«åžå ä¿æ°ïŒïŒ¥ïŒïŒ ïŒcmïŒã®æ±ºå® 280nmã«ãããåžåä¿æ°ïŒïŒ¥ïŒïŒ ïŒcmïŒãšã¯ïŒmlåœ
ããã¿ã³ãã¯è³ªãïŒmgå«ã溶液ã®280nmã«ããã
åžåä¿æ°ã§ããããçšããŠæšæºçŽåºŠã®ãŠã·è¡æž ã¢
ã«ããã³ã䜿ã€ãFOLINè©Šéšã«ãã€ãŠã¿ã³ãã¯
質æ¿åºŠã決å®ããã çµæãäžè¡šã«èŠçŽããã
ãè¡šã
ååéäžã®ããªãŒã«åºãDTNBã§ãã¹ã¯ãã
ãšããããã³ãŸã€ã«åºãçãããã280nmã«ãã
ãåžåã倧ããå¢å ãããé žååŸã¯280nmã«ãã
ãåžåã«å€§ããªå€åã¯èŠ³å¯ãããªãã€ããããã¯
é žåã¯280nmã«ãããåžåã«é¢ä¿ããã¢ããé žã«
圱é¿ãäžããªãã€ãããšã瀺ããŠããã ïŒ çé»ç¹é»æ°æ³³å éãçé»ç¹æ³³åã«ãã€ãŠåé¢ãããšPH7.5ãª
ãã8.0ã®éã«çé»ç¹ãã³ããçããããã¯ïŒ¡éã
A1éåã³A2éã®ã©ããåãã§ãã€ãã çç¶æ åã³é žåç¶æ ã®ïŒ¡éãA1éããã³A2é
ã®çé»ç¹ãæ¯èŒãããšããããã¹ã¯ãããŠããªã
å Žåã¯ïŒ¡éã«ç¹åŸŽçãªãã³ãå šãŠãPHã§0.5ãé ž
æ§æ¹åã«ç§»åããããã®çé»ç¹ç§»åã¯çç¶æ ãšé ž
åç¶æ ã®ãã®ãéãªãããšãªãèµ·ãã€ãã®ã§ã
éã®ååã¯å šãŠé žåã«ãã€ãŠåœ±é¿ãåãããšèã
ãããã å®æœäŸ ïŒ æ¬å®æœäŸã«ãããŠã¯çã®ã²ããã³ãåç©ã«éè
泚å°ããå Žåã®ãã®æ¥æ¶å€±ãšéãšãŠçŽ é žãããªãŠ
ã ã«ãã€ãŠå€æ§ãããã²ããã³ãåæ§ã«æ³šå°ãã
åŸã®ãã®ãã€ãããšããæ¶å€±ã«ã€ããŠèª¬æããã ïŒ éãšãŠçŽ é žãããªãŠã ã«ããã²ããã³ã®ä¿®é£Ÿ ã²ããã³ãã²ãããŠã ã ã«ããããŒã«ã
ïŒGelonium multiflorumïŒããçååŠãžã€ãŒã
ã«ã第255å·»ã6947â6953é ã1980幎ã«è¿°ã¹ãŠã
ãæ¹æ³ã§æœåºãã粟補ãããå®æœäŸïŒã§ãªã·ã³ïŒ¡
éã«ã€ããŠè¿°ã¹ãã®ãšåãæ¹æ³ã§é žååå¿ãè¡ã€
ãããããããªãŒã«åºã®DTNBã«ãããã¹ã¯ã¯
è¡ã€ãŠããªãã å®éã²ããã³ã®å€©ç¶ã®ããªãŒã«åºãçšããŠã²ã
ãã³ãšæäœãã«ãããªã³ã°ãããããšã¯ããŸãè¡
ãªãããŠããªãã®ã§ãããªãŒã«åºã¯ãé žååŸãã¬
ã³ç 究ïŒCancer Res.ïŒã第44å·»ã129â133é ã
1984幎ã«ãããŠèª¬æãããæè¡ãçšããŠäººå·¥çã«
å°å ¥ãããéãšãŠçŽ é žãããªãŠã 0.5M氎溶液21ÎŒ
ãïŒmlåœããïŒmgã®ã²ããã³ãå«ã溶液ïŒmlã«
ãªã³é žç·©è¡æº¶æ¶²äžã§å ãã1Mé ¢é žã§PHãïŒã«ã
ãããããææã§16æéïŒâã«ä¿ã€ããåå¿ã¯
1Mãšãã¬ã³ã°ãªã³ãŒã«æ°Žæº¶æ¶²ã105ÎŒå ããŠçµ
çµããããããã20âã§ïŒåéä¿æž©ããåŸãåå¿
ç©ãïŒâã§ãªã³é žç·©è¡æ¶²äžã«ãããŠéæããã30
åé10000Ãïœã§é å¿åé¢ã«ããããšããããã
æ¿åºŠ2.5mgïŒmlã®é žåã²ããã³2.9mgãåŸãããã ãªã·ã³ïŒ¡éãšåãããã«ãã²ããã³ã®åºæ¬çç¹
æ§ã¯ãªããœãŒã ã®60SãµããŠãããã®å解ã«ãã€
ãŠçæ žçŽ°èã«ãããã¿ã³ãã¯è³ªåæãé»å®³ããã
ãšã§ããïŒãã€ãªã±ãã«ã«ãžã€ãŒãã«ã第207å·»ã
505ã509é ã1982幎ïŒãã²ããã³ã®å Žåã«ãéãš
ãŠçŽ é žé žåã«ãã修食ã¯ã掻æ§ã®æ倱ãçããã
ãªãããšãããã€ãã ã²ããã³ã«ãããè¬ç©åæ åŠçç¹æ§ã®ç¶æ çã®ãæãã¯äžè¿°ã®æç¶ã§ä¿®é£Ÿãããã²ããã³
ããããã®è³ã®è¡ç®¡ããäžå泚å°ãããæäžãã
ã²ããã³ã®éã¯0.3ãªãã0.4mgïŒKgã§ãã€ããã
ããªã³ã®ååšäžã§è¡æ¶²ãæã æ¡åãããè¡æŒ¿ã¯ä»¥
äžRIMâïŒãšç¥ç§°ããæŸå°ç·å ç«è©ŠéšãçšããŠ
åæããã ãã®è©Šéšã¯RIMâïŒè©Šéšãšåãæè¡ãçšããã
ãã ãAc1溶液ãæ¬äŸã§ã¯ã¢ãã€ããã€ãŒã¯ãã
ãã°ã©ãã€ãŒã§ç²Ÿè£œãããæã²ããã³ãŠãµã®æäœ
溶液ã§ãããAc2æäœã¯RIMâïŒè©Šéšãšåãæäœ
ãæŸå°æ§åäœäœã§æšèãããã®ã§ãããåäžæšæ¬
äžã®çã®ã²ããã³ãšä¿®é£Ÿããã²ããã³ã®æ¿åºŠãã
ãããæšæ¬ãšã¯ç°ã€ãæ¢ç¥ã®æ¿åºŠã®æ€éç·ãšæ¯èŒ
ããããšã«ãã€ãŠæ±ºå®ãããæŸå°æšèã®æè¡ã¯
RIMâïŒã§èª¬æãããã®ãšåãã§ãããRIMâ
ïŒè©Šéšã¯RIMâïŒè©Šéšãšåçã®ä¿¡é Œæ§ãšåçŸæ§
ã瀺ãããæ¬å®éšã®çµæã¯å®æœäŸïŒã§ãªã·ã³ã®ïŒ¡
éã«ã€ããŠç€ºããã®ãšåãæ¹æ³ã§ç€ºãã å³ïŒã¯çã®åã³ä¿®é£Ÿããã²ããã³ãéè泚å°ã
ãå Žåã®è¡æŒ¿äžæ¿åºŠæ²ç·ãæéã®é¢æ°ãšããŠè¡šã
ããŠãããçã®ã²ããã³ã¯99.99ïŒ ã24æéã§æ¶
倱ããããšãããçã®ãªã·ã³ïŒ¡éãšåãããã«è¡
äžããéåžžã«æ¥éã«æ¶å€±ããããšããããïŒæ²ç·
ïŒïŒãã²ããã³ã®ããªãµãã«ãªãåäœãé žåãã
ãŠããå Žåã¯æ²ç·åœ¢ã倧ããéããæäž24æéåŸ
ã«é žåããã²ããã³ã®æ¿åºŠã¯çã®ã²ããã³ã®300
åããïŒæ²ç·ïŒïŒã åŸã€ãŠãããã®çµæã¯ãªã·ã³ïŒ¡éãšåããã
ã«ãéãšãŠçŽ é žé žåã¯ã²ããã³ã®æ¶å€±ã枬ãã®ã«
çšããããç³é¡ãããã®æ©èœã劚ããçšåºŠã«ãŸã§
修食ããããšã瀺ããŠããã å®æœäŸ ïŒ æ¬å®æœäŸã¯(1)ã¢ã¢ã«ãã€ã«ã»ã«ã©ã³ãã€ã¢
ïŒmomordica charantiaïŒããæœåºããGPIR
MOMãåç©ãžéè泚å°ããåŸã®ãã®æ¥éãªæ¶å€±
ãš(2)éãšãŠçŽ é žãããªãŠã ã§ä¿®é£ŸããGPIR
MOMãåãããã«æ³šå°ããåŸã®ãã€ãããšãã
æ¶å€±ã«é¢ããã ïŒ GPIR MOMã®éãšãŠçŽ é žãããªãŠã ã«ãã
修食 GPIR MOMãMomordica charantiaçš®åã®
å çèåããããã€ãªã±ãã«ã«ãžã£ãŒãã«
ïŒBiochemical JournalïŒç¬¬186å·»ã443â452é ã
1980幎ã§èª¬æãããŠããæ¹æ³ã§æœåºã粟補ããã
çã®MOMåã³ä¿®é£ŸãããMOMã®è¬ç©åæ åŠç
ç¹æ§ãæŸå°æšèããGPIR MOMãçšããŠèª¿ã¹
ããMOMã¯ã¯ãã©ãã³ïŒŽã®ååšäžã§125Iãçšã
ãŠæšèãããæŸå°æ§125IãïŒmlåœã100ÎŒCiå«ã溶
液10ÎŒãšã¯ãã©ãã³ïŒŽãïŒmlåœã2.5mgå«ã溶液
30ÎŒããMOMãïŒmlåœãïŒmgå«ã溶液100ÎŒ
ã«ãªã³é žç·©è¡æº¶æ¶²äžã§å ãããåå¿æ¶²ã宀枩ã§ïŒ
åéä¿ã€ããåå¿ã¯ïŒmlåœãã¡ã¿éäºç¡«é žãããª
ãŠã 0.5mgãå«ã溶液400ÎŒãå ããŠçµçµãããã
åå¿ç©ã¯æªåå¿ã®ãšãŠçŽ ãæŸå°æšèãããã¿ã³ã
ã¯è³ªããåé¢ããããã«Sephadex  25ã®ã«ã©
ã ãçšã0.1ïŒ ã®ã²ã©ãã³ãå«ããªã³é žç·©è¡æ¶²ã§
ã²ã«éããã10000Ãïœã§30åéé å¿åé¢ã«ã
ãããšãããæ¿åºŠ0.04mgïŒmlã®æŸå°æšèããã
MOMã80ÎŒgåŸãããã é žååå¿ã¯å®æœäŸïŒã«ãããŠãªã·ã³ã®ïŒ¡éã«ã€
ããŠèª¬æããã®ãšåãæ¡ä»¶äžã§è¡ãªããããäœã
ããªãŒã«åºãDTNBã§ãã¹ã¯ããåŠçã¯ãªãã
ã¿ã³ãã¯è³ªã®æ¿åºŠã¯125åäœã40ÎŒgïŒïœã§ã
ãã0.5MéãšãŠçŽ é žãããªãŠã 氎溶液20ÎŒãæŸ
å°æšèãããMOMãïŒïŒmlåœããïŒ0.04mgå«ã
溶液ïŒmlã«å ãã1Mé ¢é žã§PHãïŒã«ããããã®
åå¿æ¶²ãææã§16æéïŒâã«ä¿ã€ããåå¿ã¯1M
ãšãã¬ã³ã°ãªã³ãŒã«æ°Žæº¶æ¶²ã100ÎŒå ããŠçµçµ
ãããã15åé20âã«ä¿ã€ãåŸãåå¿ç©ãïŒâã®
äžã«ãªã³é žç·©è¡æ¶²ã§éæããã10000Ãïœã§30å
éé å¿åé¢ã«ããããšããæ¿åºŠ0.021mgïŒmlã®é ž
åãããMOMã32ÎŒgåŸãããã ããããŠåŸãããæ°ããååã®ååéã¯çã®
MOMãšå®è³ªçã«çžéããªããã¯ãŒãã·ãŒãã«ãŒ
ã§æè²ããããªã¢ã¯ãªã«ã¢ããé»æ°æ³³åã«ãããŠ
ã¿ãéãã§ã¯ã修食åŠçã¯ããå°éã®ã¿ã³ãã¯è³ª
ããªããŒãçããããã®ã¿ã§ãäœãã®å解ãåŒã
èµ·ããªãã€ãã ïŒ MOMã®è¬ç©åæ åŠçç¹æ§ã®æç¶ æŸå°æšèãããMOMããåè¿°ã®æç¶ã«ããé ž
åã®æç¡ãåããããããã®è³ã®è¡ç®¡ã«äžå泚å°
ãããæäžãããMOMã®éã¯3.50ãªãã
3.55ÎŒgïŒKgã§ããããããªã³ååšäžã§æã æ¡è¡ã
ãããè¡æŒ¿ãæ¿åºŠ25ïŒ ã®ããªã¯ããé ¢é žïŒTCAïŒ
200ÎŒãšäžç·ã«ïŒâã§30åéä¿æž©ãããé žã§æ²
殿ãããæ²éç©äžã®æŸå°èœã枬å®ããããã®åæ
æ³ã«ããã°ã圱é¿ãåããªãã€ãMOMååã®è¡
挿ã¬ãã«ã®æž¬å®ãå¯èœã«ãªããTCAã§æ²æ®¿ããª
ãäœååã®å解çæç©ã¯èæ ®ã«å ¥ããªãã€ããã
ããã®å®éšçµæã¯è¡äžã«æ®åããæŸå°èœãåæé
ã«å¯ŸããçŸåçã«ããŠæéã®é¢æ°ã§è¡šããããã®
å€ã¯âåæè¡æŒ¿æŸå°èœçŸåçïŒïŒ IPRïŒãšåŒã°
ãã次åŒã§ç®åºããã ïŒ I.P.R.ïŒïœÃPVÃ100ïŒ0.2Ã ããã§ïœã¯0.2mlã®ãã©ãºãããïœæéåŸã«æ€
åºãããæŸå°èœãã¯æäžãããå šæŸå°èœãPV
ã¯è¡æŒ¿éïŒãããã®äœéïŒKgåœã36mlãããšèã
ãããŠããïŒã§ããã å³ïŒã«ç€ºããã®ã¯ãé žåããããŸãã¯é žåãã
ãªãMOMãéè泚å°ããåŸã®è¡æŒ¿äžæ¿åºŠã§ã
ããMOMã¯ãè¡äžã®MOMã®99.9ïŒ ãïŒæéã§
æ¶å€±ããããšãããçã®ãªã·ã³ïŒ¡éãšåããã
ã«ãè¡äžããæ¥éã«æ¶å€±ããããšããããïŒæ²ç·
ïŒïŒãMOMã®ç³è³ªæ®åºãé žåãããå Žåã¯ãæ¿
床ã®æžå°é床ãäœäžããïŒæ²ç·ïŒïŒãæäžïŒæé
åŸã«é žåãããMOMã®æ¿åºŠã¯é žåãããŠããªã
MOMã®ããã®60åã«ãªã€ããåŸã€ãŠãããã®çµ
æã¯éãšãŠçŽ é žé žåã¯MOMã®çæéæ¶å€±ã®åå
ã§ããç³é¡ã修食ããããšã瀺ããŠããã å®æœäŸ 10 æ¬å®æœäŸã¯(1)ãã€ã¢ã³ããŠã¹ã»ã«ãªãªãã€ã«ã¹
ïŒDianthus caryophyllusïŒããæœåºããGRIRã
ã€ã¢ã³ãã³ãåç©ãžéè泚å°ããåŸã®ãã®æ¥éãª
æ¶å€±ãš(2)éãšãŠçŽ é žãããªãŠã ã§ä¿®é£ŸããGRIR
ãã€ã¢ã³ãã³ãåãããã«æ³šå°ããåŸã®ãã€ãã
ãšããæ¶å€±ã«é¢ããã ïŒ ãã€ã¢ã³ãã³30ã®éãšãŠçŽ é žãããªãŠã ã«ã
ã修食 ãã€ã¢ã³ãã³30ãDianthus caryophyllusã®è
ãããã€ãªã±ãã«ã«ãžã€ãŒãã«ïŒBiochemical
JournalïŒç¬¬195å·»ã339â405é ã1981幎ã§èª¬æã
ããŠããæ¹æ³ã§æœåºãã粟補ãããé žåãããå
ã¯é žåãããŠããªããã€ã¢ã³ãã³30ã®è¬ç©åæ åŠ
çç¹æ§ãæŸå°æšèãããã€ã¢ã³ãã³ãçšããŠèª¿ã¹
ãããšãŠçŽ ååã³é žååå¿ã¯å®æœäŸïŒã§MOMã«
ã€ããŠèª¬æããã®ãšåãæ¡ä»¶äžã§è¡ã€ãã ããããŠåŸãããæ°ããé žåããããã€ã¢ã³ã
ã³ååã®ååéã¯çã®ãã€ã¢ã³ãã³30ãšå®è³ªçã«
çžéããªãã ïŒ ãã€ã¢ã³ãã³30ã®è¬ç©åæ åŠçç¹æ§ã®æç¶ æŸå°æšèããããã€ã¢ã³ãã³ãåè¿°ã®æç¶ã«ã
ãé žåã®æç¡ãåããããããã®è³ã®è¡ç®¡ã«äžå
泚å°ããããã€ã¢ã³ãã³ã®è¡æŒ¿äžæ¿åºŠã¯å®æœäŸïŒ
ã§MOMã«ã€ããŠèª¬æããã®ãšåãæ¹æ³ã§æž¬å®ã
ããå³ïŒã¯é žåããããã€ã¢ã³ãã³ïŒæ²ç·ïŒïŒå
ã¯é žåãããªããã€ã¢ã³ãã³ïŒæ²ç·ïŒïŒã®è¡æŒ¿äž
æ¿åºŠãæéã®é¢æ°ã§è¡šããããã®ã§ããããã€ã¢
ã³ãã³30ã¯MOMãšåãããã«åæéã®99.9ïŒ ã
ïŒæé以å ã«æ¥éã«æ¶å€±ããŠãããäžæ¹ãã€ã¢ã³
ãã³30ã®ç³è³ªæ®åºãé žåãããå Žåã¯ãæ¿åºŠã®æž
å°é床ã倧ããäœäžãããæäžïŒæéåŸã«é žåã
ãããã€ã¢ã³ãã³ã®æ¿åºŠã¯é žåãããŠããªã
MOMã®ããã®80åã«ãªã€ããé žåããããã€ã¢
ã³ãã³ã®æ¿åºŠã¯24æéãã€ãŠããŸã é«ãã€ãïŒå
æéã®ïŒïŒ ïŒã ãããã®çµæããŸããéãšãŠçŽ é žé žåã¯ãã€ã¢
ã³ãã³ã®çæéæ¶å€±ã®åå ã§ããç³è³ªã修食ãã
ããšã瀺ããŠããã å®æœäŸ 11 ãªã·ã³ïŒ¡éã掻æ§åããããžã¹ã«ãã€ãåºã§çœ®
æã人éã®ïŒŽçŽ°èãé»å®³ããæäœãšåå¿ãããæ±
åäœãæºåããã ïœ äººéã®ïŒŽçŽ°èãé»å®³ããæäœïŒT101æäœïŒ ãã®æäœã¯å ç«åŠãžã€ãŒãã«ïŒJournal of
ImmunologyïŒç¬¬125ïŒïŒïŒå·»ã725â737é ã1980
幎ã«ãããŠèª¬æãããæ¹æ³ã«ãã€ãŠæºåããã ïœ é žåããããªã·ã³ã®ïŒ¡é ãªã·ã³ã®ïŒ¡éã¯å®æœäŸïŒã§èª¬æããæ¹æ³ã«ãã€
ãŠæºåããã 人éã®ïŒŽçŽ°èãé»å®³ãã掻æ§åæäœ ïŒâãšãã«âïŒâãžã¡ãã«ã¢ãããããã«âïŒ
âã«ã«ããžã€ãããïŒmlåœã60.3mgå«ã溶液20ÎŒ
ãïŒâïŒããªãžãã«âïŒâãžã¹ãã¢ãã«ïŒãã
ããªã³é žãïŒmlåœã20mgå«ã溶液100ÎŒã«tertâ
ãã¿ããŒã«äžã§å ããæ··åç©ãïŒåé宀枩ã§æŸçœ®
ãããããããŠåŸããã溶液68ÎŒããïŒmlåœã
æäœ8.9mgãå«ã溶液ïŒmlã«ãªã³é žç·©è¡æ¶²äžã§å
ããããã®æ··åç©ã15åé30âã§æªæãããã®åŸ
ïŒâäžã§ãªã³é žç·©è¡æ¶²ã«ãããŠéæããã次ãã§
ã¿ã³ãã¯è³ªæº¶æ¶²ãé å¿åé¢ãã掻æ§åæäœã7.9
mgïŒmlã®æ¿åºŠã§15mgåŸããïŒâã¡ã«ã«ãããšã¿ã
ãŒã«ãšã®äº€æåå¿ã«ãã€ãŠæŸåºãããããªãžã³â
ïŒâããªã³ã®343nmã«ãããåžåãã¿ããšããã®
æäœã¯1molåœã3.8åã®æŽ»æ§åãããæ··åãžã¹ã«
ãã€ãåºãæããŠããããšãããã€ãã æç¶äœçšã®ãããªã·ã³ïŒ¡éãå«æããå ç«æ¯
çŽ ã®æºå 修食ãããéãïŒmlåœã2.87mgå«ã溶液2.46
mlãšäžè¿°ã®æ¹æ³ã«ãã€ãŠåŸããã掻æ§åæäœã®æº¶
液1.5mlãæºåãïŒæ¿åºŠ7.9mgïŒmlïŒå³ã¡æŽ»æ§åæ
äœã11.8mgå«ãïŒããã®æ··åç©ã20âã§20æéæŸ
眮ããããã®æº¶æ¶²ãé å¿åé¢ã«ãããã»ãã¢ãã
ã¯ã¹G100ãçšããŠéãã粟補ããã溶åºç©ã®
å åŠå¯åºŠã280nmã§æž¬å®ãããæäœãšïŒ¡éã®äž¡æ¹
ãå«ãåç»ãåããããšå ç«æ¯çŽ ãïŒmlåœã0.7
mgå«ã溶液15mlïŒå³ã¡å ç«æ¯çŽ ã¯10.5mgïŒãåŸã
ããããã®æº¶æ¶²ã¯æäœãšã«ãããªã³ã°ãããé žå
éãïŒmlåœã0.14mgå«æããã åŸã€ãŠãã®æ¹æ³ã«ããå¹³åã«ãããªã³ã°åºŠã¯æ
äœ1molã«ã€ãé žåé1.2molã§ããã äžèšã®æ¹æ³ã§åŸãé žåããããªã·ã³ïŒ¡éãå«ã
å ç«æ¯çŽ ITïŒïŒ¡âLaïŒT101ã«ã€ããŠããã®è¬ç©
åæ åŠçç¹æ§ãšæšç现èã«å¯Ÿãã现èæ¯æ§ã調ã¹
ãã å®æœäŸ 12 æ¬å®æœäŸã«ãããŠã¯ãæç¶äœçšããã€ãªã·ã³ïŒ¡
éãå«ãå ç«æ¯çŽ ïŒITïŒïŒ¡âLaïŒT101ãšç¥ãïŒ
ã®è¡æŒ¿äžæ¿åºŠããã€ãããšæžå°ãããšããæ§è³ªã
ç²åŸããããšã瀺ãã æ¹æ³ å®æœäŸ11ã§èª¬æããæç¶ã§æºåãããæ±åäœã
ãããã®è³ã®è¡ç®¡ã«äžåºŠæ³šå°ãããæäžãããé
ã¯ïŒ¡éã«ã€ããŠäœéïŒKgåœãã0.415mgã§ããã
ãããªã³ã®ååšäžã§è¡æ¶²ãæã æ¡è¡ãããè¡æŒ¿ã
æŸå°ç·å ç«è©ŠéšïŒRIMâïŒãšç¥ãïŒã«ãã€ãŠ
ïŒïŒç®æïŒåæããã ãã®è©Šéšã¯RIMâïŒãšåãæè¡ãçšããŠè¡ã
ãããäœãAc2溶液ã¯æ¬è©Šéšã«ãããŠã¯RIMâïŒ
ã®æè¡ãçšããŠã¢ãã€ããã€ãŒã¯ãããã°ã©ãã€
ãŒã«ãã€ãŠç²Ÿè£œãããæŸå°æšèãããããŠã¹ã®
IgGãé»å®³ããã€ã®ã®æäœã§ããããã®ãµã³ãã«
ã«ããã修食ãããå ç«æ¯çŽ ã®æ¿åºŠã¯æ¢ç¥ã®ç°ã€
ãæ¿åºŠããå°ããæ€éç·ãçšããŠæ±ºå®ããã
RIMâïŒè©Šéšã¯RIMâïŒãšåãä¿¡é Œæ§åã³åçŸ
æ§ãæããã æ¯èŒå¯Ÿç §ã®ãããçã®ãªã·ã³ïŒ¡éã掻æ§åãã
ããžã¹ã«ãã€ãåºã§çœ®æããæäœã®åå¿ããåŸã
ããITT101ã®æ±åäœãšåãæ¡ä»¶äžã§æ¯èŒäŸã®è©Š
éšãè¡ã€ãããã®æ±åäœã®æºåãšçŽ°èæ¯æ§ã¯ãã©
ã³ã¹åœç¹èš±åºé¡ç¬¬2516794å·ã§èª¬æããæ¹æ³ã«ã
ã€ãŠè¡ã€ãããããã®å®éšçµæã¯å®æœäŸïŒã§ã«ã
ããªã³ã°ãããŠããªãéã«ã€ããŠè¡ã€ãã®ãšå
ãæ¹æ³ã§ç€ºããã çµæ å³ïŒã¯éè泚å°ãããITT101åã³ITïŒïŒ¡âLaïŒ
T101ã®è¡æŒ¿äžæ¿åºŠæ²ç·ã瀺ããŠãããæäž24æ
éåŸã«ITïŒïŒ¡âLaïŒT101掻æ§çŽ°èæ¯çŽ ã¯ITT101
ã®140åã«ãªã€ãŠããããã®äºå®ã¯é žåããã
éã®è¬ç©åæ åŠçç¹æ§ã¯æäœãšã«ãããªã³ã°ãã
ãåŸãä¿æãããŠããããšã瀺ããŠããã å®æœäŸ 13 æ¬å®æœäŸã«ãããŠã¯ITïŒïŒ¡âLaïŒT101ã®æšç
现èã«å¯Ÿãã现èæ¯çŽ ç¹æ§ã®ä¿åã«ã€ããŠè¿°ã¹
ãã ãªã·ã³ïŒ¡éã®åºæ¬çãªçç©åŠçç¹æ§ã¯çŽ°èäžã®
ã¿ã³ãã¯è³ªåæããªããœãŒã ã®60SãµããŠããã
ã®å解ã«ãã€ãŠé»å®³ããããšã§ããã ãã®æ¹æ³ã¯å¹é€äžã®ã¬ã³çŽ°èã«14Cã§æšèãã
ãã€ã·ã³ïŒä»¥äž14Câãã€ã·ã³ãããïŒãåã蟌
ãŸããŠç 究ãããŠããç©è³ªã®å¹æã枬å®ãã现è
ç³»ãçšããã çšãããã现èã¯ãæåT65ãéã¶äººéã®ïŒŽçœ
è¡ç ããèªå°ãããCEM现èç³»ã«å±ããããã®
现èã¯ç®çã®ç©è³ªã®ååšäžã§ä¿æž©ããåŸã现èãž
ã®14Câãã€ã·ã³ã®åã蟌ã¿ã®çšåºŠã枬å®ããã
ãã®æž¬å®ã«ã¯çç©ååŠãžã£ãŒãã«ïŒJournal of
Biological ChemistryïŒç¬¬249å·»11å·ã3557â
3562é ã§èª¬æããããã¿ã³ãã¯è³ªåæéã枬å®ã
ãã®ã«14Câãã€ã·ã³ã®ãã¬ãŒãµãŒãçšããæ¹æ³
ã«ãã€ãŠè¡ããåã蟌ãŸããæŸå°èœã¯ãéãã现
èã®å šäœã«ã€ããŠæž¬å®ããã å®éã®åºæºãšããŠç·éïŒå¹ææ²ç·ãæãããšã
ã§ããããã®æ²ç·æšªè»žã«ã¯ç®çç©è³ªäžã®ïŒ¡éã®ã¢
ã«æ¿åºŠã瞊軞ã«ã¯ãã¿ã³ãã¯è³ªåæãé»å®³ããç©
質ã®ååšããªãæ¯èŒçŽ°èã«ããã14Câãã€ã·ã³
ã®åã蟌ã¿éã«å¯ŸããçŸåçãããããããŠåŸã
ããã ããããŠããããã®ç©è³ªã«ã€ããŠ14Câãã€ã·
ã³åã蟌ã¿éã50ïŒ é»å®³ããæ¿åºŠãŸãã¯50ïŒ é»å®³
æ¿åºŠïŒIC50ïŒã決å®ããããšãã§ããã å³ïŒã¯ææž©åªäœäžã§10mMå¡©åã¢ã³ã¢ããŠã ã®
ååšäžã§ITïŒïŒ¡âLaïŒT101ãšã«ãããªã³ã°ãã
ãŠããªãéã«ã€ããŠè¡ã€ãåãå®éšããæ²ç·ã
瀺ããŠããããã®å³ãã¿ããšITïŒïŒ¡âLaïŒT101
ã¯åäžæ¡ä»¶ã§æž¬å®ãããã«ãããªã³ã°ãé žåãã
ãŠããªãéã«æ¯ã¹çŽïŒäžåã®éåžžã«åŒ·ã现èæ¯
æ§ïŒIC50ïŒ5.5Ã10-12ïŒïŒãæããããšããããã å®æœäŸ 14 æ¬å®æœäŸã¯ã¯ããŒã³åæ§è©Šéšã«ãããŠç¢ºèªãã
ãCEMæšç现èã«å¯ŸããITïŒïŒ¡âLaïŒT101ãš
ITT101ã®çŽ°èæ¯æ§çå¹èœã®æ¯èŒã瀺ããå ç«æ¯
çŽ ã¯æšç现èãäžã€äžã€ç Žå£ããäœçšãæ ããã
ã®äœçšã¯æ床ã®é«ãæè¡ãçšããŠæž¬å®ããããšã
ã§ãããã³ãããŒåœ¢æé»å®³è©Šéšã«ããã°ãäžåã®
çå现èãæ°çŸäžã®æ»ãã 现èããèŠãåºããã
ããã®å¯èœæ§ããããããã¯äººéã®CEMãªã³ã
ç³»ã«å¿ããã²ã«åªäœã«ãããæé©ãªå¹é€æ¡ä»¶ã«ã
ã€ãŠå¯èœã«ãªãã ã³ãããŒåœ¢æé»å®³è©Šéšã«ãã现èæ¯çŽ ã®æž¬å®
æè¡ ã¯ããŒãã³ã°ã«çšããããåªäœã¯ã±ãã°ã«ã¿ã«
é žãããªãŠã ïŒããªmolããªããµãé ¢é žãããªãŠ
ã ïŒããªmolãïŒïŒ ã®äžæŽ»æ§ä»ãŠã·è¡æž åã³10ïŒ
ã®äžæŽ»æ§ãŠãè¡æž ãå ããããRPMI1640ã§ã
ããæåã«0.3ïŒ ã®å¯å€©æº¶æ¶²ïŒã¢ã¬ããŒã¹åã
ã·ã°ãïŒSIGMAïŒç 究æ補ïŒããããªç¿ã®ãã®
åªäœäžã«èå±€ã®ããã«ããŠçšæããïŒâã§ååºã
ããã现èã¯37âã«ä¿æž©ãã0.275ïŒ å¯å€©æº¶æ¶²ãš
æ··ãåããããããæåã®å¯å€©å±€äžã«æµã蟌ãã§
ååºããããããã«çšããå¯å€©ã®æ¿åºŠã¯ãã¯ããŒ
ãã³ã°ã®å¹çãã³ãããŒã®å€§ããåã³åªäœã®åäž
æ§ã®äžè ãåæã«æé©åããç®çã§è¡ã€ãäºåè©Š
éšã®çµæããå®ãããææž©ã«ä¿ã€ãŠãã15æ¥åŸ
ã«ãèªåã³ãããŒèšæ°åšïŒâã¢ã«ããã¯âããã€ã
ããã¯ç€Ÿãç±³åœïŒãçšããŠã³ãããŒãèšæ°ããã
ã¯ããŒãã³ã°å¹çãå³ã¡å ç«æ¯çŽ åŠçã§çãæ®ã€
ã现èã®æ£ç¢ºãªæ°ã決å®ããã«ã¯ãæ¥çš®ããã现
èã®æ°ã圢æãããã³ãããŒã®æ°ã®é¢æ°ãšããŠè¡š
ãæ€éç·ãã€ããããšã倧åã§ãããçºæè çã¯
ãã®æ€éç·ããåŸãããã¯ããŒãã³ã°å¹çã¯ã现
èãå ç«æ¯çŽ åŠçããå Žåããã¿ãããããã«ã
æ»ãã 现èãé«ãå²åã§ãã€ãŠã圱é¿ãããªãã
ãšã蚌æããã å ç«æ¯çŽ åŠçã¯ã10ïŒ ã®äžæŽ»æ§ä»ãŠã·è¡æž ãš10
ããªmolã®å¡©åã¢ã³ã¢ããŠã ãå«ãRPMI1640åª
äœã®å šéïŒmlã«å¯ŸããŠããããç°ã€ãæ¿åºŠã®IT
ïŒïŒ¡âLaïŒT101åã³ITT101ã®å ç«æ¯çŽ ãçšãã
ææ°çã«æé·ããŠãã现èãä¿æž©ããããšã«ãã€
ãŠè¡ããä¿æž©ã¯ïŒïŒ ã®äºé žåççŽ ãå«ãé°å²æ°äž
ã§è©Šéšç®¡ãæ°Žå¹³æ¹åã«æ¯ãããšïŒããŠãŒãã«ã³ã¹
ãŠã€ãã¯ç€Ÿâãžã©ããªââïŒâæªæåšãçšããŠ
2500rpmã®ããŒã¹ïŒã«ãã€ãŠ37âã«ä¿ã€ããçå
现èã®æ°ãæ€éç·ã«ãã€ãŠæ倧æ床ç¯å²ã§æž¬å®ã§
ããããã«å¯å€©æº¶æ¶²ãšæ··åããåã«ã现èãæŽæµ
ããããããç°ã€ãåžéã«ããŠæºåãããçµæã¯
次ã®é¢ä¿åŒãçšããã¯ããŒãã³ã°å¹çããå€æ¿ã
ãŠçå现èã®çµ¶å¯Ÿæ°ã§è¡šãããçå现èã®çµ¶å¯Ÿæ°
ã¯æ¬¡åŒã§è¡šãããããÃïœïŒïŒ¥ãããã§ïŒ£ã¯ãã ãªç¿ïŒç¿åœãã®ã¯ããŒã³ã®æ°ãïœã¯çŽ°èã®åžéå
åãã¯æ€éç·ã®åŸé ããæ±ããããã¯ããŒãã³
ã°å¹çã§ãããããããã®å€ã¯ïŒåã®è©Šéšçµæã®
å¹³åããšã€ãã çµæ å³ïŒã¯å¡©åã¢ã³ã¢ããŠã 10ããªmolã®ååšäžã«
ãããCEM现èã«å¯ŸããITïŒïŒ¡âLaïŒT101åã³
ITT101å ç«æ¯çŽ ã®çŽ°èæ¯æ§æ²ç·ãå ç«æ¯çŽ ã®æ¿
床ïŒïŒ¡éã®ã¢ã«æ¿åºŠïŒã®é¢æ°ãšããŠè¡šããŠããã
ãããïŒã€ã®æ¯çŽ ã®å¹çã¯åããªãŒããŒã®å€§ãã
ã§ããããšã¯æããã§ããã现èæ°æžå°ã®åºŠåã¯
äž¡è ãšã倧ããããããã¯10-11ïŒçšåºŠã®äœãæ¿
床ã«ãããŠã¯æ®åçå现èã®å²åã¯åæå€ã«æ¯ã¹
ãŠ0.001ïŒ ã®ãªãŒããŒã«ãªã€ãŠããŸãããã§ããã
ãã®å¹æã¯é«åºŠã«ç¹ç°çã§ãããäœæ ãªãããã
ã®æ¿åºŠã«ãããŠã¯ã«ãããªã³ã°ãããŠããªãé
ãšéç¹ç°çãªå ç«æ¯çŽ ã¯ããããã®çŽ°èã«å¯ŸããŠ
å¹æããã€ãŠããªãããšã蚌æãããããã§ã
ãã æ¬å®æœäŸã«ãã€ãŠITïŒïŒ¡âLaïŒT101ã¯åŸæ¥ã®
ITT101ãšå®è³ªçã«åäžãªç¹ç°çŽ°èæ¯æ§ãæãã
ããšããããã å®æœäŸ 15 ãªã·ã³ã®é žåããå®èœåºãå°å ¥ããé
ïŒNEMïŒãšæŽ»æ§åããããžã¹ã«ãã€ãåºã§çœ®æ
ãã人éã®ïŒŽçŽ°èãé»å®³ããæäœïŒT62æåã«äœ
çšããæäœïŒãšã®æ±åäœãã«ãããªã³ã°ã¯æŽ»æ§å
ããããžã«ãã€ãåºãšïŒ¡éã®å®èœåºãå°å ¥ããã
ç³è³ªæ®åºã®éã§èµ·ããã ïŒ å ç«æ¯çŽ ã®æºå ïœ å®èœåºãå°å ¥ããéã®æºå éã®SHåºãâãšãã«ãã¬ã€ããã§ãã¹ã¯
ãã次ãã§å®æœäŸïŒã§èª¬æããæ¹æ³ãçšããŠ18æ
éãããŠé žåããã ã·ã¹ã¿ãã³ãšã®ã«ãããªã³ã° PH9.5ã®çé žç·©è¡æ¶²ã§éæããåŸãã¿ã³ãã¯è³ª
ãïŒmlåœã4.65mgå«ã溶液5.2mlãå¡©é žã·ã¹ã¿ã
ã³18mgãšå ±ã«25âã§ïŒæéä¿æž©ãããããããŠä¿
æž©ãããã®ãããŠæ°ŽçŽ åãããªãŠã ïŒïŒ¡éïŒã¢ã«
ã«ã€ã200çéå³ã¡0.1Næ°Žé žåãããªãŠã 溶液ïŒ
mlã«17.6mgã®ããŠæ°ŽçŽ åãããªãŠã ãå«ã溶液
156ÎŒïŒãçšãã25âã§ïŒæééå ããã éå°ã®è©Šè¬ã¯PHïŒã®ãªã³é žç·©è¡æ¶²125mMã§é£
ç¶éæããŠé€å»ãããåºå®ããã·ã¹ã¿ãã³ã®ãžã¹
ã«ãã€ãããªããžã30âã§ïŒæéåŸã«æ¿åºŠïŒïŒ ã«
ãªããããªïŒâã¡ã«ã«ãããšã¿ããŒã«ã§éå ãã
ãã®åŸããã«PHïŒã®125mMãªã³é žç·©è¡æ¶²ã§é£ç¶
éæïŒæ¯æ300mlã§å šé20ïŒãããéæåã³é
å¿åé¢åŸãé1molåœã0.25åã®SHåºããšã«ã
ã³æ³ã«ãã€ãŠå®éããã ïœ æäœã®æºåïŒå®æœäŸ11åç §ïŒ ïœ ã«ãããªã³ã°åå¿ ä¿®é£Ÿããããªã·ã³ïŒ¡éã®æº¶æ¶²1.5mlïŒïŒ¡éã¯
0.058ÎŒmolïŒãåèšïœïŒã§åŸããã掻æ§åæäœæº¶
液211ÎŒïŒæäœã¯0.006ÎŒmolïŒã«å ããããã®æ··
åç©ã30âã§18æéåå¿ãããã次ãã§ãã®åå¿
ç©ããªã³é žç·©è¡æ¶²ïŒãªã³é žå¡©10mMãå¡©åãããª
ãŠã 140mMã®å²åã§PH7.4ïŒã§éæãããé å¿å
é¢åŸãããªã¢ã¯ãªãã¢ããé»æ°æ³³åã«ããããšã
åŸãããå ç«æ¯çŽ ã¯å¹³åããŠæäœ1molåœãé
0.8åã®ã«ãããªã³ã°åºŠãæããããšãããã€ãã ïŒ å ç«æ¯çŽ ITïŒïŒ¡ïŒNEMïŒâLaâã·ã¹ãã¢ãã³ïŒ
T101ã®æ§è³ª ïœ ç¹ç°ç现èæ¯çŽ æŽ»æ§ åè¿°ã®æç¶ã§æºåããå ç«æ¯çŽ ã¯CEMæšç现
èã«å¯ŸããŠéåžžã«åŒ·åãªçŽ°èæ¯çŽ 掻æ§ïŒIC50ïŒ
1.2Ã10-11ãå®æœäŸ13ã§èª¬æãã枬å®æ³ã«ããïŒ
ãæããã ïœ è¡æŒ¿äžæ¿åºŠã®æžå° å ç«æ¯çŽ ããããã®è³ã®è¡ç®¡ã«äžå泚å°ããã
è¡æŒ¿ãµã³ãã«ã¯22æéåŸã«æ¡åããŠãRIAâïŒå
ç«æ€å®æ³ïŒå®æœäŸ12åç §ïŒã«ãã€ãŠåæãããçµ
æãäžè¡šã«ç€ºããIT101ã®å€ã¯çžå¯Ÿçãªå€ã§ç€ºã
ãŠããã
ãšããããã³ãŸã€ã«åºãçãããã280nmã«ãã
ãåžåã倧ããå¢å ãããé žååŸã¯280nmã«ãã
ãåžåã«å€§ããªå€åã¯èŠ³å¯ãããªãã€ããããã¯
é žåã¯280nmã«ãããåžåã«é¢ä¿ããã¢ããé žã«
圱é¿ãäžããªãã€ãããšã瀺ããŠããã ïŒ çé»ç¹é»æ°æ³³å éãçé»ç¹æ³³åã«ãã€ãŠåé¢ãããšPH7.5ãª
ãã8.0ã®éã«çé»ç¹ãã³ããçããããã¯ïŒ¡éã
A1éåã³A2éã®ã©ããåãã§ãã€ãã çç¶æ åã³é žåç¶æ ã®ïŒ¡éãA1éããã³A2é
ã®çé»ç¹ãæ¯èŒãããšããããã¹ã¯ãããŠããªã
å Žåã¯ïŒ¡éã«ç¹åŸŽçãªãã³ãå šãŠãPHã§0.5ãé ž
æ§æ¹åã«ç§»åããããã®çé»ç¹ç§»åã¯çç¶æ ãšé ž
åç¶æ ã®ãã®ãéãªãããšãªãèµ·ãã€ãã®ã§ã
éã®ååã¯å šãŠé žåã«ãã€ãŠåœ±é¿ãåãããšèã
ãããã å®æœäŸ ïŒ æ¬å®æœäŸã«ãããŠã¯çã®ã²ããã³ãåç©ã«éè
泚å°ããå Žåã®ãã®æ¥æ¶å€±ãšéãšãŠçŽ é žãããªãŠ
ã ã«ãã€ãŠå€æ§ãããã²ããã³ãåæ§ã«æ³šå°ãã
åŸã®ãã®ãã€ãããšããæ¶å€±ã«ã€ããŠèª¬æããã ïŒ éãšãŠçŽ é žãããªãŠã ã«ããã²ããã³ã®ä¿®é£Ÿ ã²ããã³ãã²ãããŠã ã ã«ããããŒã«ã
ïŒGelonium multiflorumïŒããçååŠãžã€ãŒã
ã«ã第255å·»ã6947â6953é ã1980幎ã«è¿°ã¹ãŠã
ãæ¹æ³ã§æœåºãã粟補ãããå®æœäŸïŒã§ãªã·ã³ïŒ¡
éã«ã€ããŠè¿°ã¹ãã®ãšåãæ¹æ³ã§é žååå¿ãè¡ã€
ãããããããªãŒã«åºã®DTNBã«ãããã¹ã¯ã¯
è¡ã€ãŠããªãã å®éã²ããã³ã®å€©ç¶ã®ããªãŒã«åºãçšããŠã²ã
ãã³ãšæäœãã«ãããªã³ã°ãããããšã¯ããŸãè¡
ãªãããŠããªãã®ã§ãããªãŒã«åºã¯ãé žååŸãã¬
ã³ç 究ïŒCancer Res.ïŒã第44å·»ã129â133é ã
1984幎ã«ãããŠèª¬æãããæè¡ãçšããŠäººå·¥çã«
å°å ¥ãããéãšãŠçŽ é žãããªãŠã 0.5M氎溶液21ÎŒ
ãïŒmlåœããïŒmgã®ã²ããã³ãå«ã溶液ïŒmlã«
ãªã³é žç·©è¡æº¶æ¶²äžã§å ãã1Mé ¢é žã§PHãïŒã«ã
ãããããææã§16æéïŒâã«ä¿ã€ããåå¿ã¯
1Mãšãã¬ã³ã°ãªã³ãŒã«æ°Žæº¶æ¶²ã105ÎŒå ããŠçµ
çµããããããã20âã§ïŒåéä¿æž©ããåŸãåå¿
ç©ãïŒâã§ãªã³é žç·©è¡æ¶²äžã«ãããŠéæããã30
åé10000Ãïœã§é å¿åé¢ã«ããããšããããã
æ¿åºŠ2.5mgïŒmlã®é žåã²ããã³2.9mgãåŸãããã ãªã·ã³ïŒ¡éãšåãããã«ãã²ããã³ã®åºæ¬çç¹
æ§ã¯ãªããœãŒã ã®60SãµããŠãããã®å解ã«ãã€
ãŠçæ žçŽ°èã«ãããã¿ã³ãã¯è³ªåæãé»å®³ããã
ãšã§ããïŒãã€ãªã±ãã«ã«ãžã€ãŒãã«ã第207å·»ã
505ã509é ã1982幎ïŒãã²ããã³ã®å Žåã«ãéãš
ãŠçŽ é žé žåã«ãã修食ã¯ã掻æ§ã®æ倱ãçããã
ãªãããšãããã€ãã ã²ããã³ã«ãããè¬ç©åæ åŠçç¹æ§ã®ç¶æ çã®ãæãã¯äžè¿°ã®æç¶ã§ä¿®é£Ÿãããã²ããã³
ããããã®è³ã®è¡ç®¡ããäžå泚å°ãããæäžãã
ã²ããã³ã®éã¯0.3ãªãã0.4mgïŒKgã§ãã€ããã
ããªã³ã®ååšäžã§è¡æ¶²ãæã æ¡åãããè¡æŒ¿ã¯ä»¥
äžRIMâïŒãšç¥ç§°ããæŸå°ç·å ç«è©ŠéšãçšããŠ
åæããã ãã®è©Šéšã¯RIMâïŒè©Šéšãšåãæè¡ãçšããã
ãã ãAc1溶液ãæ¬äŸã§ã¯ã¢ãã€ããã€ãŒã¯ãã
ãã°ã©ãã€ãŒã§ç²Ÿè£œãããæã²ããã³ãŠãµã®æäœ
溶液ã§ãããAc2æäœã¯RIMâïŒè©Šéšãšåãæäœ
ãæŸå°æ§åäœäœã§æšèãããã®ã§ãããåäžæšæ¬
äžã®çã®ã²ããã³ãšä¿®é£Ÿããã²ããã³ã®æ¿åºŠãã
ãããæšæ¬ãšã¯ç°ã€ãæ¢ç¥ã®æ¿åºŠã®æ€éç·ãšæ¯èŒ
ããããšã«ãã€ãŠæ±ºå®ãããæŸå°æšèã®æè¡ã¯
RIMâïŒã§èª¬æãããã®ãšåãã§ãããRIMâ
ïŒè©Šéšã¯RIMâïŒè©Šéšãšåçã®ä¿¡é Œæ§ãšåçŸæ§
ã瀺ãããæ¬å®éšã®çµæã¯å®æœäŸïŒã§ãªã·ã³ã®ïŒ¡
éã«ã€ããŠç€ºããã®ãšåãæ¹æ³ã§ç€ºãã å³ïŒã¯çã®åã³ä¿®é£Ÿããã²ããã³ãéè泚å°ã
ãå Žåã®è¡æŒ¿äžæ¿åºŠæ²ç·ãæéã®é¢æ°ãšããŠè¡šã
ããŠãããçã®ã²ããã³ã¯99.99ïŒ ã24æéã§æ¶
倱ããããšãããçã®ãªã·ã³ïŒ¡éãšåãããã«è¡
äžããéåžžã«æ¥éã«æ¶å€±ããããšããããïŒæ²ç·
ïŒïŒãã²ããã³ã®ããªãµãã«ãªãåäœãé žåãã
ãŠããå Žåã¯æ²ç·åœ¢ã倧ããéããæäž24æéåŸ
ã«é žåããã²ããã³ã®æ¿åºŠã¯çã®ã²ããã³ã®300
åããïŒæ²ç·ïŒïŒã åŸã€ãŠãããã®çµæã¯ãªã·ã³ïŒ¡éãšåããã
ã«ãéãšãŠçŽ é žé žåã¯ã²ããã³ã®æ¶å€±ã枬ãã®ã«
çšããããç³é¡ãããã®æ©èœã劚ããçšåºŠã«ãŸã§
修食ããããšã瀺ããŠããã å®æœäŸ ïŒ æ¬å®æœäŸã¯(1)ã¢ã¢ã«ãã€ã«ã»ã«ã©ã³ãã€ã¢
ïŒmomordica charantiaïŒããæœåºããGPIR
MOMãåç©ãžéè泚å°ããåŸã®ãã®æ¥éãªæ¶å€±
ãš(2)éãšãŠçŽ é žãããªãŠã ã§ä¿®é£ŸããGPIR
MOMãåãããã«æ³šå°ããåŸã®ãã€ãããšãã
æ¶å€±ã«é¢ããã ïŒ GPIR MOMã®éãšãŠçŽ é žãããªãŠã ã«ãã
修食 GPIR MOMãMomordica charantiaçš®åã®
å çèåããããã€ãªã±ãã«ã«ãžã£ãŒãã«
ïŒBiochemical JournalïŒç¬¬186å·»ã443â452é ã
1980幎ã§èª¬æãããŠããæ¹æ³ã§æœåºã粟補ããã
çã®MOMåã³ä¿®é£ŸãããMOMã®è¬ç©åæ åŠç
ç¹æ§ãæŸå°æšèããGPIR MOMãçšããŠèª¿ã¹
ããMOMã¯ã¯ãã©ãã³ïŒŽã®ååšäžã§125Iãçšã
ãŠæšèãããæŸå°æ§125IãïŒmlåœã100ÎŒCiå«ã溶
液10ÎŒãšã¯ãã©ãã³ïŒŽãïŒmlåœã2.5mgå«ã溶液
30ÎŒããMOMãïŒmlåœãïŒmgå«ã溶液100ÎŒ
ã«ãªã³é žç·©è¡æº¶æ¶²äžã§å ãããåå¿æ¶²ã宀枩ã§ïŒ
åéä¿ã€ããåå¿ã¯ïŒmlåœãã¡ã¿éäºç¡«é žãããª
ãŠã 0.5mgãå«ã溶液400ÎŒãå ããŠçµçµãããã
åå¿ç©ã¯æªåå¿ã®ãšãŠçŽ ãæŸå°æšèãããã¿ã³ã
ã¯è³ªããåé¢ããããã«Sephadex  25ã®ã«ã©
ã ãçšã0.1ïŒ ã®ã²ã©ãã³ãå«ããªã³é žç·©è¡æ¶²ã§
ã²ã«éããã10000Ãïœã§30åéé å¿åé¢ã«ã
ãããšãããæ¿åºŠ0.04mgïŒmlã®æŸå°æšèããã
MOMã80ÎŒgåŸãããã é žååå¿ã¯å®æœäŸïŒã«ãããŠãªã·ã³ã®ïŒ¡éã«ã€
ããŠèª¬æããã®ãšåãæ¡ä»¶äžã§è¡ãªããããäœã
ããªãŒã«åºãDTNBã§ãã¹ã¯ããåŠçã¯ãªãã
ã¿ã³ãã¯è³ªã®æ¿åºŠã¯125åäœã40ÎŒgïŒïœã§ã
ãã0.5MéãšãŠçŽ é žãããªãŠã 氎溶液20ÎŒãæŸ
å°æšèãããMOMãïŒïŒmlåœããïŒ0.04mgå«ã
溶液ïŒmlã«å ãã1Mé ¢é žã§PHãïŒã«ããããã®
åå¿æ¶²ãææã§16æéïŒâã«ä¿ã€ããåå¿ã¯1M
ãšãã¬ã³ã°ãªã³ãŒã«æ°Žæº¶æ¶²ã100ÎŒå ããŠçµçµ
ãããã15åé20âã«ä¿ã€ãåŸãåå¿ç©ãïŒâã®
äžã«ãªã³é žç·©è¡æ¶²ã§éæããã10000Ãïœã§30å
éé å¿åé¢ã«ããããšããæ¿åºŠ0.021mgïŒmlã®é ž
åãããMOMã32ÎŒgåŸãããã ããããŠåŸãããæ°ããååã®ååéã¯çã®
MOMãšå®è³ªçã«çžéããªããã¯ãŒãã·ãŒãã«ãŒ
ã§æè²ããããªã¢ã¯ãªã«ã¢ããé»æ°æ³³åã«ãããŠ
ã¿ãéãã§ã¯ã修食åŠçã¯ããå°éã®ã¿ã³ãã¯è³ª
ããªããŒãçããããã®ã¿ã§ãäœãã®å解ãåŒã
èµ·ããªãã€ãã ïŒ MOMã®è¬ç©åæ åŠçç¹æ§ã®æç¶ æŸå°æšèãããMOMããåè¿°ã®æç¶ã«ããé ž
åã®æç¡ãåããããããã®è³ã®è¡ç®¡ã«äžå泚å°
ãããæäžãããMOMã®éã¯3.50ãªãã
3.55ÎŒgïŒKgã§ããããããªã³ååšäžã§æã æ¡è¡ã
ãããè¡æŒ¿ãæ¿åºŠ25ïŒ ã®ããªã¯ããé ¢é žïŒTCAïŒ
200ÎŒãšäžç·ã«ïŒâã§30åéä¿æž©ãããé žã§æ²
殿ãããæ²éç©äžã®æŸå°èœã枬å®ããããã®åæ
æ³ã«ããã°ã圱é¿ãåããªãã€ãMOMååã®è¡
挿ã¬ãã«ã®æž¬å®ãå¯èœã«ãªããTCAã§æ²æ®¿ããª
ãäœååã®å解çæç©ã¯èæ ®ã«å ¥ããªãã€ããã
ããã®å®éšçµæã¯è¡äžã«æ®åããæŸå°èœãåæé
ã«å¯ŸããçŸåçã«ããŠæéã®é¢æ°ã§è¡šããããã®
å€ã¯âåæè¡æŒ¿æŸå°èœçŸåçïŒïŒ IPRïŒãšåŒã°
ãã次åŒã§ç®åºããã ïŒ I.P.R.ïŒïœÃPVÃ100ïŒ0.2Ã ããã§ïœã¯0.2mlã®ãã©ãºãããïœæéåŸã«æ€
åºãããæŸå°èœãã¯æäžãããå šæŸå°èœãPV
ã¯è¡æŒ¿éïŒãããã®äœéïŒKgåœã36mlãããšèã
ãããŠããïŒã§ããã å³ïŒã«ç€ºããã®ã¯ãé žåããããŸãã¯é žåãã
ãªãMOMãéè泚å°ããåŸã®è¡æŒ¿äžæ¿åºŠã§ã
ããMOMã¯ãè¡äžã®MOMã®99.9ïŒ ãïŒæéã§
æ¶å€±ããããšãããçã®ãªã·ã³ïŒ¡éãšåããã
ã«ãè¡äžããæ¥éã«æ¶å€±ããããšããããïŒæ²ç·
ïŒïŒãMOMã®ç³è³ªæ®åºãé žåãããå Žåã¯ãæ¿
床ã®æžå°é床ãäœäžããïŒæ²ç·ïŒïŒãæäžïŒæé
åŸã«é žåãããMOMã®æ¿åºŠã¯é žåãããŠããªã
MOMã®ããã®60åã«ãªã€ããåŸã€ãŠãããã®çµ
æã¯éãšãŠçŽ é žé žåã¯MOMã®çæéæ¶å€±ã®åå
ã§ããç³é¡ã修食ããããšã瀺ããŠããã å®æœäŸ 10 æ¬å®æœäŸã¯(1)ãã€ã¢ã³ããŠã¹ã»ã«ãªãªãã€ã«ã¹
ïŒDianthus caryophyllusïŒããæœåºããGRIRã
ã€ã¢ã³ãã³ãåç©ãžéè泚å°ããåŸã®ãã®æ¥éãª
æ¶å€±ãš(2)éãšãŠçŽ é žãããªãŠã ã§ä¿®é£ŸããGRIR
ãã€ã¢ã³ãã³ãåãããã«æ³šå°ããåŸã®ãã€ãã
ãšããæ¶å€±ã«é¢ããã ïŒ ãã€ã¢ã³ãã³30ã®éãšãŠçŽ é žãããªãŠã ã«ã
ã修食 ãã€ã¢ã³ãã³30ãDianthus caryophyllusã®è
ãããã€ãªã±ãã«ã«ãžã€ãŒãã«ïŒBiochemical
JournalïŒç¬¬195å·»ã339â405é ã1981幎ã§èª¬æã
ããŠããæ¹æ³ã§æœåºãã粟補ãããé žåãããå
ã¯é žåãããŠããªããã€ã¢ã³ãã³30ã®è¬ç©åæ åŠ
çç¹æ§ãæŸå°æšèãããã€ã¢ã³ãã³ãçšããŠèª¿ã¹
ãããšãŠçŽ ååã³é žååå¿ã¯å®æœäŸïŒã§MOMã«
ã€ããŠèª¬æããã®ãšåãæ¡ä»¶äžã§è¡ã€ãã ããããŠåŸãããæ°ããé žåããããã€ã¢ã³ã
ã³ååã®ååéã¯çã®ãã€ã¢ã³ãã³30ãšå®è³ªçã«
çžéããªãã ïŒ ãã€ã¢ã³ãã³30ã®è¬ç©åæ åŠçç¹æ§ã®æç¶ æŸå°æšèããããã€ã¢ã³ãã³ãåè¿°ã®æç¶ã«ã
ãé žåã®æç¡ãåããããããã®è³ã®è¡ç®¡ã«äžå
泚å°ããããã€ã¢ã³ãã³ã®è¡æŒ¿äžæ¿åºŠã¯å®æœäŸïŒ
ã§MOMã«ã€ããŠèª¬æããã®ãšåãæ¹æ³ã§æž¬å®ã
ããå³ïŒã¯é žåããããã€ã¢ã³ãã³ïŒæ²ç·ïŒïŒå
ã¯é žåãããªããã€ã¢ã³ãã³ïŒæ²ç·ïŒïŒã®è¡æŒ¿äž
æ¿åºŠãæéã®é¢æ°ã§è¡šããããã®ã§ããããã€ã¢
ã³ãã³30ã¯MOMãšåãããã«åæéã®99.9ïŒ ã
ïŒæé以å ã«æ¥éã«æ¶å€±ããŠãããäžæ¹ãã€ã¢ã³
ãã³30ã®ç³è³ªæ®åºãé žåãããå Žåã¯ãæ¿åºŠã®æž
å°é床ã倧ããäœäžãããæäžïŒæéåŸã«é žåã
ãããã€ã¢ã³ãã³ã®æ¿åºŠã¯é žåãããŠããªã
MOMã®ããã®80åã«ãªã€ããé žåããããã€ã¢
ã³ãã³ã®æ¿åºŠã¯24æéãã€ãŠããŸã é«ãã€ãïŒå
æéã®ïŒïŒ ïŒã ãããã®çµæããŸããéãšãŠçŽ é žé žåã¯ãã€ã¢
ã³ãã³ã®çæéæ¶å€±ã®åå ã§ããç³è³ªã修食ãã
ããšã瀺ããŠããã å®æœäŸ 11 ãªã·ã³ïŒ¡éã掻æ§åããããžã¹ã«ãã€ãåºã§çœ®
æã人éã®ïŒŽçŽ°èãé»å®³ããæäœãšåå¿ãããæ±
åäœãæºåããã ïœ äººéã®ïŒŽçŽ°èãé»å®³ããæäœïŒT101æäœïŒ ãã®æäœã¯å ç«åŠãžã€ãŒãã«ïŒJournal of
ImmunologyïŒç¬¬125ïŒïŒïŒå·»ã725â737é ã1980
幎ã«ãããŠèª¬æãããæ¹æ³ã«ãã€ãŠæºåããã ïœ é žåããããªã·ã³ã®ïŒ¡é ãªã·ã³ã®ïŒ¡éã¯å®æœäŸïŒã§èª¬æããæ¹æ³ã«ãã€
ãŠæºåããã 人éã®ïŒŽçŽ°èãé»å®³ãã掻æ§åæäœ ïŒâãšãã«âïŒâãžã¡ãã«ã¢ãããããã«âïŒ
âã«ã«ããžã€ãããïŒmlåœã60.3mgå«ã溶液20ÎŒ
ãïŒâïŒããªãžãã«âïŒâãžã¹ãã¢ãã«ïŒãã
ããªã³é žãïŒmlåœã20mgå«ã溶液100ÎŒã«tertâ
ãã¿ããŒã«äžã§å ããæ··åç©ãïŒåé宀枩ã§æŸçœ®
ãããããããŠåŸããã溶液68ÎŒããïŒmlåœã
æäœ8.9mgãå«ã溶液ïŒmlã«ãªã³é žç·©è¡æ¶²äžã§å
ããããã®æ··åç©ã15åé30âã§æªæãããã®åŸ
ïŒâäžã§ãªã³é žç·©è¡æ¶²ã«ãããŠéæããã次ãã§
ã¿ã³ãã¯è³ªæº¶æ¶²ãé å¿åé¢ãã掻æ§åæäœã7.9
mgïŒmlã®æ¿åºŠã§15mgåŸããïŒâã¡ã«ã«ãããšã¿ã
ãŒã«ãšã®äº€æåå¿ã«ãã€ãŠæŸåºãããããªãžã³â
ïŒâããªã³ã®343nmã«ãããåžåãã¿ããšããã®
æäœã¯1molåœã3.8åã®æŽ»æ§åãããæ··åãžã¹ã«
ãã€ãåºãæããŠããããšãããã€ãã æç¶äœçšã®ãããªã·ã³ïŒ¡éãå«æããå ç«æ¯
çŽ ã®æºå 修食ãããéãïŒmlåœã2.87mgå«ã溶液2.46
mlãšäžè¿°ã®æ¹æ³ã«ãã€ãŠåŸããã掻æ§åæäœã®æº¶
液1.5mlãæºåãïŒæ¿åºŠ7.9mgïŒmlïŒå³ã¡æŽ»æ§åæ
äœã11.8mgå«ãïŒããã®æ··åç©ã20âã§20æéæŸ
眮ããããã®æº¶æ¶²ãé å¿åé¢ã«ãããã»ãã¢ãã
ã¯ã¹G100ãçšããŠéãã粟補ããã溶åºç©ã®
å åŠå¯åºŠã280nmã§æž¬å®ãããæäœãšïŒ¡éã®äž¡æ¹
ãå«ãåç»ãåããããšå ç«æ¯çŽ ãïŒmlåœã0.7
mgå«ã溶液15mlïŒå³ã¡å ç«æ¯çŽ ã¯10.5mgïŒãåŸã
ããããã®æº¶æ¶²ã¯æäœãšã«ãããªã³ã°ãããé žå
éãïŒmlåœã0.14mgå«æããã åŸã€ãŠãã®æ¹æ³ã«ããå¹³åã«ãããªã³ã°åºŠã¯æ
äœ1molã«ã€ãé žåé1.2molã§ããã äžèšã®æ¹æ³ã§åŸãé žåããããªã·ã³ïŒ¡éãå«ã
å ç«æ¯çŽ ITïŒïŒ¡âLaïŒT101ã«ã€ããŠããã®è¬ç©
åæ åŠçç¹æ§ãšæšç现èã«å¯Ÿãã现èæ¯æ§ã調ã¹
ãã å®æœäŸ 12 æ¬å®æœäŸã«ãããŠã¯ãæç¶äœçšããã€ãªã·ã³ïŒ¡
éãå«ãå ç«æ¯çŽ ïŒITïŒïŒ¡âLaïŒT101ãšç¥ãïŒ
ã®è¡æŒ¿äžæ¿åºŠããã€ãããšæžå°ãããšããæ§è³ªã
ç²åŸããããšã瀺ãã æ¹æ³ å®æœäŸ11ã§èª¬æããæç¶ã§æºåãããæ±åäœã
ãããã®è³ã®è¡ç®¡ã«äžåºŠæ³šå°ãããæäžãããé
ã¯ïŒ¡éã«ã€ããŠäœéïŒKgåœãã0.415mgã§ããã
ãããªã³ã®ååšäžã§è¡æ¶²ãæã æ¡è¡ãããè¡æŒ¿ã
æŸå°ç·å ç«è©ŠéšïŒRIMâïŒãšç¥ãïŒã«ãã€ãŠ
ïŒïŒç®æïŒåæããã ãã®è©Šéšã¯RIMâïŒãšåãæè¡ãçšããŠè¡ã
ãããäœãAc2溶液ã¯æ¬è©Šéšã«ãããŠã¯RIMâïŒ
ã®æè¡ãçšããŠã¢ãã€ããã€ãŒã¯ãããã°ã©ãã€
ãŒã«ãã€ãŠç²Ÿè£œãããæŸå°æšèãããããŠã¹ã®
IgGãé»å®³ããã€ã®ã®æäœã§ããããã®ãµã³ãã«
ã«ããã修食ãããå ç«æ¯çŽ ã®æ¿åºŠã¯æ¢ç¥ã®ç°ã€
ãæ¿åºŠããå°ããæ€éç·ãçšããŠæ±ºå®ããã
RIMâïŒè©Šéšã¯RIMâïŒãšåãä¿¡é Œæ§åã³åçŸ
æ§ãæããã æ¯èŒå¯Ÿç §ã®ãããçã®ãªã·ã³ïŒ¡éã掻æ§åãã
ããžã¹ã«ãã€ãåºã§çœ®æããæäœã®åå¿ããåŸã
ããITT101ã®æ±åäœãšåãæ¡ä»¶äžã§æ¯èŒäŸã®è©Š
éšãè¡ã€ãããã®æ±åäœã®æºåãšçŽ°èæ¯æ§ã¯ãã©
ã³ã¹åœç¹èš±åºé¡ç¬¬2516794å·ã§èª¬æããæ¹æ³ã«ã
ã€ãŠè¡ã€ãããããã®å®éšçµæã¯å®æœäŸïŒã§ã«ã
ããªã³ã°ãããŠããªãéã«ã€ããŠè¡ã€ãã®ãšå
ãæ¹æ³ã§ç€ºããã çµæ å³ïŒã¯éè泚å°ãããITT101åã³ITïŒïŒ¡âLaïŒ
T101ã®è¡æŒ¿äžæ¿åºŠæ²ç·ã瀺ããŠãããæäž24æ
éåŸã«ITïŒïŒ¡âLaïŒT101掻æ§çŽ°èæ¯çŽ ã¯ITT101
ã®140åã«ãªã€ãŠããããã®äºå®ã¯é žåããã
éã®è¬ç©åæ åŠçç¹æ§ã¯æäœãšã«ãããªã³ã°ãã
ãåŸãä¿æãããŠããããšã瀺ããŠããã å®æœäŸ 13 æ¬å®æœäŸã«ãããŠã¯ITïŒïŒ¡âLaïŒT101ã®æšç
现èã«å¯Ÿãã现èæ¯çŽ ç¹æ§ã®ä¿åã«ã€ããŠè¿°ã¹
ãã ãªã·ã³ïŒ¡éã®åºæ¬çãªçç©åŠçç¹æ§ã¯çŽ°èäžã®
ã¿ã³ãã¯è³ªåæããªããœãŒã ã®60SãµããŠããã
ã®å解ã«ãã€ãŠé»å®³ããããšã§ããã ãã®æ¹æ³ã¯å¹é€äžã®ã¬ã³çŽ°èã«14Cã§æšèãã
ãã€ã·ã³ïŒä»¥äž14Câãã€ã·ã³ãããïŒãåã蟌
ãŸããŠç 究ãããŠããç©è³ªã®å¹æã枬å®ãã现è
ç³»ãçšããã çšãããã现èã¯ãæåT65ãéã¶äººéã®ïŒŽçœ
è¡ç ããèªå°ãããCEM现èç³»ã«å±ããããã®
现èã¯ç®çã®ç©è³ªã®ååšäžã§ä¿æž©ããåŸã现èãž
ã®14Câãã€ã·ã³ã®åã蟌ã¿ã®çšåºŠã枬å®ããã
ãã®æž¬å®ã«ã¯çç©ååŠãžã£ãŒãã«ïŒJournal of
Biological ChemistryïŒç¬¬249å·»11å·ã3557â
3562é ã§èª¬æããããã¿ã³ãã¯è³ªåæéã枬å®ã
ãã®ã«14Câãã€ã·ã³ã®ãã¬ãŒãµãŒãçšããæ¹æ³
ã«ãã€ãŠè¡ããåã蟌ãŸããæŸå°èœã¯ãéãã现
èã®å šäœã«ã€ããŠæž¬å®ããã å®éã®åºæºãšããŠç·éïŒå¹ææ²ç·ãæãããšã
ã§ããããã®æ²ç·æšªè»žã«ã¯ç®çç©è³ªäžã®ïŒ¡éã®ã¢
ã«æ¿åºŠã瞊軞ã«ã¯ãã¿ã³ãã¯è³ªåæãé»å®³ããç©
質ã®ååšããªãæ¯èŒçŽ°èã«ããã14Câãã€ã·ã³
ã®åã蟌ã¿éã«å¯ŸããçŸåçãããããããŠåŸã
ããã ããããŠããããã®ç©è³ªã«ã€ããŠ14Câãã€ã·
ã³åã蟌ã¿éã50ïŒ é»å®³ããæ¿åºŠãŸãã¯50ïŒ é»å®³
æ¿åºŠïŒIC50ïŒã決å®ããããšãã§ããã å³ïŒã¯ææž©åªäœäžã§10mMå¡©åã¢ã³ã¢ããŠã ã®
ååšäžã§ITïŒïŒ¡âLaïŒT101ãšã«ãããªã³ã°ãã
ãŠããªãéã«ã€ããŠè¡ã€ãåãå®éšããæ²ç·ã
瀺ããŠããããã®å³ãã¿ããšITïŒïŒ¡âLaïŒT101
ã¯åäžæ¡ä»¶ã§æž¬å®ãããã«ãããªã³ã°ãé žåãã
ãŠããªãéã«æ¯ã¹çŽïŒäžåã®éåžžã«åŒ·ã现èæ¯
æ§ïŒIC50ïŒ5.5Ã10-12ïŒïŒãæããããšããããã å®æœäŸ 14 æ¬å®æœäŸã¯ã¯ããŒã³åæ§è©Šéšã«ãããŠç¢ºèªãã
ãCEMæšç现èã«å¯ŸããITïŒïŒ¡âLaïŒT101ãš
ITT101ã®çŽ°èæ¯æ§çå¹èœã®æ¯èŒã瀺ããå ç«æ¯
çŽ ã¯æšç现èãäžã€äžã€ç Žå£ããäœçšãæ ããã
ã®äœçšã¯æ床ã®é«ãæè¡ãçšããŠæž¬å®ããããšã
ã§ãããã³ãããŒåœ¢æé»å®³è©Šéšã«ããã°ãäžåã®
çå现èãæ°çŸäžã®æ»ãã 现èããèŠãåºããã
ããã®å¯èœæ§ããããããã¯äººéã®CEMãªã³ã
ç³»ã«å¿ããã²ã«åªäœã«ãããæé©ãªå¹é€æ¡ä»¶ã«ã
ã€ãŠå¯èœã«ãªãã ã³ãããŒåœ¢æé»å®³è©Šéšã«ãã现èæ¯çŽ ã®æž¬å®
æè¡ ã¯ããŒãã³ã°ã«çšããããåªäœã¯ã±ãã°ã«ã¿ã«
é žãããªãŠã ïŒããªmolããªããµãé ¢é žãããªãŠ
ã ïŒããªmolãïŒïŒ ã®äžæŽ»æ§ä»ãŠã·è¡æž åã³10ïŒ
ã®äžæŽ»æ§ãŠãè¡æž ãå ããããRPMI1640ã§ã
ããæåã«0.3ïŒ ã®å¯å€©æº¶æ¶²ïŒã¢ã¬ããŒã¹åã
ã·ã°ãïŒSIGMAïŒç 究æ補ïŒããããªç¿ã®ãã®
åªäœäžã«èå±€ã®ããã«ããŠçšæããïŒâã§ååºã
ããã现èã¯37âã«ä¿æž©ãã0.275ïŒ å¯å€©æº¶æ¶²ãš
æ··ãåããããããæåã®å¯å€©å±€äžã«æµã蟌ãã§
ååºããããããã«çšããå¯å€©ã®æ¿åºŠã¯ãã¯ããŒ
ãã³ã°ã®å¹çãã³ãããŒã®å€§ããåã³åªäœã®åäž
æ§ã®äžè ãåæã«æé©åããç®çã§è¡ã€ãäºåè©Š
éšã®çµæããå®ãããææž©ã«ä¿ã€ãŠãã15æ¥åŸ
ã«ãèªåã³ãããŒèšæ°åšïŒâã¢ã«ããã¯âããã€ã
ããã¯ç€Ÿãç±³åœïŒãçšããŠã³ãããŒãèšæ°ããã
ã¯ããŒãã³ã°å¹çãå³ã¡å ç«æ¯çŽ åŠçã§çãæ®ã€
ã现èã®æ£ç¢ºãªæ°ã決å®ããã«ã¯ãæ¥çš®ããã现
èã®æ°ã圢æãããã³ãããŒã®æ°ã®é¢æ°ãšããŠè¡š
ãæ€éç·ãã€ããããšã倧åã§ãããçºæè çã¯
ãã®æ€éç·ããåŸãããã¯ããŒãã³ã°å¹çã¯ã现
èãå ç«æ¯çŽ åŠçããå Žåããã¿ãããããã«ã
æ»ãã 现èãé«ãå²åã§ãã€ãŠã圱é¿ãããªãã
ãšã蚌æããã å ç«æ¯çŽ åŠçã¯ã10ïŒ ã®äžæŽ»æ§ä»ãŠã·è¡æž ãš10
ããªmolã®å¡©åã¢ã³ã¢ããŠã ãå«ãRPMI1640åª
äœã®å šéïŒmlã«å¯ŸããŠããããç°ã€ãæ¿åºŠã®IT
ïŒïŒ¡âLaïŒT101åã³ITT101ã®å ç«æ¯çŽ ãçšãã
ææ°çã«æé·ããŠãã现èãä¿æž©ããããšã«ãã€
ãŠè¡ããä¿æž©ã¯ïŒïŒ ã®äºé žåççŽ ãå«ãé°å²æ°äž
ã§è©Šéšç®¡ãæ°Žå¹³æ¹åã«æ¯ãããšïŒããŠãŒãã«ã³ã¹
ãŠã€ãã¯ç€Ÿâãžã©ããªââïŒâæªæåšãçšããŠ
2500rpmã®ããŒã¹ïŒã«ãã€ãŠ37âã«ä¿ã€ããçå
现èã®æ°ãæ€éç·ã«ãã€ãŠæ倧æ床ç¯å²ã§æž¬å®ã§
ããããã«å¯å€©æº¶æ¶²ãšæ··åããåã«ã现èãæŽæµ
ããããããç°ã€ãåžéã«ããŠæºåãããçµæã¯
次ã®é¢ä¿åŒãçšããã¯ããŒãã³ã°å¹çããå€æ¿ã
ãŠçå现èã®çµ¶å¯Ÿæ°ã§è¡šãããçå现èã®çµ¶å¯Ÿæ°
ã¯æ¬¡åŒã§è¡šãããããÃïœïŒïŒ¥ãããã§ïŒ£ã¯ãã ãªç¿ïŒç¿åœãã®ã¯ããŒã³ã®æ°ãïœã¯çŽ°èã®åžéå
åãã¯æ€éç·ã®åŸé ããæ±ããããã¯ããŒãã³
ã°å¹çã§ãããããããã®å€ã¯ïŒåã®è©Šéšçµæã®
å¹³åããšã€ãã çµæ å³ïŒã¯å¡©åã¢ã³ã¢ããŠã 10ããªmolã®ååšäžã«
ãããCEM现èã«å¯ŸããITïŒïŒ¡âLaïŒT101åã³
ITT101å ç«æ¯çŽ ã®çŽ°èæ¯æ§æ²ç·ãå ç«æ¯çŽ ã®æ¿
床ïŒïŒ¡éã®ã¢ã«æ¿åºŠïŒã®é¢æ°ãšããŠè¡šããŠããã
ãããïŒã€ã®æ¯çŽ ã®å¹çã¯åããªãŒããŒã®å€§ãã
ã§ããããšã¯æããã§ããã现èæ°æžå°ã®åºŠåã¯
äž¡è ãšã倧ããããããã¯10-11ïŒçšåºŠã®äœãæ¿
床ã«ãããŠã¯æ®åçå现èã®å²åã¯åæå€ã«æ¯ã¹
ãŠ0.001ïŒ ã®ãªãŒããŒã«ãªã€ãŠããŸãããã§ããã
ãã®å¹æã¯é«åºŠã«ç¹ç°çã§ãããäœæ ãªãããã
ã®æ¿åºŠã«ãããŠã¯ã«ãããªã³ã°ãããŠããªãé
ãšéç¹ç°çãªå ç«æ¯çŽ ã¯ããããã®çŽ°èã«å¯ŸããŠ
å¹æããã€ãŠããªãããšã蚌æãããããã§ã
ãã æ¬å®æœäŸã«ãã€ãŠITïŒïŒ¡âLaïŒT101ã¯åŸæ¥ã®
ITT101ãšå®è³ªçã«åäžãªç¹ç°çŽ°èæ¯æ§ãæãã
ããšããããã å®æœäŸ 15 ãªã·ã³ã®é žåããå®èœåºãå°å ¥ããé
ïŒNEMïŒãšæŽ»æ§åããããžã¹ã«ãã€ãåºã§çœ®æ
ãã人éã®ïŒŽçŽ°èãé»å®³ããæäœïŒT62æåã«äœ
çšããæäœïŒãšã®æ±åäœãã«ãããªã³ã°ã¯æŽ»æ§å
ããããžã«ãã€ãåºãšïŒ¡éã®å®èœåºãå°å ¥ããã
ç³è³ªæ®åºã®éã§èµ·ããã ïŒ å ç«æ¯çŽ ã®æºå ïœ å®èœåºãå°å ¥ããéã®æºå éã®SHåºãâãšãã«ãã¬ã€ããã§ãã¹ã¯
ãã次ãã§å®æœäŸïŒã§èª¬æããæ¹æ³ãçšããŠ18æ
éãããŠé žåããã ã·ã¹ã¿ãã³ãšã®ã«ãããªã³ã° PH9.5ã®çé žç·©è¡æ¶²ã§éæããåŸãã¿ã³ãã¯è³ª
ãïŒmlåœã4.65mgå«ã溶液5.2mlãå¡©é žã·ã¹ã¿ã
ã³18mgãšå ±ã«25âã§ïŒæéä¿æž©ãããããããŠä¿
æž©ãããã®ãããŠæ°ŽçŽ åãããªãŠã ïŒïŒ¡éïŒã¢ã«
ã«ã€ã200çéå³ã¡0.1Næ°Žé žåãããªãŠã 溶液ïŒ
mlã«17.6mgã®ããŠæ°ŽçŽ åãããªãŠã ãå«ã溶液
156ÎŒïŒãçšãã25âã§ïŒæééå ããã éå°ã®è©Šè¬ã¯PHïŒã®ãªã³é žç·©è¡æ¶²125mMã§é£
ç¶éæããŠé€å»ãããåºå®ããã·ã¹ã¿ãã³ã®ãžã¹
ã«ãã€ãããªããžã30âã§ïŒæéåŸã«æ¿åºŠïŒïŒ ã«
ãªããããªïŒâã¡ã«ã«ãããšã¿ããŒã«ã§éå ãã
ãã®åŸããã«PHïŒã®125mMãªã³é žç·©è¡æ¶²ã§é£ç¶
éæïŒæ¯æ300mlã§å šé20ïŒãããéæåã³é
å¿åé¢åŸãé1molåœã0.25åã®SHåºããšã«ã
ã³æ³ã«ãã€ãŠå®éããã ïœ æäœã®æºåïŒå®æœäŸ11åç §ïŒ ïœ ã«ãããªã³ã°åå¿ ä¿®é£Ÿããããªã·ã³ïŒ¡éã®æº¶æ¶²1.5mlïŒïŒ¡éã¯
0.058ÎŒmolïŒãåèšïœïŒã§åŸããã掻æ§åæäœæº¶
液211ÎŒïŒæäœã¯0.006ÎŒmolïŒã«å ããããã®æ··
åç©ã30âã§18æéåå¿ãããã次ãã§ãã®åå¿
ç©ããªã³é žç·©è¡æ¶²ïŒãªã³é žå¡©10mMãå¡©åãããª
ãŠã 140mMã®å²åã§PH7.4ïŒã§éæãããé å¿å
é¢åŸãããªã¢ã¯ãªãã¢ããé»æ°æ³³åã«ããããšã
åŸãããå ç«æ¯çŽ ã¯å¹³åããŠæäœ1molåœãé
0.8åã®ã«ãããªã³ã°åºŠãæããããšãããã€ãã ïŒ å ç«æ¯çŽ ITïŒïŒ¡ïŒNEMïŒâLaâã·ã¹ãã¢ãã³ïŒ
T101ã®æ§è³ª ïœ ç¹ç°ç现èæ¯çŽ æŽ»æ§ åè¿°ã®æç¶ã§æºåããå ç«æ¯çŽ ã¯CEMæšç现
èã«å¯ŸããŠéåžžã«åŒ·åãªçŽ°èæ¯çŽ 掻æ§ïŒIC50ïŒ
1.2Ã10-11ãå®æœäŸ13ã§èª¬æãã枬å®æ³ã«ããïŒ
ãæããã ïœ è¡æŒ¿äžæ¿åºŠã®æžå° å ç«æ¯çŽ ããããã®è³ã®è¡ç®¡ã«äžå泚å°ããã
è¡æŒ¿ãµã³ãã«ã¯22æéåŸã«æ¡åããŠãRIAâïŒå
ç«æ€å®æ³ïŒå®æœäŸ12åç §ïŒã«ãã€ãŠåæãããçµ
æãäžè¡šã«ç€ºããIT101ã®å€ã¯çžå¯Ÿçãªå€ã§ç€ºã
ãŠããã
ãè¡šã
æäž22æéåŸã«ã修食ãããéãå«ãITã®
æ¿åºŠã¯ITT101ã®30åãã€ãã å®æœäŸ 16 ã¡ãã«åãããé žåãããå®èœåºãå°å ¥ããã
ãªã·ã³ïŒ¡éïŒNEMïŒãšäººéã®ïŒŽçŽ°èãé»å®³ãã
æäœïŒT65æåã«å¯ŸããæäœïŒã®æ±åäœãã«ãã
ãªã³ã°ã¯æŽ»æ§åããããžã¹ã«ãã€ãåºãšïŒ¡éã®ä¿®
食ãããç³è³ªæ®åºã®éã§èµ·ããã ïŒ å ç«æ¯çŽ ã®æºå ïœ å®èœåºãå°å ¥ããéã®æºå éã®SHåºãâãšãã«ãã¬ã€ããã§ãã¹ã¯
ãã次ãã§å®æœäŸïŒã§èª¬æããæ¹æ³ãçšããŠ18æ
éãããŠã¡ãã«åãšé žåãè¡ã€ãã ã·ã¹ããã³ãšã®ã«ãããªã³ã° PH9.5ã®0.1Mçé žç·©è¡æ¶²ã§éæããåŸãã¿ã³ã
ã¯è³ªãïŒmlåœã4.65mgå«ã溶液18.5mlãå¡©é žã·ã¹
ããã³35.6mgãšå ±ã«25âã§ïŒæéä¿æž©ããããã
ããŠä¿æž©ãããã®ãããŠæ°ŽçŽ åãããªãŠã ïŒïŒ¡é
ïŒã¢ã«ã«ã€ãã200çéå³ã¡0.1Næ°Žé žåãããªãŠ
ã 溶液ïŒmlã«17.6mgã®ããŠæ°ŽçŽ åãããªãŠã ãå«
ã溶液395ÎŒïŒãçšã25âã§ïŒæééå ããã éå°ã®è©Šè¬ã¯PHïŒã®ãªã³é žç·©è¡æ¶²125mMã§é£
ç¶éæããŠé€å»ãããåºå®ããã·ã¹ããã³ã®ãžã¹
ã«ãã€ãããªããžã30âã§ïŒæéåŸã«æ¿åºŠïŒïŒ ã«
ãªããããªïŒâã¡ã«ã«ãããšã¿ããŒã«ã§éå ãã
ãã®åŸããã«PHïŒã®125mMãªã³é žç·©è¡æ¶²ã§é£ç¶
éæïŒæ¯æ300mlã§å šé20ïŒãããéæåã³é
å¿åé¢åŸïŒ¡é1molåœã0.32åã®SHåºããšã«ãã³
æ³ã«ãã€ãŠå®éããã ïœ ä¿®é£Ÿãããæäœã®æºå ãšãã«ã¢ã«ã³ãŒã«äžã«ïŒ®âãµã¯ã·ãããã€ã«â
ïŒâããªãžãã«âïŒâãžããªããããªããŒã2.12
mgãå«ã溶液ãT101æäœãïŒmlåœã4.4mgå«ã溶
液23.5mlïŒæäœã¯0.68ÎŒmolã«ãªãïŒã«å ãããæ··
åç©ã30åé25âã§æªæãã次ãã§PHïŒã®
125mMãªã³é žç·©è¡æ¶²ã§éæããããã®åŸã¿ã³ã
ã¯è³ªæº¶æ¶²ãé å¿åé¢ã«ããã修食ãããæäœãïŒ
mlåœã4.2mgå«ã溶液23.5mlãåŸãã ïŒâã¡ã«ã«ãããšã¿ããŒã«ãšã®äº€æåå¿ã«ãã€
ãŠæŸåºãããããªãžã³âïŒâããªã³ã®343nmã«ã
ããŠåå åæãããšãããåŸãããæäœã¯ïŒã¢ã«
åœã3.2åã®æŽ»æ§åãããæ··åãžã¹ã«ãã€ãåºã
æããŠããããšãããã€ãã ïœ ã«ãããªã³ã°åå¿ ä¿®é£Ÿããããªã·ã³ïŒ¡éã®æº¶æ¶²7.3mlïŒïŒ¡éã¯
0.275ÎŒmolïŒãåèšïœïŒã§åŸããã掻æ§åæäœæº¶
液781ÎŒïŒæäœ0.022ÎŒmolïŒã«å ããããã®æ··å
ç©ã30âã§18æéåå¿ãããã次ãã§ãã®åå¿ç©
ããªã³é žç·©è¡æ¶²ïŒãªã³é žå¡©10mMãå¡©åãããªãŠ
ã 120mMã®å²åã§PH7.4ïŒã§éæããã é å¿åé¢åŸãããªã¢ã¯ãªãã¢ããé»æ°æ³³åã«ã
ãããšåŸãããå ç«æ¯çŽ ã¯å¹³åããŠæäœ1molåœ
ãé žåããã¡ãã«åãããéïŒNEMïŒ0.8åã®
ã«ãããªã³ã°åºŠãæããããšãããã€ãã äžè¿°ã®æ¹æ³ã§åŸãã¡ãã«åããé žåããããªã·
ã³ïŒ¡éïŒNEMïŒãå«ãå ç«æ¯çŽ ã®è¬ç©åæ åŠç
ç¹æ§ãšæšç现èã«å¯Ÿããç¹ç°ç现èæ¯æ§ã調ã¹
ãã ïŒ ITïŒã¡ãã«åïŒNEMïŒâLaâã·ã¹ã¿ã¢ãã³ïŒ
T101å ç«æ¯çŽ ã®ç¹æ§ ïœ ç¹ç°ç现èæ¯çŽ æŽ»æ§ åè¿°ã®æç¶ã§æºåããå ç«æ¯çŽ ã¯CEMæšç现
èã«å¯ŸããŠéåžžã«åŒ·åãªçŽ°èæ¯çŽ 掻æ§ïŒIC50ïŒïŒ
Ã10-12ãå®æœäŸ13ã§èª¬æãã枬å®æ³ã«ããïŒã
æããã ïœ è¡æŒ¿äžæ¿åºŠã®æžå° å ç«æ¯çŽ ããããã®è³ã®è¡ç®¡ã«äžå泚å°ããã
è¡æŒ¿ãµã³ãã«ã¯22æéåŸã«æ¡åããŠãRIAâïŒå
ç«æ€å®æ³ïŒå®æœäŸ12åç §ïŒã«ãã€ãŠåæãããçµ
æãäžè¡šã«ç€ºããIT101ã®å€ã¯çžå¯Ÿçãªå€ã§ç€ºã
ãŠããã
æ¿åºŠã¯ITT101ã®30åãã€ãã å®æœäŸ 16 ã¡ãã«åãããé žåãããå®èœåºãå°å ¥ããã
ãªã·ã³ïŒ¡éïŒNEMïŒãšäººéã®ïŒŽçŽ°èãé»å®³ãã
æäœïŒT65æåã«å¯ŸããæäœïŒã®æ±åäœãã«ãã
ãªã³ã°ã¯æŽ»æ§åããããžã¹ã«ãã€ãåºãšïŒ¡éã®ä¿®
食ãããç³è³ªæ®åºã®éã§èµ·ããã ïŒ å ç«æ¯çŽ ã®æºå ïœ å®èœåºãå°å ¥ããéã®æºå éã®SHåºãâãšãã«ãã¬ã€ããã§ãã¹ã¯
ãã次ãã§å®æœäŸïŒã§èª¬æããæ¹æ³ãçšããŠ18æ
éãããŠã¡ãã«åãšé žåãè¡ã€ãã ã·ã¹ããã³ãšã®ã«ãããªã³ã° PH9.5ã®0.1Mçé žç·©è¡æ¶²ã§éæããåŸãã¿ã³ã
ã¯è³ªãïŒmlåœã4.65mgå«ã溶液18.5mlãå¡©é žã·ã¹
ããã³35.6mgãšå ±ã«25âã§ïŒæéä¿æž©ããããã
ããŠä¿æž©ãããã®ãããŠæ°ŽçŽ åãããªãŠã ïŒïŒ¡é
ïŒã¢ã«ã«ã€ãã200çéå³ã¡0.1Næ°Žé žåãããªãŠ
ã 溶液ïŒmlã«17.6mgã®ããŠæ°ŽçŽ åãããªãŠã ãå«
ã溶液395ÎŒïŒãçšã25âã§ïŒæééå ããã éå°ã®è©Šè¬ã¯PHïŒã®ãªã³é žç·©è¡æ¶²125mMã§é£
ç¶éæããŠé€å»ãããåºå®ããã·ã¹ããã³ã®ãžã¹
ã«ãã€ãããªããžã30âã§ïŒæéåŸã«æ¿åºŠïŒïŒ ã«
ãªããããªïŒâã¡ã«ã«ãããšã¿ããŒã«ã§éå ãã
ãã®åŸããã«PHïŒã®125mMãªã³é žç·©è¡æ¶²ã§é£ç¶
éæïŒæ¯æ300mlã§å šé20ïŒãããéæåã³é
å¿åé¢åŸïŒ¡é1molåœã0.32åã®SHåºããšã«ãã³
æ³ã«ãã€ãŠå®éããã ïœ ä¿®é£Ÿãããæäœã®æºå ãšãã«ã¢ã«ã³ãŒã«äžã«ïŒ®âãµã¯ã·ãããã€ã«â
ïŒâããªãžãã«âïŒâãžããªããããªããŒã2.12
mgãå«ã溶液ãT101æäœãïŒmlåœã4.4mgå«ã溶
液23.5mlïŒæäœã¯0.68ÎŒmolã«ãªãïŒã«å ãããæ··
åç©ã30åé25âã§æªæãã次ãã§PHïŒã®
125mMãªã³é žç·©è¡æ¶²ã§éæããããã®åŸã¿ã³ã
ã¯è³ªæº¶æ¶²ãé å¿åé¢ã«ããã修食ãããæäœãïŒ
mlåœã4.2mgå«ã溶液23.5mlãåŸãã ïŒâã¡ã«ã«ãããšã¿ããŒã«ãšã®äº€æåå¿ã«ãã€
ãŠæŸåºãããããªãžã³âïŒâããªã³ã®343nmã«ã
ããŠåå åæãããšãããåŸãããæäœã¯ïŒã¢ã«
åœã3.2åã®æŽ»æ§åãããæ··åãžã¹ã«ãã€ãåºã
æããŠããããšãããã€ãã ïœ ã«ãããªã³ã°åå¿ ä¿®é£Ÿããããªã·ã³ïŒ¡éã®æº¶æ¶²7.3mlïŒïŒ¡éã¯
0.275ÎŒmolïŒãåèšïœïŒã§åŸããã掻æ§åæäœæº¶
液781ÎŒïŒæäœ0.022ÎŒmolïŒã«å ããããã®æ··å
ç©ã30âã§18æéåå¿ãããã次ãã§ãã®åå¿ç©
ããªã³é žç·©è¡æ¶²ïŒãªã³é žå¡©10mMãå¡©åãããªãŠ
ã 120mMã®å²åã§PH7.4ïŒã§éæããã é å¿åé¢åŸãããªã¢ã¯ãªãã¢ããé»æ°æ³³åã«ã
ãããšåŸãããå ç«æ¯çŽ ã¯å¹³åããŠæäœ1molåœ
ãé žåããã¡ãã«åãããéïŒNEMïŒ0.8åã®
ã«ãããªã³ã°åºŠãæããããšãããã€ãã äžè¿°ã®æ¹æ³ã§åŸãã¡ãã«åããé žåããããªã·
ã³ïŒ¡éïŒNEMïŒãå«ãå ç«æ¯çŽ ã®è¬ç©åæ åŠç
ç¹æ§ãšæšç现èã«å¯Ÿããç¹ç°ç现èæ¯æ§ã調ã¹
ãã ïŒ ITïŒã¡ãã«åïŒNEMïŒâLaâã·ã¹ã¿ã¢ãã³ïŒ
T101å ç«æ¯çŽ ã®ç¹æ§ ïœ ç¹ç°ç现èæ¯çŽ æŽ»æ§ åè¿°ã®æç¶ã§æºåããå ç«æ¯çŽ ã¯CEMæšç现
èã«å¯ŸããŠéåžžã«åŒ·åãªçŽ°èæ¯çŽ 掻æ§ïŒIC50ïŒïŒ
Ã10-12ãå®æœäŸ13ã§èª¬æãã枬å®æ³ã«ããïŒã
æããã ïœ è¡æŒ¿äžæ¿åºŠã®æžå° å ç«æ¯çŽ ããããã®è³ã®è¡ç®¡ã«äžå泚å°ããã
è¡æŒ¿ãµã³ãã«ã¯22æéåŸã«æ¡åããŠãRIAâïŒå
ç«æ€å®æ³ïŒå®æœäŸ12åç §ïŒã«ãã€ãŠåæãããçµ
æãäžè¡šã«ç€ºããIT101ã®å€ã¯çžå¯Ÿçãªå€ã§ç€ºã
ãŠããã
ãè¡šã
æäž22æéåŸã«ã修食ãããéãå«ãITã®
æ¿åºŠã¯ITT101ã®17.5åãã€ãã å®æœäŸ 17 é žåãããéã®åç©ã®äœå šäœãžã®æ¯ç©åŠçç¹
æ§ïŒå ç«æ¯çŽ ã®æ¯æ§ã¯çã¢ã«éã«ãããéãšå
ããªãŒããŒã®å€§ããã§ããïŒã調ã¹ãããšã¯éèŠ
ã§ãããããã¯ãã€ãŒã«ãºãªããŒãã©ã³ã¹CD1ã
ãŠã¹ã«éè泚å°ãããé žåéã®åæ°èŽæ»éãç
ã®ïŒ¡éãšã®æ¯èŒã«ãããŠæ±ºå®ããããšã«ãã€ãŠè¡
ãããã ãã®çµæãäžè¡šã«ç€ºãã
æ¿åºŠã¯ITT101ã®17.5åãã€ãã å®æœäŸ 17 é žåãããéã®åç©ã®äœå šäœãžã®æ¯ç©åŠçç¹
æ§ïŒå ç«æ¯çŽ ã®æ¯æ§ã¯çã¢ã«éã«ãããéãšå
ããªãŒããŒã®å€§ããã§ããïŒã調ã¹ãããšã¯éèŠ
ã§ãããããã¯ãã€ãŒã«ãºãªããŒãã©ã³ã¹CD1ã
ãŠã¹ã«éè泚å°ãããé žåéã®åæ°èŽæ»éãç
ã®ïŒ¡éãšã®æ¯èŒã«ãããŠæ±ºå®ããããšã«ãã€ãŠè¡
ãããã ãã®çµæãäžè¡šã«ç€ºãã
ãè¡šã
äžã®çµæã¯é
žåãããéã®æ¯æ§ã¯çã®ïŒ¡éã
ãäœãããšã瀺ããŠãããããã¯ïŒ¡éãé žåã«ã
ã€ãŠä¿®é£ŸããããšïŒ¡éã®è¡æŒ¿äžæ¿åºŠã¯èããå¢å
ããããã©ãããã®æ¯æ§ã¯å¢å ããã©ããããå
察ã«ããªãæžå°ããããšãæå³ããŠããã åŸã€ãŠä¿®é£Ÿããã现èæ¯æ§ãµããŠããããå ã
å ç«æ¯çŽ ã¯äººéã®æ²»çè¬ãšããŠäœ¿ããããããã®
修食ãããå ç«æ¯çŽ ã¯ãæšç现èãå ç«æ¯çŽ ãæº
åããã®ã«çšããããæäœã«ãã€ãŠèå¥ãããã
ããªã¬ã³ãŸãã¯ã¬ã³ã§ãªãç æ°ã®æ²»çã«çšããã
ããæé©ãªæäžéãšæ²»çæéã¯åé¡ã®ç æ°ã«ãã
ã€ãæ£è ãšãã®ç æ°ã®ç¹è³ªã«å¿ããŠå®ããããã¹
ãã§ããã ããäžè¬çãªèšèã§ããã°ãç³è³ªåäœãéãšãŠ
çŽ ã€ãªã³ã«ãã€ãŠä¿®é£Ÿããã察å¿ãã修食ã®ãªã
æè «çç³ã¿ã³ãã¯è³ªãããåæžæã®é·ãæè «çç³
ã¿ã³ãã¯è³ªã¯è¬ãšããŠæçšã ãšããããšã§ããã åŸã€ãŠããäžã€ã®ç¹åŸŽã«ããã°ãæ¬çºæã¯ç³è³ª
åäœãéãšãŠçŽ é žã€ãªã³ã®é žåã«ãã€ãŠä¿®é£Ÿãã
ãŠããæè «çç³ã¿ã³ãã¯è³ªã泚å°å¥œãŸããã¯éè
泚å°ã«é©ããŠåœ¢æ ã«ãªã€ãŠããæè «çè¬ã«é¢ã
ãã
ãäœãããšã瀺ããŠãããããã¯ïŒ¡éãé žåã«ã
ã€ãŠä¿®é£ŸããããšïŒ¡éã®è¡æŒ¿äžæ¿åºŠã¯èããå¢å
ããããã©ãããã®æ¯æ§ã¯å¢å ããã©ããããå
察ã«ããªãæžå°ããããšãæå³ããŠããã åŸã€ãŠä¿®é£Ÿããã现èæ¯æ§ãµããŠããããå ã
å ç«æ¯çŽ ã¯äººéã®æ²»çè¬ãšããŠäœ¿ããããããã®
修食ãããå ç«æ¯çŽ ã¯ãæšç现èãå ç«æ¯çŽ ãæº
åããã®ã«çšããããæäœã«ãã€ãŠèå¥ãããã
ããªã¬ã³ãŸãã¯ã¬ã³ã§ãªãç æ°ã®æ²»çã«çšããã
ããæé©ãªæäžéãšæ²»çæéã¯åé¡ã®ç æ°ã«ãã
ã€ãæ£è ãšãã®ç æ°ã®ç¹è³ªã«å¿ããŠå®ããããã¹
ãã§ããã ããäžè¬çãªèšèã§ããã°ãç³è³ªåäœãéãšãŠ
çŽ ã€ãªã³ã«ãã€ãŠä¿®é£Ÿããã察å¿ãã修食ã®ãªã
æè «çç³ã¿ã³ãã¯è³ªãããåæžæã®é·ãæè «çç³
ã¿ã³ãã¯è³ªã¯è¬ãšããŠæçšã ãšããããšã§ããã åŸã€ãŠããäžã€ã®ç¹åŸŽã«ããã°ãæ¬çºæã¯ç³è³ª
åäœãéãšãŠçŽ é žã€ãªã³ã®é žåã«ãã€ãŠä¿®é£Ÿãã
ãŠããæè «çç³ã¿ã³ãã¯è³ªã泚å°å¥œãŸããã¯éè
泚å°ã«é©ããŠåœ¢æ ã«ãªã€ãŠããæè «çè¬ã«é¢ã
ãã
第ïŒå³ãªãã第ïŒå³ã¯æ¬çºæã®ç³ã¿ã³ãã¯è³ªã®
ç¹æ§ã瀺ãç·å³ã§ããã
ç¹æ§ã瀺ãç·å³ã§ããã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ ç³éåäœãéãšãŠçŽ é žã€ãªã³ã«ããé žåã«ã
ã€ãŠä¿®é£ŸãããŠãããæè «çäœçšãæããç³ã¿ã³
ãã¯ã ïŒ ãªããœãŒã ãäžæŽ»åããç³ã¿ã³ãã¯ã§ãã€
ãŠããã®ç³éåäœãéãšãŠçŽ é žã€ãªã³ã«ããé žå
ã«ãã€ãŠä¿®é£ŸãããŠããããªããœãŒã ãäžæŽ»åã
ãæªä¿®é£Ÿç³ã¿ã³ãã¯ãšå®è³ªã«åäžã®æŽ»æ§ãæãã
ã€ãããããé·ã掻æ§åæžæãæããç³ã¿ã³ã
ã¯ã ïŒ ãªããœãŒã ãäžæŽ»åãã延é·ãããäœçšãæ
ããç³ã¿ã³ãã¯ã§ãã€ãŠãåœè©²ããªãŒã«åºãå Žå
ã«å¿ããŠä¿è·ãããŠããç³ã¿ã³ãã¯ã®æ°Žæº¶æ¶²ãé
ãšãŠçŽ é žã¢ã«ã«ãªéå±ã®æ°Žæº¶æ¶²ã§ãå ã®äžååšäž
ã«ãïŒâãªãã15âã®æž©åºŠã§0.2ãªãã24æéåŠ
çããå Žåã«å¿ããŠããªãŒã«åºã®ä¿è·åºãé€å»
ããããã³åŸãããçæç©ãåé¢ããããšã«ãã€
ãŠåŸãããç³ã¿ã³ãã¯ã ïŒ ç³ã¿ã³ãã¯ã®æ°Žæº¶æ¶²ããªã·ã³ã®ïŒ¡éã®æ°Žæº¶æ¶²
ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ç³ã¿ã³ãã¯ã ïŒ ãªã·ã³ã®ïŒ¡éãæå¿åãããŠããç¹èš±è«æ±ã®
ç¯å²ç¬¬ïŒé èšèŒã®ç³ã¿ã³ãã¯ã ïŒ ãªã·ã³ã®ïŒ¡éãã¡ãã«åã«ãã€ãŠæå¿åãã
ãŠããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ç³ã¿ã³ãã¯ã ïŒ ç³ã¿ã³ãã¯ã®æ°Žæº¶æ¶²ãã²ããã³ã®æ°Žæº¶æ¶²ã§ã
ãç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ç³ã¿ã³ãã¯ã ïŒ ç³ã¿ã³ãã¯ã®æ°Žæº¶æ¶²ãGPIR MOMã®æ°Žæº¶æ¶²
ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ç³ã¿ã³ãã¯ã ïŒ ç³ã¿ã³ãã¯ã®æ°Žæº¶æ¶²ãGPIRãžã¢ã³ãã³30ã®
氎溶液ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ç³ã¿ã³
ãã¯ã ïŒïŒ ç³ã¿ã³ãã¯ã®æ°Žæº¶æ¶²ãããžã¢ã³ãã³32ãã¢
ã°ãã¹ãã³ïŒ¡ãã¢ã°ãã¹ãã³ïŒ¢ãHCIãŸãã¯ã¢ã¹
ãã©ã¬ã¹ã»ãªãã€ã·ããªã¹ç±æ¥é»å®³å€ã®æ°Žæº¶æ¶²ã§
ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ç³ã¿ã³ãã¯ã ïŒïŒ çã®ãªã·ã³ãããã¯çã®ãªã·ã³ã®ïŒ¡éæç
ã§ãããªã·ã³ïŒ¡éããããŸãã¯éºäŒåã修食ãã
ã现èã«ãã€ãŠçåæããããªã·ã³ïŒ¡éãããã¯
ãã®æçãã補é ãããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èš
èŒã®ç³ã¿ã³ãã¯ã ïŒïŒ å°ãªããšãïŒã€ã®ããªãŒã«åºãïŒïŒ2â²âãž
ãããâïŒïŒ5â²âãžããªãžãã³ãŸãšãŒããšã®åå¿
ã«ããä¿è·ãããŠãããªã·ã³ïŒ¡éã®æ°Žæº¶æ¶²ãéãš
ãŠçŽ é žãããªãŠã ã®æ°Žæº¶æ¶²ã§ãå ã®äžååšäžã«ã
çŽïŒâã®æž©åºŠã§0.2ãªãã24æéåŠçããã€ãã§
ïŒâã¡ã«ã«ãããšã¿ããŒã«ã§åŠçããåŸãããç
æç©ãåé¢ããããšã«ãã€ãŠåŸãããç¹èš±è«æ±ã®
ç¯å²ç¬¬ïŒïŒé èšèŒã®ç³ã¿ã³ãã¯ã ïŒïŒ ã²ããã³ã®æ°Žæº¶æ¶²ãéãšãŠçŽ é žãããªãŠã
ã®æ°Žæº¶æ¶²ã§ãå ã®äžååšäžã«ãçŽïŒâã®æž©åºŠã§
0.2ãªãã24æéåŠçããã€ãã§ïŒâã¡ã«ã«ãã
ãšã¿ããŒã«ã§åŠçããåŸãããçæç©ãåé¢ãã
ããšã«ãã€ãŠåŸããã®ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒ
é èšèŒã®ç³ã¿ã³ãã¯ã ïŒïŒ æªä¿®é£Ÿã®ãæè «çæ§ç³ã¿ã³ãã¯ãéãšãŠçŽ
é žã€ãªã³ã«ããé žååŠçã«äŸããããšãç¹åŸŽãšã
ãæè «çäœçšãæããç³ã¿ã³ãã¯ã®è£œé æ¹æ³ã ïŒïŒ ãªããœãŒã ãäžæŽ»åãã延é·ãããäœçšã
æããç³ã¿ã³ãã¯ã®è£œé æ¹æ³ã§ãã€ãŠãåœè©²ããª
ãŒã«åºãå Žåã«å¿ããŠä¿è·ãããŠããç³ã¿ã³ãã¯
ã®æ°Žæº¶æ¶²ãéãšãŠçŽ é žã¢ã«ã«ãªéå±ã®æ°Žæº¶æ¶²ã§ã
å ã®äžååšäžã«ãïŒâãªãã15âã®æž©åºŠã§0.2ãª
ãã24æéåŠçããå Žåã«å¿ããŠããªãŒã«åºã®ä¿
è·åºãé€å»ããããã³åŸãããçæç©ãåé¢ãã
ããšãç¹åŸŽãšãã補é æ¹æ³ã ïŒïŒ åºçºç³ã¿ã³ãã¯ãçã®ãªã·ã³ãããã¯çã®
ãªã·ã³ã®ïŒ¡éæçã§ãããªã·ã³ïŒ¡éããŸãã¯éºäŒ
åã修食ããã现èã«ãã€ãŠçåæããããªã·ã³
éãããã¯ãã®æçã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒ
ïŒé èšèŒã®è£œé æ¹æ³ã
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8409703 | 1984-06-20 | ||
FR8409703A FR2566271B1 (fr) | 1984-06-20 | 1984-06-20 | Nouveaux conjugues cytotoxiques utilisables en therapeutique et procede d'obtention |
FR8502067 | 1985-02-13 | ||
FR8502067A FR2577137B1 (fr) | 1985-02-13 | 1985-02-13 | Glycoproteines antitumorales, modifiees sur leurs motifs glucidiques |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS6112628A JPS6112628A (ja) | 1986-01-21 |
JPH0582400B2 true JPH0582400B2 (ja) | 1993-11-18 |
Family
ID=26224020
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP60135217A Granted JPS6112628A (ja) | 1984-06-20 | 1985-06-20 | æè «çäœçšãæããç³ã¿ã³ãã¯ããã³ãã®è£œé æ¹æ³ |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0172045B1 (ja) |
JP (1) | JPS6112628A (ja) |
KR (1) | KR930000058B1 (ja) |
AT (1) | ATE40700T1 (ja) |
AU (1) | AU593211B2 (ja) |
CA (1) | CA1248874A (ja) |
DE (1) | DE3568167D1 (ja) |
DK (1) | DK166626B1 (ja) |
ES (1) | ES8605681A1 (ja) |
GR (1) | GR851497B (ja) |
IE (1) | IE58514B1 (ja) |
IL (1) | IL75484A0 (ja) |
NZ (1) | NZ212439A (ja) |
PT (1) | PT80662B (ja) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2577135B1 (fr) * | 1985-02-13 | 1989-12-15 | Sanofi Sa | Immunotoxines a longue duree d'action comportant un constituant glycopeptidique inactivant les ribosomes modifie sur ses motifs polysaccharidiques |
IL80973A (en) * | 1985-12-20 | 1992-08-18 | Sanofi Sa | Modified ribosome-inactivating glycoproteins,their preparation,immunotoxins containing them and pharmaceutical compositions containing such immunotoxins |
FR2602682B1 (fr) * | 1986-08-12 | 1988-12-02 | Sanofi Sa | Immunotoxines a longue duree d'action in vivo comportant une glycoproteine inhibant les ribosomes, modifiee par oxydation des motifs osidiques et formation d'une base de schiff |
FR2601679B1 (fr) * | 1986-07-15 | 1990-05-25 | Sanofi Sa | Immunotoxines, procede de preparation et compositions pharmaceutiques en contenant |
DE4106389A1 (de) * | 1991-02-28 | 1992-09-03 | Behringwerke Ag | Fusionsproteine zur prodrug-aktivierung, ihre herstellung und verwendung |
US6610299B1 (en) | 1989-10-19 | 2003-08-26 | Aventis Pharma Deutschland Gmbh | Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates |
US6475486B1 (en) | 1990-10-18 | 2002-11-05 | Aventis Pharma Deutschland Gmbh | Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates |
US7241595B2 (en) | 1989-10-20 | 2007-07-10 | Sanofi-Aventis Pharma Deutschland Gmbh | Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates |
US5250532A (en) * | 1991-04-11 | 1993-10-05 | Dowelanco | 3,4,N-trisubstituted-4,5-dihydro-1H-pyrazole-1-carboxamides and their use as insecticides |
GB9808485D0 (en) * | 1998-04-21 | 1998-06-17 | Univ Cambridge Tech | Improvements relating to immunotherapy |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL47372A (en) * | 1975-05-27 | 1979-10-31 | Yeda Res & Dev | Fab'dimers bound to daunomycin or adriamycin,their preparation and pharmaceutical compositions containing same |
FR2437213A1 (fr) * | 1978-09-28 | 1980-04-25 | Cm Ind | Produits cytotoxiques formes par liaison covalente de la chaine a de la ricine avec un anticorps et leur procede de preparation |
JPS5616418A (en) * | 1979-07-20 | 1981-02-17 | Teijin Ltd | Antitumor protein complex and its preparation |
JPS5843926A (ja) * | 1981-09-08 | 1983-03-14 | Suntory Ltd | éžææ§å¶çå€ |
-
1985
- 1985-06-09 PT PT80662A patent/PT80662B/pt not_active IP Right Cessation
- 1985-06-11 IL IL75484A patent/IL75484A0/xx not_active IP Right Cessation
- 1985-06-13 AU AU43646/85A patent/AU593211B2/en not_active Ceased
- 1985-06-13 CA CA000483940A patent/CA1248874A/en not_active Expired
- 1985-06-17 NZ NZ212439A patent/NZ212439A/xx unknown
- 1985-06-18 IE IE151185A patent/IE58514B1/en not_active IP Right Cessation
- 1985-06-18 DE DE8585401201T patent/DE3568167D1/de not_active Expired
- 1985-06-18 AT AT85401201T patent/ATE40700T1/de not_active IP Right Cessation
- 1985-06-18 EP EP85401201A patent/EP0172045B1/fr not_active Expired
- 1985-06-19 KR KR1019850004354A patent/KR930000058B1/ko not_active IP Right Cessation
- 1985-06-19 DK DK277985A patent/DK166626B1/da not_active IP Right Cessation
- 1985-06-19 GR GR851497A patent/GR851497B/el unknown
- 1985-06-19 ES ES544337A patent/ES8605681A1/es not_active Expired
- 1985-06-20 JP JP60135217A patent/JPS6112628A/ja active Granted
Also Published As
Publication number | Publication date |
---|---|
IL75484A0 (en) | 1985-10-31 |
EP0172045A1 (fr) | 1986-02-19 |
IE58514B1 (en) | 1993-10-06 |
AU593211B2 (en) | 1990-02-08 |
AU4364685A (en) | 1986-01-02 |
IE851511L (en) | 1985-12-20 |
DK277985D0 (da) | 1985-06-19 |
ES8605681A1 (es) | 1986-04-01 |
ES544337A0 (es) | 1986-04-01 |
GR851497B (ja) | 1985-11-25 |
PT80662B (en) | 1986-12-09 |
KR930000058B1 (ko) | 1993-01-06 |
KR860000315A (ko) | 1986-01-28 |
ATE40700T1 (de) | 1989-02-15 |
JPS6112628A (ja) | 1986-01-21 |
DE3568167D1 (en) | 1989-03-16 |
PT80662A (en) | 1985-07-01 |
NZ212439A (en) | 1989-01-27 |
DK166626B1 (da) | 1993-06-21 |
CA1248874A (en) | 1989-01-17 |
EP0172045B1 (fr) | 1989-02-08 |
DK277985A (da) | 1985-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2034324A (en) | Cytotoxic products formed by covalent bonding of the a chain of ricin with an antibody and the process for their preparation and use | |
EP0044167A2 (en) | Antibody targeted cytotoxic agent | |
HU189246B (en) | Process for preparing conjugates of an enzyme and an antobody formed by covalents bonds | |
US5024834A (en) | Thioether linked immunotoxin conjugates | |
JP3273608B2 (ja) | æ²»çè¬ã®éšäœç¹ç°çã€ã³ãã掻æ§å | |
JPH0582400B2 (ja) | ||
KR930003333B1 (ko) | íìí묌 ëšìê° ë³íë 늬볎ìì ë¹íì±íìí€ë ë¹ëšë°±ì§ ì±ë¶ì íšì íë ì§ì-ìì©ì± ë©Žìë ìì ì ì¡°ë°©ë² | |
US5104976A (en) | Ribosome-inactivating glycoproteins, modified by oxidation of their osidic units and formation of a schiff's base and in-vivo prolonged action immunotoxins containing such a glycoprotein | |
US4582703A (en) | Cytotoxic medicament formed from the association of at least one immunotoxin and chloroquin | |
US4919928A (en) | Conjugates in which a monovalent carboxylic ionophore is associated by means of a covalent bond with a macromolecule, their use as immunotoxin potentiators and the intermediate activated ionophores | |
US4911912A (en) | Ribosome-inactivating glycoproteins, modified by oxidation of their osidic units and reduction, and in vivo prolonged-action immunotoxins containing such a glycoprotein | |
JPH04266829A (ja) | å ç«çµåäœã圢æããããã®æäœã®ååŠä¿®é£Ÿ | |
US5185434A (en) | Prolonged-action immunotoxins containing a glycopeptide constituent which inactivates ribosomes, modified on its polysaccharide units | |
US4397843A (en) | Mannose-6-phosphate-low density protein reagent effective against hypercholesterolemia | |
EP0261225B1 (en) | Lectin complex and method and probe for making same | |
JPS6156198A (ja) | ã€ãªãããªã¢ãšé«ååãšãã«ãããªã³ã°ãããå åäœããã³ãã®äœ¿çšæ³ |